Nothing Special   »   [go: up one dir, main page]

WO2020162021A1 - Drug supply device - Google Patents

Drug supply device Download PDF

Info

Publication number
WO2020162021A1
WO2020162021A1 PCT/JP2019/047822 JP2019047822W WO2020162021A1 WO 2020162021 A1 WO2020162021 A1 WO 2020162021A1 JP 2019047822 W JP2019047822 W JP 2019047822W WO 2020162021 A1 WO2020162021 A1 WO 2020162021A1
Authority
WO
WIPO (PCT)
Prior art keywords
drug
medicine
unit
control unit
detection
Prior art date
Application number
PCT/JP2019/047822
Other languages
French (fr)
Japanese (ja)
Inventor
弘史 和田
Original Assignee
株式会社タカゾノ
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by 株式会社タカゾノ filed Critical 株式会社タカゾノ
Publication of WO2020162021A1 publication Critical patent/WO2020162021A1/en

Links

Images

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61J—CONTAINERS SPECIALLY ADAPTED FOR MEDICAL OR PHARMACEUTICAL PURPOSES; DEVICES OR METHODS SPECIALLY ADAPTED FOR BRINGING PHARMACEUTICAL PRODUCTS INTO PARTICULAR PHYSICAL OR ADMINISTERING FORMS; DEVICES FOR ADMINISTERING FOOD OR MEDICINES ORALLY; BABY COMFORTERS; DEVICES FOR RECEIVING SPITTLE
    • A61J3/00—Devices or methods specially adapted for bringing pharmaceutical products into particular physical or administering forms
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61J—CONTAINERS SPECIALLY ADAPTED FOR MEDICAL OR PHARMACEUTICAL PURPOSES; DEVICES OR METHODS SPECIALLY ADAPTED FOR BRINGING PHARMACEUTICAL PRODUCTS INTO PARTICULAR PHYSICAL OR ADMINISTERING FORMS; DEVICES FOR ADMINISTERING FOOD OR MEDICINES ORALLY; BABY COMFORTERS; DEVICES FOR RECEIVING SPITTLE
    • A61J3/00—Devices or methods specially adapted for bringing pharmaceutical products into particular physical or administering forms
    • A61J3/06—Devices or methods specially adapted for bringing pharmaceutical products into particular physical or administering forms into the form of pills, lozenges or dragees

Definitions

  • the present invention relates to a drug supply device.
  • Patent Document 1 As a prior document disclosing the configuration of the drug supply device, there is International Publication No. 2016/013553 (Patent Document 1).
  • the drug supply device described in Patent Document 1 includes a drug delivery unit including a first rotating body, a second rotating body, and a guide member.
  • the first rotating body has a circular surface that is rotatably arranged in a state of being inclined with respect to the horizontal plane.
  • the second rotating body is rotatably arranged on the outer peripheral side of the first rotating body and has an annular surface arranged on the horizontal plane.
  • the guide member is disposed above the circular surface of the first rotating body, extends in the radial direction with respect to the circular surface, and is located on the downstream side in the rotational direction of the first rotating body as it extends outward in the radial direction. It has a guide surface with which the medicine placed on the first rotating body can come into contact with the rotation of the one rotating body.
  • the medicine is discharged from the discharge port.
  • the drug discharged from the discharge port can be detected and counted by the sensor.
  • the present invention has been made in view of the above problems, and an object of the present invention is to provide a drug supply device capable of detecting that a plurality of drugs have been simultaneously discharged from a discharge unit.
  • the drug supply device includes a drug supply unit, a first detection unit, a second detection unit, and a control unit.
  • the drug supply unit has a discharge unit, transports the drugs while aligning them toward the discharge unit, and discharges and supplies the drugs one by one from the beginning from the discharge unit.
  • the first detection unit outputs the first detection signal when detecting that the medicine has reached the first detection position outside the discharge unit.
  • the second detection unit outputs the second detection signal when it is detected that the medicine has passed the second detection position that is farther from the medicine supply unit than the first detection position.
  • the control unit controls the drug supply unit.
  • the control unit receives the first detection signal from the first detection unit, controls the drug supply unit according to the first detection signal, receives the second detection signal from the second detection unit, and receives the second detection signal.
  • the drug supplied from the drug supply unit is counted in accordance with the above.
  • control unit temporarily stops the delivery of the drug by the drug supply unit when the first detection signal is input.
  • the control unit when the first detection signal is input, temporarily causes the drug supply unit to transfer the drug in the reverse direction.
  • a drug information signal having drug information related to the shape of the drug is input to the control unit.
  • the control unit controls the drug supply unit according to the drug information.
  • control unit determines that the abnormality is detected when the second detection signal is input a plurality of times during the input interval when the first detection signal is input.
  • FIG. 7 is a perspective view showing a state in which the opening/closing section is rotated upward and the discharge section is opened in the medicine supply unit included in the medicine supply device according to the embodiment of the present invention. It is a perspective view showing composition of a medicine storage container of a medicine replenishment part with which a medicine supply device concerning one embodiment of the present invention is provided.
  • FIG. 3 is a vertical cross-sectional view showing a state in which a lid is removed, in a drug container of a drug replenishing unit included in a drug supply device according to an embodiment of the present invention.
  • FIG. 3 is a partial perspective view showing the shape of the medicine replenishing unit included in the medicine supply device according to the embodiment of the present invention on the side of the opening of the medicine container. It is a partial perspective view which shows the structure of the base part with which the chemical
  • FIG. 4 is a front view showing a state in which a cover of a part of the base part is removed in a state where the drug supply part and the drug container are attached to the base part included in the drug supply device according to the embodiment of the present invention. It is a front side perspective view showing the state where a medicine storage container and a part of cover of a base part were removed from a medicine supply device concerning one embodiment of the present invention.
  • FIG. 1 is a perspective view showing the external appearance of a medicine packaging device according to an embodiment of the present invention.
  • FIG. 2 is a vertical cross-sectional view showing the configuration of the medicine packaging device according to the embodiment of the present invention.
  • FIG. 3 is a plan view of the medicine packaging device of FIG. 2 seen from the direction of arrow III. Note that FIG. 1 illustrates a state in which the door of the housing is open and the manual cassette is slid to the front side of the housing. In FIG. 3, the ceiling part of the medicine packaging apparatus is seen through.
  • a medicine packing apparatus 400 includes a medicine supply device unit, a housing 410, a rotating drum 420, a hopper 430, and a medicine packaging device unit 440. It has and.
  • the medicine packaging device 400 further includes a control device unit described later.
  • the drug supply device unit has a plurality of drug supply devices for supplying a drug.
  • the drug supply device unit includes a plurality of first drug supply devices 10, a plurality of second drug supply devices 20, and a third drug supply device 30.
  • Each of the plurality of second drug supply devices 20 accommodates a plurality of drugs and is configured to be able to supply the required number of drugs.
  • the second medicine supply device 20 is an automatic medicine supply cassette.
  • the third medicine supply device 30 is a manual medicine supply cassette.
  • the hand-delivered medicine supply cassette has compartments arranged in a matrix, and each compartment accommodates one package of medicine.
  • Each of the plurality of first drug supply devices 10 can supply the drug in place of the second drug supply device 20 of the plurality of second drug supply devices 20, which is empty of the drug. Further, each of the plurality of first drug supply devices 10 can supply another drug different from the drug contained in each of the plurality of second drug supply devices 20.
  • the drug supply device unit supplies the drug one by one from the drug supply device selected from the plurality of drug supply devices.
  • the medicine packaging device unit 440 packages the medicines supplied from the medicine supply device unit one by one.
  • the control device unit controls each of the medicine supply device unit and the medicine packaging device unit.
  • the housing 410 accommodates a drug supply device unit, a rotary drum 420, a hopper 430, and a drug packaging device unit 440.
  • the housing 410 has a door that can be opened and closed.
  • the operation panel 50 is provided on the front surface of the housing 410.
  • the rotary drum 420 is rotatably supported around the axis 4 in the housing 410.
  • a plurality of first drug supply devices 10 and a plurality of second drug supply devices 20 are attached to the rotary drum 420. That is, the first drug supply device 10 is housed in the housing 410 in a movable state.
  • the rotary drum 420 is provided with a drug delivery path 421.
  • the medicine transport path 421 is located above the hopper 430.
  • the first drug supply device 10 and the second drug supply device 20 are annularly arranged side by side on the outer peripheral side of the rotary drum 420.
  • the first drug supply device 10 and the second drug supply device 20 are arranged side by side in the vertical direction.
  • Each of the first drug supply device 10 and the second drug supply device 20 is connected to the drug delivery path 421.
  • the medicine supplied from each of the first medicine supply device 10 and the second medicine supply device 20 passes through the medicine conveyance path 421 and is put into the hopper 430.
  • the medicine supplied from the third medicine supply device 30 is put into the hopper 430.
  • the medicine put into the hopper 430 is packed in the medicine packing device unit 440.
  • each of the first drug supply device 10 and the second drug supply device 20 may be attached to a slidable rack instead of the rotating drum 420.
  • each of the first drug supply device 10 and the second drug supply device 20 can be moved to the outside of the casing 410 by pulling out the rack to the outside of the casing 410.
  • the sliding direction of the rack may be the front-rear direction of the housing 410 or the left-right direction of the housing 410.
  • the door of the housing 410 may have a double-door structure.
  • FIG. 4 is a front view showing the configuration of the drug supply device according to the embodiment of the present invention.
  • the first drug supply device 10 according to an embodiment of the present invention includes a drug supply module 100, which is a drug supply unit, and a drug replenishment unit 12.
  • the first medicine supply device 10 further includes a base unit 200.
  • a display unit 250 and a stop switch 238 are provided on the front surface of the base unit 200.
  • the medicine replenishing unit 12 includes a medicine storage container 300 that stores a medicine.
  • Each of the drug supply module 100 and the drug container 300 can be separately attached to and detached from the base unit 200.
  • FIG. 5 is a perspective view showing a configuration of a drug supply unit included in the drug supply device according to the embodiment of the present invention.
  • FIG. 6 is a plan view of the medicine supply unit of FIG. 5 viewed from the direction of arrow VI.
  • FIG. 7 is a perspective view of the medicine supply unit of FIG. 5 viewed from the arrow VII direction.
  • FIG. 8 is a diagram of the medicine supply unit of FIG. 5 viewed from the direction of arrow VIII.
  • FIG. 9 is a view of the medicine supply unit of FIG. 5 viewed from the arrow IX direction.
  • FIGS. 6 and 7 a lid portion described later is shown in a see-through manner.
  • a lid member and an opening/closing member which will be described later are not shown.
  • the lid portion is shown in a see-through manner, and the support portion described later is not shown.
  • a drug supply module 100 which is a drug supply unit included in the first drug supply device 10 according to an embodiment of the present invention, includes a rotating body 110, a peripheral wall part, and a discharge part 131. Equipped with.
  • the drug supply module 100 further includes a support part 150, a lid part 126, and an opening/closing part 141.
  • the drug supply module 100 has a drug receiving position and a discharging unit 131 for receiving the refilled drug, and conveys the drugs while aligning the drugs in a line from the drug receiving position to the discharging unit 131, and the discharging unit. It functions as a drug supply unit that sequentially discharges and supplies the drugs one by one from 131.
  • the drug supply module 100 is integrally configured by including the rotating body 110, the peripheral wall portion, the discharging portion 131, and the opening/closing portion 141.
  • the opening/closing unit 141 does not necessarily have to be provided. That is, the medicine supply module 100 may be integrally configured by including the rotating body 110, the peripheral wall portion, and the discharging portion 131.
  • FIG. 10 is a side view showing the configuration of the rotating body included in the drug supply unit included in the drug supply device according to the embodiment of the present invention.
  • the rotating body is shown when viewed from the same direction as in FIG. 9.
  • the rotating body 110 rotates about an axis 1 that extends in the vertical direction, and is coaxial with the axis 1 that is inclined downward as it goes radially outward about the axis 1. It has a conical slope 110s.
  • the rotating body 110 includes a first rotating portion 111 and a second rotating portion 112 that are coaxially arranged.
  • the second rotating portion 112 is located below the first rotating portion 111.
  • the side surface of the first rotating portion 111 and the side surface of the second rotating portion 112 form an inclined surface 110s.
  • Each of the first rotating unit 111 and the second rotating unit 112 is rotatably provided separately from each other. As shown in FIGS. 8 to 10, the first rotating portion 111 is connected to the first driven gear 111g.
  • the second rotating portion 112 is connected to the second driven gear 112g.
  • the slope 110s of the rotating body 110 is provided with a rolling prevention unit that prevents the medicine from rolling.
  • the rolling prevention portion is composed of a concave streak portion radially provided from the apex of the slope 110s.
  • the rolling prevention portion is composed of a first groove portion 111c provided on the first rotating portion 111 and a second groove portion 112c provided on the second rotating portion 112.
  • the rolling prevention unit does not necessarily have to be provided.
  • the rotating body 110 is rotatably supported by the supporting portion 150 located below the rotating body 110.
  • the rotating body 110 is provided so as to be attachable to and detachable from the supporting unit 150.
  • the support portion 150 includes a substantially circular horizontal plane portion 151, an upright portion 152 that stands up from the edge of the horizontal plane portion 151 in a substantially cylindrical shape, and a substantially cylindrical shape below the horizontal plane portion 151.
  • Each of the first driven gear 111g and the second driven gear 112g is located on the inner peripheral side of the base portion 153.
  • the drug supply module 100 includes a plurality of peripheral wall portions.
  • the medicine supply module 100 includes a first peripheral wall portion 121, a second peripheral wall portion 122, and a third peripheral wall portion 123.
  • the number of peripheral wall portions included in the drug supply module 100 is not limited to three and may be one or more.
  • each of the first peripheral wall portion 121, the second peripheral wall portion 122, and the third peripheral wall portion 123 extends in an arc shape along the circumferential direction about the axis 1 above the slope 110s. ing.
  • Each of the 1st peripheral wall part 121, the 2nd peripheral wall part 122, and the 3rd peripheral wall part 123 supports the chemical
  • the 1st peripheral wall part 121, the 2nd peripheral wall part 122, and the 3rd peripheral wall part 123 are located in a line with each other in the rotation direction 2 of the rotating body 110, and the peripheral wall part located in the downstream of the rotation direction 2 has the said radial direction. It is located outside and below.
  • the second peripheral wall portion 122 is located on the downstream side in the rotation direction 2 with respect to the first peripheral wall portion 121, and is radially outward and downward with respect to the first peripheral wall portion 121. Is located in.
  • the third peripheral wall portion 123 is located on the downstream side in the rotation direction 2 with respect to the second peripheral wall portion 122, and is located outside and below in the radial direction with respect to the second peripheral wall portion 122. ..
  • Each of the first peripheral wall portion 121 and the second peripheral wall portion 122 is located above the first rotating portion 111.
  • the third peripheral wall portion 123 is located above the second rotating portion 112. Therefore, the 1st rotation part 111 conveys the chemical
  • the first rotating unit 111 conveys the drug supported by the second peripheral wall 122 along the second peripheral wall 122.
  • the second rotating portion 112 conveys the medicine supported by the third peripheral wall portion 123 along the third peripheral wall portion 123.
  • each of the first peripheral wall portion 121, the second peripheral wall portion 122, and the third peripheral wall portion 123 is separated from the slope 110s.
  • each of the first peripheral wall portion 121, the second peripheral wall portion 122, and the third peripheral wall portion 123 has a slope 110 s within a range in which the medicine supplied onto the slope 110 s can be supported from the outside in the radial direction. Separated from each other.
  • the peripheral wall portions that are adjacent to each other in the rotational direction 2 are located on the downstream side in the rotational direction 2.
  • the end portion is separated from the slope 110s as it goes downstream in the rotation direction 2.
  • downstream end of the first peripheral wall portion 121 in the rotation direction 2 is separated from the slope 110s as it goes to the downstream side in the rotation direction 2.
  • downstream end of the second peripheral wall portion 122 in the rotation direction 2 is separated from the slope 110 s as it goes downstream in the rotation direction 2.
  • the peripheral wall portions adjacent to each other in the rotation direction 2 extend outward in the radial direction as they go downstream in the rotation direction 2. They are connected to each other by a slanted wall portion that descends.
  • the inclined wall portion does not necessarily have to be provided.
  • first peripheral wall portion 121 and the second peripheral wall portion 122 are connected to each other by the first inclined wall portion 124.
  • the second peripheral wall portion 122 and the third peripheral wall portion 123 are connected to each other by the second inclined wall portion 125.
  • each of the first inclined wall portion 124 and the second inclined wall portion 125 inclines toward the downstream side in the rotational direction 2 as it goes away from the slope 110s. Therefore, each of the boundary line between the first peripheral wall portion 121 and the first inclined wall portion 124 and the boundary line between the second peripheral wall portion 122 and the first inclined wall portion 124 increases with increasing distance from the slope 110s. , Is inclined to the downstream side in the rotation direction 2. Similarly, each of the boundary line between the second peripheral wall portion 122 and the second inclined wall portion 125 and the boundary line between the third peripheral wall portion 123 and the second inclined wall portion 125 is separated upward from the slope 110s. Therefore, it is inclined to the downstream side in the rotation direction 2.
  • each of the first peripheral wall portion 121, the second peripheral wall portion 122 and the third peripheral wall portion 123 is configured integrally with the lid portion 126. ..
  • Each of the first peripheral wall 121, the second peripheral wall 122, and the third peripheral wall 123 extends downward from the lower surface of the lid 126.
  • the lid 126 does not necessarily have to be provided, and the peripheral wall may be provided above the slope 110s.
  • Each of the first inclined wall portion 124 and the second inclined wall portion 125 is configured integrally with the lid portion 126. Each of the first inclined wall portion 124 and the second inclined wall portion 125 extends downward from the lower surface of the lid portion 126.
  • the lid 126 covers the slope 110s from above.
  • the lid 126 is provided so that the slope 110s can be opened upward.
  • the lid 126 is arranged on the support 150. Specifically, the lid 126 is provided on the lid member 120.
  • Each of the first peripheral wall portion 121, the second peripheral wall portion 122, and the third peripheral wall portion 123 is provided on the lid member 120.
  • Each of the first inclined wall portion 124 and the second inclined wall portion 125 is provided on the lid member 120.
  • the lid member 120 is detachably mounted on the support portion 150 with respect to the support portion 150.
  • a cushioning member 170 is provided between the lid 126 and the support 150.
  • the lid member 120 is placed on the horizontal surface portion 151 of the support portion 150 via the buffer member 170 having an arc shape.
  • the cushioning member 170 is made of an elastic body such as rubber.
  • the buffer member 170 does not necessarily have to be provided.
  • the lid member 120 is made of a transparent member. Therefore, each of the lid 126, the first peripheral wall 121, the second peripheral wall 122, and the third peripheral wall 123 is made of a transparent member. Thereby, the inside of the lid member 120 can be visually recognized from the outside of the lid member 120.
  • the lid member 120 may be made of a non-transparent member.
  • FIG. 11 is a perspective view showing an external appearance of a lid member included in a drug supply unit included in the drug supply device according to the embodiment of the present invention.
  • FIG. 12 is a view of the lid member of FIG. 11 viewed from the arrow XII direction.
  • FIG. 13 is a diagram of the lid member of FIG. 12 viewed from the arrow XIII direction.
  • FIG. 14 is a view of the lid member of FIG. 13 viewed from the arrow XIV direction.
  • FIG. 15 is a view of the lid member of FIG. 13 viewed from the arrow XV direction.
  • 11 and 12 show a state in which a later-described vibration transmission plate is removed from the lid member 120.
  • the lid member 120 is provided with the medicine supply hole 127, the cutout portion 128, and the attachment portion 129. Specifically, each of the medicine supply hole 127 and the attachment portion 129 is provided on the top surface of the lid member 120.
  • the cutout 128 is provided on the peripheral edge of the lid member 120 on the lower end side.
  • the drug supply hole 127 is provided to supply a drug from the outside of the lid member 120 to the inside of the lid member 120.
  • the cutout portion 128 is provided for disposing a discharge member, which will be described later, on the support portion 150.
  • the attachment portion 129 is provided to attach a vibration transmission plate, which will be described later, to the lid member 120.
  • the first peripheral wall portion 121 is located below the drug supply hole 127, and the first inclined wall portion 124 is located adjacent to the first peripheral wall portion 121. Then, the second peripheral wall portion 122 is positioned adjacent to the first inclined wall portion 124, the second inclined wall portion 125 is positioned adjacent to the second peripheral wall portion 122, and the second inclined wall portion 125 is adjacent.
  • the third peripheral wall portion 123 is located, and the cutout portion 128 is located adjacent to the third peripheral wall portion 123.
  • the mounting portion 129 is provided with a screw hole.
  • the vibration transmission plate 160 is fixed to the mounting portion 129 by screws.
  • the vibration transmission plate 160 constitutes a part of the lid 126.
  • the vibration transmission plate 160 is made of a magnetic material.
  • the vibration transmission plate 160 may be made of a non-magnetic material.
  • the vibration transmission plate 160 does not necessarily have to be provided.
  • a discharge member 130 is provided on the support portion 150 so as to be fitted into the cutout portion 128.
  • the discharge member 130 has an outer shape corresponding to the shape of the cutout 128.
  • a slight gap is provided between the discharge member 130 and the lid member 120.
  • the discharging member 130 discharges the medicine, which is sequentially conveyed along each of the first peripheral wall portion 121, the second peripheral wall portion 122, and the third peripheral wall portion 123, by the rotation of the rotating body 110 from the slope 110s. Is provided.
  • the discharge member 130 is provided with a standing wall portion 132. That is, the standing wall portion 132 is configured as a member different from the peripheral wall portion.
  • the standing wall portion 132 is provided between the third peripheral wall portion 123 and the discharge portion 131, and supports the medicine from the outside in the radial direction.
  • the standing wall portion 132 extends in an arc shape along the circumferential direction around the axis 1.
  • the third peripheral wall portion 123, the standing wall portion 132, and the discharge portion 131 are arranged along the circumferential direction centered on the axis 1.
  • the standing wall portion 132 does not necessarily have to be provided.
  • the discharge member 130 is provided with a pair of bearings 130b that supports a rotating shaft 140s that rotates the opening/closing part 141.
  • the pair of bearings 130b is erected at a position above the discharge part 131.
  • the opening/closing part 141 is configured to be able to open/close the discharging part 131 by being rotated by the rotating shaft 140s.
  • the opening/closing part 141 is connected to the biasing member 140t and is biased in the direction of closing the discharging part 131.
  • the biasing member 140t is composed of a torsion spring, but is not limited to the torsion spring.
  • the urging member 140t does not necessarily have to be provided.
  • the base unit 200 is provided with an open/close sensor 237 which will be described later and detects the open/closed state of the open/close unit 141.
  • the drug supply module 100 further includes a drug stopper 142.
  • the medicine stopping portion 142 is adjacent to the discharging portion 131 while extending in the radial direction along the slope 110s on the upstream side in the rotation direction 2 of the rotating body 110 with respect to the discharging portion 131.
  • the medicine stopper 142 is provided so as to be able to come into contact with and separate from the slope 110s.
  • the medicine stopping portion 142 is configured integrally with the opening/closing portion 141.
  • the medicine stopper 142 does not necessarily have to be provided.
  • FIG. 16 is a perspective view showing the outer appearance of the opening/closing member included in the drug supply unit included in the drug supply device according to the embodiment of the present invention.
  • FIG. 17 is a view of the opening/closing member of FIG. 16 seen from the direction of arrow XVII.
  • the opening/closing member 140 is provided with an opening/closing portion 141, a drug stopping portion 142, and a pair of engagement holes 140b.
  • the medicine stopping portion 142 projects from one edge in the width direction of the substantially flat plate-shaped opening/closing portion 141 so as to be orthogonal to the opening/closing portion 141.
  • the pair of engagement holes 140b are erected at a position above the opening/closing portion 141.
  • Each of the pair of engagement holes 140b has a D-shaped inner peripheral surface in a side view.
  • Each of the pair of engagement holes 140b engages with a portion of the rotating shaft 140s having a D-shaped cross section.
  • FIG. 18 is a perspective view showing a state in which the opening/closing section pivots upward and the discharge section is opened in the medicine supply unit included in the medicine supply device according to the embodiment of the present invention.
  • the medicine supply module 100 is illustrated when viewed from the same direction as FIG. 5.
  • the opening/closing member 140 rotates around the rotating shaft 140s, and the discharging portion 131 closed by the opening/closing portion 141 is opened. Then, the medicine stopper 142 is separated from the slope 110s.
  • the opening/closing member 140 rotates about the rotating shaft 140s, and the opening/closing part 141 closes the discharge part 131 and the medicine stopping part. 142 approaches the slope 110s.
  • FIG. 19 is a perspective view showing a configuration of a drug container of a drug replenishing unit included in the drug supply device according to the embodiment of the present invention.
  • FIG. 20 is a perspective view showing a state in which the outer lid is removed in the medicine container of the medicine replenishing unit included in the medicine supply device according to the embodiment of the present invention.
  • FIG. 21 is a perspective view showing a state in which the lid is removed in the medicine container of the medicine replenishing unit included in the medicine supply device according to the embodiment of the present invention.
  • FIG. 22 is a side view showing a state in which the lid is removed in the medicine container of the medicine replenishing unit included in the medicine supply device according to the embodiment of the present invention.
  • FIG. 20 is a perspective view showing a state in which the outer lid is removed in the medicine container of the medicine replenishing unit included in the medicine supply device according to the embodiment of the present invention.
  • FIG. 21 is a perspective view showing a state in which the lid is removed in the medicine container of the medicine replenishing unit included in the
  • FIG. 23 is a plan view showing a state in which the lid is removed in the drug container of the drug replenishing unit included in the drug feeding device according to the embodiment of the present invention.
  • FIG. 24 is a bottom view showing a state in which the lid is removed in the medicine container of the medicine replenishing unit included in the medicine supply device according to the embodiment of the present invention.
  • FIG. 25 is a vertical cross-sectional view showing a state in which the lid is removed in the medicine container of the medicine replenishing unit included in the medicine supply device according to the embodiment of the present invention.
  • the drug storage container 300 of the drug replenishing unit 12 included in the first drug supply device 10 has a bottomed cylindrical shape including a bottom and an opening. It also has a spiral groove formed on the inner peripheral surface thereof.
  • the drug container 300 includes a main body cylinder 310, a cylindrical portion 320, a bottom portion 330, and a lid portion 340.
  • the main body cylinder 310 has a spiral groove 312 formed on the inner peripheral surface thereof.
  • the main body cylinder 310 has a first opening 313 at one end and a second opening 314 at the other end.
  • the central axis of the main body cylinder 310 is located on the axis 3 of the medicine container 300. In FIG. 25, a vertical line 4 perpendicular to the axis 3 is shown.
  • the angle ⁇ formed by the perpendicular line 4 and the wall surface located on the side of the first opening 313 on the pair of wall surfaces facing each other of the spiral groove 312 formed on the inner peripheral surface of the main body cylinder 310 is
  • FIG. 26 is a partial perspective view showing the shape of the medicine replenishing section of the medicine supply device according to the embodiment of the present invention on the side of the opening of the medicine container. In FIG. 26, the state where the cylindrical portion 320 is removed from the main body cylinder 310 is shown.
  • the spiral groove 312 is formed on the inner peripheral surface of the main body cylinder 310 so as to continue until it reaches the first opening 313 of the main body cylinder 310.
  • a terminal end 312e of the spiral groove 312 on the first opening 313 side has a shape cut along the end surface of the main body cylinder 310 on the first opening 313 side.
  • the spiral groove 312 is formed on the inner peripheral surface of the main body cylinder 310 so as to continue to a position before reaching the second opening 314 of the main body cylinder 310.
  • the end of the spiral groove 312 on the second opening 314 side is connected to a circumferential groove 315 extending in the circumferential direction around the axis 3. Therefore, the groove width does not become narrow even in the vicinity of the second opening 314 of the main body cylinder 310. Therefore, it is possible to prevent the medicine from being clogged in the groove.
  • the cylindrical portion 320 is attached to the outer periphery of the main body cylinder 310 on the side of the first opening 313.
  • a male screw for attaching the lid 340 is formed on the outer circumference of the end of the cylindrical portion 320 on the side of the first opening 313 in the direction of the axis 3.
  • the bottom portion 330 is attached to the outer periphery of the main body cylinder 310 on the second opening 314 side.
  • the bottom portion 330 has a bottom surface 330b that closes the second opening 314.
  • the bottom surface 330b is curved in a convex shape on the side away from the second opening 314 in the axis 3 direction. That is, the inner bottom surface of the medicine container 300 has a convex curved surface shape on the outside of the medicine container 300.
  • the bottom portion 330 further has an annular portion 330c that protrudes annularly outward from the peripheral edge of the bottom surface 330b.
  • the identifier 331 is arranged in the space defined by the bottom surface 330b and the annular portion 330c.
  • the bottom portion 330 further includes a disc portion 332 that closes a space defined by the bottom surface 330b and the annular portion 330c.
  • the disc portion 332 is fixed to the bottom surface 330b with a screw.
  • the identifier 331 is sandwiched between the bottom surface 330b and the disc portion 332.
  • the identifier 331 is a permanent magnet.
  • the identifier 331 is formed so as to be different from each other in each of the plurality of drug storage containers 300. That is, each of the plurality of drug storage containers 300 has an identifier 331 that can identify each other.
  • the identifier 331 is not limited to the permanent magnet, and may be another magnetic body. Moreover, the identifier 331 does not necessarily have to be provided.
  • the lid 340 can close the first opening 313.
  • the lid portion 340 is composed of an outer lid 341 and an inner lid 342.
  • the outer lid 341 is rotatably provided with respect to the inner lid 342.
  • the outer lid 341 is provided with an arm portion 341a having a pair of engagement holes 341h.
  • a rotary shaft portion 342p having a pair of engagement protrusions 342s is provided on a side portion of the inner lid 342.
  • the pair of engagement holes 341h and the pair of engagement protrusions 342s are engaged with each other, whereby the arm portion 341a is supported rotatably around the rotation shaft portion 342p.
  • the outer lid 341 becomes rotatable with respect to the inner lid 342.
  • a plurality of openings 342h are formed on the inner lid surface 342c of the inner lid 342.
  • a space is formed between the outer lid 341 and the inner lid surface 342c for inserting the ear of a PTP (Press-Through-Package) packaging sheet of a desiccant or a medicine.
  • PTP Pressure-Through-Package
  • FIG. 27 is a partial perspective view showing the configuration of the base portion included in the drug supply device according to the embodiment of the present invention.
  • FIG. 28 is a partial rear view showing the configuration of the base portion included in the drug supply device according to the embodiment of the present invention.
  • FIG. 29 is a partial perspective view showing a state in which the drug supply unit included in the drug supply device according to the embodiment of the present invention is mounted on the base unit.
  • the base unit 200 includes a first drive shaft 210, a second drive shaft 240, a discharge chute 220, a first sensor 231 which is a first detection unit, and a second detection unit which is a second detection unit.
  • Two sensors 232, a drug detection sensor 235 which is a drug detection unit, and a vibration unit 260 are provided.
  • the base unit 200 is provided with a first motor that is a first drive source that drives the rotating body 110 and a second motor that is a second drive source that drives the opening/closing unit 141.
  • Each of the first sensor 231, the second sensor 232, the drug detection sensor 235, and the vibrating section 260 may not necessarily be provided.
  • the first drive shaft 210 is connected to the first motor.
  • the first drive shaft 210 extends upward from the bottom portion of the base portion 200.
  • a first drive gear 211g and a second drive gear 212g are provided at the tip of the first drive shaft 210.
  • the first drive gear 211g engages with the first driven gear 111g.
  • the second drive gear 212g engages with the second driven gear 112g.
  • the first rotating portion 111 rotates via the first drive gear 211g and the first driven gear 111g, and the second drive gear 212g and the second drive gear 212g.
  • the second rotating portion 112 rotates via the driven gear 112g. That is, each of the first rotating unit 111 and the second rotating unit 112 is driven by the common drive source.
  • the rotation speed of the second rotation unit 112 is higher than the rotation speed of the first rotation unit 111.
  • the number of teeth of each of the first drive gear 211g, the second drive gear 212g, the first driven gear 111g, and the second driven gear 112g is such that the rotation speed of the second rotating portion 112 is equal to that of the first rotating portion 111. It is set to be higher than the rotation speed.
  • the second drive shaft 240 is connected to the second motor.
  • the second drive shaft 240 extends substantially horizontally from one side portion of the base portion 200 toward the other side portion.
  • the tip of the second drive shaft 240 engages with the rotating shaft 140s.
  • the second motor drives and the second drive shaft 240 rotates, so that the opening/closing member 140 rotates together with the rotating shaft 140s.
  • each of the opening/closing unit 141 and the medicine stopping unit 142 also rotates about the rotation shaft 140s. In this way, each of the opening/closing section 141 and the medicine stopping section 142 is driven by the common drive source.
  • the discharge chute 220 guides the medicine discharged from the discharge part 131 to the outside of the base part 200.
  • the inlet of the discharge chute 220 faces the discharge part 131.
  • the first sensor 231 is arranged adjacent to the discharging unit 131.
  • a second sensor 232 is arranged on the discharge chute 220. The second sensor 232 is located farther from the discharge unit 131 than the first sensor 231.
  • the first sensor 231 detects that the medicine on the slope 110s has been discharged from the discharge portion 131.
  • the first sensor 231 outputs a first detection signal when detecting that the medicine has reached the first detection position outside the discharging unit 131.
  • the first sensor 231 is composed of a photoelectric sensor and has a light projecting unit and a light receiving unit which are arranged so as to sandwich the region immediately downstream of the discharge unit 131 between them. The arrival of the drug discharged from the discharge unit 131 is detected by detecting that the optical axis between the light projecting unit and the light receiving unit is blocked by the drug.
  • the second sensor 232 detects the drug discharged from the discharge unit 131.
  • the second sensor 232 outputs a second detection signal when it is detected that the medicine has passed a second detection position which is far from the medicine supply module 100 from the first detection position.
  • the second sensor 232 is composed of a photoelectric sensor and has a light projecting unit and a light receiving unit which are arranged so as to sandwich the drug passage defined by the discharge chute 220 therebetween.
  • the passage of the medicine discharged from the discharging portion 131 is detected by detecting that the optical axis between the light projecting portion and the light receiving portion has returned from the state blocked by the medicine to the original opened state.
  • the drug detection sensor 235 detects the presence or absence of a drug at the drug receiving position on the slope 110s of the drug supply module 100 and outputs a drug detection signal.
  • the drug detection sensor 235 is composed of a photoelectric sensor and has a light projecting unit and a light receiving unit which are arranged so as to sandwich the region below the drug supply hole 127 between them. That is, the region located below the drug supply hole 127 on the slope 110s is the drug receiving position for receiving the refilled drug.
  • the drug detection sensor 235 detects the presence or absence of a drug at the drug receiving position by detecting whether or not the optical axis between the light projecting unit and the light receiving unit is blocked by the drug.
  • the drug detection sensor 235 has a first detection state in which it is detected that there is a drug at the drug receiving position, and a second detection state in which it is detected that there is no drug at the drug receiving position.
  • the lid member 120 at least a portion on the optical axis is transparent.
  • the vibrating section 260 vibrates each of the first peripheral wall section 121, the second peripheral wall section 122, and the third peripheral wall section 123.
  • the vibrating section 260 vibrates each of the first peripheral wall section 121, the second peripheral wall section 122, and the third peripheral wall section 123 via the lid section 126.
  • the vibration unit 260 is provided so as to be located directly above the vibration transmission plate 160.
  • the vibrating section 260 is provided with a permanent magnet (not shown).
  • the vibration transmission plate 160 is made of a magnetic material.
  • the vibrating section 260 and the vibration transmitting plate 160 are attracted to each other by the magnetic force of the permanent magnet. That is, the contact portions of the vibrating portion 260 and the lid portion 126 are attracted to each other by the magnetic force.
  • the vibration of the vibrating section 260 propagates to each of the first peripheral wall section 121, the second peripheral wall section 122, and the third peripheral wall section 123 through the lid section 126.
  • the vibrating section 260 vibrates in a direction inclined with respect to the horizontal plane.
  • the vibrating section 260 is driven by an eccentric motor 273 described later in which the motor shaft is arranged so as to be inclined with respect to the horizontal plane.
  • the vibration is generated.
  • the vibration caused by the portion 260 does not directly propagate to the standing wall portion 132.
  • a cushioning member may be provided at the connection between the vibrating section 260 and the base section 200 to suppress the vibration from the vibrating section 260 from propagating to the base section 200. Accordingly, it is possible to suppress the vibration from the vibrating section 260 from propagating to the standing wall section 132 through the base section 200 and the supporting section 150.
  • the vibration part 260 is provided in the base part 200, and the lid part 126 is provided in the drug supply module 100, so that the vibration is generated.
  • the part 260 can be brought into and out of contact with the lid part 126.
  • the base unit 200 is provided with a module detection sensor 236 which will be described later and detects that the medicine supply module 100 is attached.
  • FIG. 30 is a front view showing a state in which a cover of a part of the base part is removed in a state where each of the drug supply part and the drug storage container is attached to the base part included in the drug supply device according to the embodiment of the present invention. It is a figure.
  • FIG. 31 is a front side perspective view showing a state in which the medicine container and the partial cover of the base portion are removed from the medicine supply device according to the embodiment of the present invention.
  • FIG. 32 is a rear perspective view showing a state in which the other part of the cover of the base part is removed from the drug supply device according to the embodiment of the present invention.
  • the drug container 300 is attached to the base part 200 with the lid part 340 removed.
  • the medicine container 300 attached to the base portion 200 is located above the medicine supply module 100.
  • the axis 3 of the medicine container 300 is inclined with respect to the horizontal plane.
  • the axis 3 of the medicine container 300 is inclined by 20° with respect to the horizontal plane.
  • the base portion 200 is provided with four roller portions that support the medicine container 300 so as to be rotatable about the axis 3.
  • the base portion 200 is provided with a pair of rotating shafts.
  • a pair of roller portions 281 are attached to one of the pair of rotating shafts with a space therebetween.
  • a pair of roller portions 282 are attached to the other of the pair of rotating shafts with a space therebetween.
  • the base unit 200 is provided with a container detection sensor 233 that detects that the medicine container 300 is attached.
  • a path 290 is provided in the base part 200.
  • the base unit 200 is provided with an identification sensor 234 that recognizes the identifier 331 of the drug container 300.
  • the identification sensor 234 is a magnetic sensor.
  • the identification sensor 234 is not limited to the magnetic sensor and may be any sensor that can recognize the identifier 331. Further, the identification sensor 234 does not necessarily have to be provided.
  • the first motor 270 which is the first drive source for driving the rotating body 110 and the second motor source 270 which is the second drive source for driving the opening/closing unit 141 are provided.
  • a motor 271 is provided.
  • the base portion 200 is provided with a third motor 272 that is a third drive source that drives the other of the pair of rotating shafts.
  • the drug replenishing unit 12 shown in FIGS. 4 and 30 includes a drug container 300, the above-mentioned pair of rotary shafts, a pair of roller units 281, a pair of roller units 282, a third motor 272, a container detection sensor 233, and An identification sensor 234 is included.
  • the drug storage container 300 stores a drug and is driven to refill the drug receiving position of the drug supply module 100 with the drug. That is, the medicine replenishing unit 12 replenishes the medicine at the medicine receiving position.
  • a display unit 250 is provided on the front surface of the base unit 200.
  • the display unit 250 selectively emits light of one color from a plurality of colors. Further, the display unit 250 can also emit blinking light.
  • the light emission pattern of the display unit 250 can indicate the state of the first medicine supply device 10.
  • FIG. 33 is a block diagram showing a connection system of the medicine packaging device according to the embodiment of the present invention.
  • the medicine packaging device 400 according to the embodiment of the present invention includes a main control unit 41.
  • the main controller 41 is electrically connected to each of the medicine packaging device unit 440, the medicine supply device unit 450, and the operation panel 50.
  • the main controller 41 is electrically connected to a prescription information receiving device 90 that receives prescription information via the operation panel 50.
  • FIG. 34 is a block diagram showing a connection system of the drug supply device according to the embodiment of the present invention.
  • the first drug supply device 10 according to one embodiment of the present invention has a control unit 11 that controls each of the drug supply module 100, which is a drug supply unit, and the drug replenishment unit 12. ..
  • the control unit 11 is provided in the base unit 200.
  • the control unit 11 includes the first sensor 231, the second sensor 232, the container detection sensor 233, the identification sensor 234, the drug detection sensor 235, the module detection sensor 236, the open/close sensor 237, the stop switch 238, the display unit 250, and the first motor 270.
  • the second motor 271, the third motor 272, and the eccentric motor 273 are electrically connected.
  • the control unit 11 is electrically connected to the main control unit 41.
  • a control device unit 460 is configured by the control unit 11 of each of the plurality of first drug supply devices 10 and the main control unit 41.
  • the medicine packaging device 400 includes the control device unit 460.
  • the operation of the first drug supply device 10 according to the embodiment of the present invention will be described below. First, the operation of the drug supply module 100, which is a drug supply unit, will be described.
  • the medicine supplied from the medicine supply hole 127 to the inside of the lid member 120 is received at the medicine receiving position on the slope 110s and is supported by the first peripheral wall portion 121.
  • Each of the first rotating unit 111 and the second rotating unit 112 is driven by the first motor 270.
  • the medicine supported by the first peripheral wall portion 121 is conveyed along the first peripheral wall portion 121.
  • the medicines supported by the first peripheral wall portion 121 are aligned along the first peripheral wall portion 121 while being transported along the first peripheral wall portion 121.
  • the medicine supported by the first peripheral wall portion 121 sequentially moves downward from the medicine located on the leading side in the rotation direction 2 along the first inclined wall portion 124 and moves outward in the radial direction around the axis 1. By doing so, it is supported by the second peripheral wall portion 122.
  • the medicine that descends along the first inclined wall portion 124 is accelerated by gravity, and thus has a higher moving speed than the medicine that is conveyed along the first peripheral wall portion 121. As a result, the distance between the medicine that has descended along the first inclined wall portion 124 and the medicine that has not yet descended along the first inclined wall portion 124 becomes wider.
  • the medicine supported by the second peripheral wall portion 122 is conveyed along the second peripheral wall portion 122.
  • the medicine supported by the second peripheral wall portion 122 sequentially moves downward from the medicine located on the leading side in the rotation direction 2 along the second inclined wall portion 125 and moves to the outer side in the radial direction, thereby the third medicine. It is supported by the peripheral wall portion 123.
  • the medicine that descends along the second inclined wall portion 125 is accelerated by gravity, and therefore has a higher moving speed than the medicine that is conveyed along the second peripheral wall portion 122. As a result, the interval between the medicine that has descended along the second inclined wall portion 125 and the medicine that has not yet descended along the second inclined wall portion 125 becomes wider.
  • the medicine supported by the third peripheral wall portion 123 is conveyed along the third peripheral wall portion 123. Since the rotation speed of the second rotating portion 112 is higher than the rotation speed of the first rotating portion 111, the distance between the medicine supported by the third peripheral wall portion 123 and the medicine supported by the second peripheral wall portion 122 is small. Get wider
  • the medicines supported by the third peripheral wall 123 are sequentially supported by the standing wall 132 from the medicine located on the leading side in the rotation direction 2.
  • the medicine supported by the standing wall portion 132 is conveyed along the standing wall portion 132.
  • the medicine stopping portion 142 When the medicine stopping portion 142 is close to the slope 110s, the medicine conveyed along the standing wall portion 132 is prevented from moving to the discharging portion 131. Therefore, the rotation shaft 140s is rotated by the second motor 271.
  • the opening/closing member 140 When the rotating shaft 140s is rotated to one side, the opening/closing member 140 is rotated around the rotating shaft 140s, the discharging portion 131 closed by the opening/closing portion 141 is opened, and the medicine stopping portion 142 is opened. It is separated from the slope 110s. As a result, among the medicines supported by the standing wall portion 132, the medicines located on the leading side in the rotation direction 2 are discharged one by one from the discharge portion 131.
  • the first sensor 231 detects that the medicine on the slope 110s is discharged from the discharge portion 131.
  • the second sensor 232 detects the drug discharged from the discharging unit 131.
  • the rotating shaft 140s is rotated to the other side, whereby the opening/closing member 140 is rotated around the rotating shaft 140s, and the discharge portion 131 is closed by the opening/closing portion 141.
  • the drug stopper 142 approaches the slope 110s.
  • the medicine supported by the upright wall portion 132 is prevented from moving to the discharging portion 131 by the medicine stopping portion 142, and is prevented from being discharged from the discharging portion 131 by the opening/closing portion 141.
  • the opening/closing unit 141 is in the open state when the drug is supplied from the drug supply unit, and is in the closed state when the drug is not supplied from the drug supply unit.
  • the medicine supply unit moves with respect to the housing 410, the medicine supply unit is stopped and the opening/closing unit 141 is closed, and then the movement of the medicine supply unit is started. In this case, it is possible to suppress the discharge of the undesired drug from the discharge unit 131 during the movement of the drug supply unit.
  • the opening/closing unit 141 When resuming the supply of the drug from the drug supply unit, the opening/closing unit 141 is opened and the drug supply unit is restarted. In this case, the drug can be discharged from the discharge unit 131 immediately after the drug supply unit is restarted.
  • the medicine replenishing unit 12 By rotating the pair of roller portions 282 by the third motor 272, the medicine container 300 is rotationally driven around the axis 3.
  • the medicine in the medicine container 300 is conveyed from the bottom 330 side of the medicine container 300 to the first opening 313 side by the spiral groove 312, and the first opening 313 is formed. It is discharged from the section 313.
  • the medicine discharged from the first opening 313 passes through the connection conduit 290 of the base 200 and is supplied into the medicine supply hole 127 of the lid member 120.
  • the medicines supplied into the medicine supply holes 127 of the lid member 120 are discharged one by one from the discharge portion 131 of the medicine supply module 100.
  • the base portion 200 is attached with one medicine container 300 selected in sequence from a plurality of medicine containers 300.
  • Each of the plurality of drug storage containers 300 is driven under different drive conditions set based on the identifier 331.
  • the drug supply unit is driven corresponding to each of the plurality of drug storage containers 300.
  • drugs there are two types of drugs: general drugs, which are small tablets, and special drugs, such as capsules, long and thin tablets, spherical tablets, and triangular column tablets.
  • a general medicine or a special medicine is stored in each of the plurality of medicine storage containers 300.
  • the control unit 11 to which the detection signal of the identifier 331 from the identification sensor 234 is input is housed inside the medicine container 300 attached to the base unit 200.
  • Determine the type of drug present That is, the control unit 11 is input with a drug information signal including drug information regarding the shape of the drug, which is included in the detection signal of the identifier 331 from the identification sensor 234.
  • FIG. 35 is a time chart when the medicine packaging device according to an aspect of the present invention operates according to prescription information.
  • FIG. 36 is a diagram for explaining prescription information and packaging information.
  • prescription information is input to the prescription information reception device 90.
  • the prescription information includes information such as the type of drug, time of administration, number of days of administration, daily dose, and dose at each time of administration.
  • the drug for 3 days is prescribed in one prescription
  • the required number of drug A in one prescription is 9
  • the required number of drug B in one prescription is 6 Is.
  • the required number of drug A is one after breakfast, after lunch, and after dinner.
  • the required number of B drugs is 0 after breakfast and after dinner, and 2 after lunch.
  • one packaging information is created based on one prescription information.
  • one prescription corresponds to one packaging information based on one prescription information.
  • multiple packaging information may be created based on one prescription information.
  • one prescription information includes three kinds of medicines
  • first packaging information is created for two kinds of the three kinds of medicines
  • second packaging information for the remaining one kind. May be created.
  • each of the created plurality of packaging information corresponds to one prescription here.
  • one packaging information may be created based on a part of one prescription information. For example, when one prescription information includes three kinds of medicines, one packaging information may be created for two kinds of the three kinds of medicines and the packaging information may not be created for the remaining one kind of medicines. is there. In this case, one piece of created packaging information corresponds to one prescription here.
  • the prescription information reception device 90 inputs the packaging information according to the input prescription information into the operation panel 50.
  • the packaging information includes information for packaging the medicine according to the prescription information.
  • a packing instruction for causing the medicine packing apparatus 400 to start the packing operation is input from the input unit provided on the operation panel 50.
  • the packing information including the selection information is input from the operation panel 50 to the main control unit 41.
  • the main control unit 41 to which the packaging information including the selection information is input, inputs the required number of drugs in one prescription to the control unit 11 of the first drug supply device 10 selected by the selection information.
  • the packaging information signal having the packaging information of the medicine is input to the control device unit 460 including the control unit 11 and the main control unit 41 of each of the plurality of first drug supply devices 10.
  • the required number of medicines in one package and the supply instruction for starting the supply operation are sequentially input from the main control unit 41 to the control unit 11 at appropriate timing.
  • the control unit 11 executes the supply operation for one package.
  • a notification of the completion is input from the control unit 11 to the main control unit 41.
  • FIG. 37 is a flow chart for explaining the operation of the control unit of the drug supply device, in which the required number of drugs in one prescription is input from the main control unit.
  • the drug storage container 300 is identified by the input signal from the identification sensor 234. (Step S11).
  • the control unit 11 that has identified the medicine container 300 causes the medicine replenishment unit 12 to start replenishment of the medicine (step S12).
  • FIG. 38 is a flow chart for explaining the operation of the control unit when the medicine is replenished by the medicine replenishing unit.
  • the control unit 11 determines whether the supply number is less than the required number of medicines in one prescription after starting the medicine replenishment by the medicine replenishment unit 12 (step S12) (step S12). S21).
  • the control unit 11 of the first drug supply device 10 in which the drug storage container 300 that stores the A drug is mounted indicates that the supply number of the A drug is It is determined whether the required number is less than 9.
  • the control unit 11 of the first drug supply device 10 in which the drug storage container 300 containing the B drug is mounted determines whether the number of supplies of the B drug is less than the required number of 6.
  • the control unit 11 determines from the medicine detection signal whether the medicine detection sensor 235, which is a medicine detection unit, detects that there is a medicine at the medicine receiving position. (Step S22).
  • the control unit 11 stops the third motor 272, which is a replenishing motor, when the medicine detection sensor 235 is in the first detection state in which the medicine is detected at the medicine receiving position (step S23). That is, the control unit 11 causes the drug replenishment unit 12 to stop refilling the drug when the drug detection unit is in the first detection state. After that, the control unit 11 returns to step S21.
  • the third motor 272 which is a replenishing motor
  • the control unit 11 rotates the third motor 272 in the forward rotation direction in the second detection state in which the medicine detection sensor 235 detects that there is no medicine at the medicine receiving position (step S24). That is, the control unit 11 causes the drug replenishment unit 12 to replenish the drug when the drug detection unit is in the second detection state. After that, the control unit 11 returns to step S21.
  • control unit 11 receives the drug detection signal from the drug detection unit and controls the drug replenishment unit 12 according to the drug detection signal.
  • the control unit 11 may be configured to cause the drug replenishment unit 12 to replenish the drug after a waiting time has elapsed from the time when the drug detection unit changed from the first detection state to the second detection state.
  • the control unit 11 receives the drug information signal including the drug information regarding the shape of the drug, which is included in the detection signal of the identifier 331 from the identification sensor 234.
  • the control unit 11 sets the waiting time according to the drug information.
  • the control unit 11 rotates the third motor 272 in the reverse direction (step S25). Thereby, the medicine contained in the medicine container 300 can be returned to the inside of the medicine container 300 from the first opening 313 side.
  • the control unit 11 stops the third motor 272 after a lapse of a certain time after rotating the third motor 272 in the reverse direction (step S26).
  • control unit 11 causes the drug replenishment unit 12 to replenish the drug when the drug detection unit changes from the second detection state to the first detection state in a state where the number of supplies is less than the required number of drugs in one prescription. It is the later one of the time when the operation amount of the drug supply unit exceeds the set value from the time of stopping and the first detection state and the time when the drug detection unit changes from the first detection state to the second detection state.
  • the medicine replenishment unit 12 may be configured to restart the medicine replenishment at the time point. In this case, the control unit 11 sets the set value according to the drug information.
  • the operation amount of the drug supply unit is the cumulative rotation angle of the first rotation unit 111 in the rotation direction 2 of the drug supply unit from the time when the first detection state is reached, or the rotation of the first rotation unit 111. It is the cumulative drive time in the direction 2.
  • the set value of the cumulative rotation angle is, for example, 60°.
  • the set value of the cumulative drive time is a drive time required for the cumulative rotation angle to be, for example, 60°.
  • the above replenishment operation is performed at any time in each of the plurality of first drug supply devices 10 that supplies the drug necessary for one prescription.
  • the control device unit 460 in the first drug supply device 10 that supplies the drug next to the first drug supply device 10 that is supplying the drug, according to the packaging information, the drug supply unit.
  • the medicine replenishment unit 12 starts replenishment of the medicine before the first operation start time.
  • the control unit 11 of the first medicine supply apparatus 10 causes the medicine replenishment unit 12 to start replenishment of the medicine when the required number of medicines in one prescription is input from the main control unit 41.
  • the control unit 11 of the first medicine supply apparatus 10 causes the medicine replenishment unit 12 to start replenishment of medicines even if the supply instruction is not input from the main control unit 41.
  • the control device unit 460 for example, the first medicine supply device 10 that supplies the medicine A has 3 days from the first day to the third day after breakfast. While supplying the drug A for the package, the first drug supply device 10 for supplying the drug B for the three packages from the first day to the third day after lunch is next tested.
  • the medicine replenishment unit 12 starts the medicine replenishment before the time when the 1-motor 270 starts driving.
  • the medicine replenishing unit 12 has completed the first replenishment at the time when the first medicine supplying apparatus 10 that supplies the medicine next starts to supply the medicine, and the medicine is in the medicine receiving position. Has become.
  • the control device unit 460 stops the drug replenishment by the drug replenishment unit 12 sequentially from the first drug supply device 10 which has finished supplying the required number of drugs in one prescription according to the packaging information.
  • the control device unit 460 finishes the supply of the B medicine necessary for the three packages from the first day to the third day after lunch,
  • the replenishment of the B medicine by the medicine replenishing unit 12 of the first medicine supplying apparatus 10 which has finished supplying the required number of B medicines in the prescription is stopped.
  • the controller unit 460 then completes the supply of the A drug necessary for the 3 packages from the first day to the third day after dinner, and then supplies the necessary number of A drugs in one prescription.
  • the replenishment of the medicine A by the medicine replenishing unit 12 of the supply device 10 is stopped.
  • FIG. 39 is a flowchart for explaining the operation of the control unit of the drug supply device, which is input with the required number of drugs and the supply instruction of the drug from the main control unit.
  • the discharge unit that is blocked by the opening/closing unit 141. 131 is opened (step S31).
  • the control unit 11 After opening the discharge unit 131, the control unit 11 causes the drug supply module 100, which is a drug supply unit, to start supplying the drug in one package (S32). After starting the supply of the medicine by the medicine supply module 100 (step S32), the control unit 11 counts the medicines supplied from the medicine supply module 100 (step S33). When the number of medicines supplied exceeds the necessary number of medicines in one package, the medicine supply by the medicine supply module 100 is terminated (step S34).
  • the control unit 11 determines whether or not the number of medicines supplied is equal to or larger than the necessary number of medicines in one prescription (step S35). When the supply number is more than the required number of medicines in one prescription, the opening/closing section 141 closes the discharge section 131 (step S36). When the supply number is less than the required number of medicines in one prescription, the control unit 11 ends the operation of supplying one package of medicine while maintaining the discharge unit 131 in an open state.
  • FIG. 40 is a flow chart for explaining the operation of the control unit when a drug is supplied by the drug supply unit. As shown in FIG. 40, the control unit 11 determines whether the supply number is less than the required number of drugs in one package after starting the supply of the drug by the drug supply module 100 (step S32) (step S32). S41).
  • the first drug supply device 10 in which the drug container 300 containing the drug A is mounted determines whether the supply number of the A medicine is less than the required number of 1.
  • the control unit 11 of the first drug supply device 10 in which the drug storage container 300 that stores the B drug is mounted determines whether the supply number of the B drug is less than the required number of 2.
  • the control unit 11 drives the first motor 270, which is a supply motor, in the forward rotation direction, and also drives the eccentric motor 273, which is a vibration motor ( Step S42). As a result, each of the first rotating portion 111 and the second rotating portion 112 rotates in the forward rotation direction and the vibrating portion 260 vibrates.
  • control unit 11 determines whether or not the first sensor 231 which is the first detection unit has detected the drug based on the presence or absence of the input of the first detection signal from the first sensor 231 (step S43).
  • the control unit 11 stops the first motor 270 and the eccentric motor 273 (step S44). As described above, when the first detection signal is input, the control unit 11 temporarily stops the drug delivery by the drug supply unit.
  • control unit 11 drives the first motor 270 in the reverse rotation direction by the set amount (step S45). In this way, when the first detection signal is input, the control unit 11 temporarily reverses the drug transport direction of the drug supply unit to the reverse direction.
  • the control unit 11 drives the first motor 270 in the reverse rotation direction by the set amount, stops the first motor 270, and returns to step S41.
  • control unit 11 terminates the supply operation of the medicines for one package (step S34).
  • FIG. 41 is a flowchart illustrating the operation of the control unit when counting the medicines supplied by the medicine supply unit.
  • the control unit 11 determines whether the first sensor 231 as the first detection unit has detected the drug. The determination is made based on the presence or absence of the input of the first detection signal from the first sensor 231 (step S51).
  • the control unit 11 turns on the arrival flag (step S52).
  • the control unit 11 leaves the arrival flag as it is.
  • control unit 11 determines whether or not the second sensor 232, which is the second detection unit, has detected the drug based on the presence or absence of the input of the second detection signal from the second sensor 232 (step S53).
  • step S53 when the second sensor 232 is detecting the drug, the drug blocks the optical axis between the light projecting unit and the light receiving unit that configure the second sensor 232.
  • step S53 the control unit 11 determines whether the second sensor 232, which is the second detection unit, detects the drug as a second detection signal from the second sensor 232. It is determined whether or not there is an input (step S54).
  • step S54 in the state where the second sensor 232 is not detecting the medicine, the medicine passes through the optical axis between the light projecting section and the light receiving section which constitute the second sensor 232, and the optical axis concerned. Is the state in which it has returned to the original open state.
  • the control unit 11 returns to step S51.
  • step S54 the control unit 11 confirms whether the arrival flag is on (step S55). When the second sensor 232 does not detect the drug in step S54, the control unit 11 returns to step S54.
  • step S54 When the second sensor 232 does not detect the drug and the arrival flag is on in step S54, the control unit 11 increments the supply number by 1 (step S56) and turns off the arrival flag (step S56). Step S57).
  • step S59 the control unit 11 determines that the drug is abnormal when the second detection signal is input a plurality of times during the input interval in which the first detection signal is input.
  • step S58 the control unit 11 determines whether the supply number is equal to or more than the required number of medicines in one package. When the supply number is equal to or more than the required number of medicines in one package, the control unit 11 finishes counting the medicines. When the supply number is less than the required number of medicines in one package, the control unit 11 returns to step S51.
  • control unit 11 receives the first detection signal from the first sensor 231, controls the medicine supply unit according to the first detection signal, and inputs the second detection signal from the second sensor 232. Then, the medicines supplied from the medicine supply unit are counted according to the second detection signal.
  • the control unit 11 controls the drug supply unit according to the drug information. Specifically, when it is determined from the drug information that the drug contained in the drug container 300 is a general drug, the general drug is supplied for each rotation amount of the drug container 300. Since the amount discharged to the portion is large, the control unit 11 stops the rotation drive of the medicine container 300 immediately after the medicine detection sensor 235 detects that there is a medicine at the medicine receiving position. After this, when the drug is no longer detected by the drug detection sensor 235, the rotation of the drug container 300 is restarted. This can prevent the medicine from being excessively supplied to the medicine supply unit.
  • the control unit 11 determines the time from the detection of the drug at the drug receiving position by the drug detection sensor 235 until the rotation drive of the drug container 300 is stopped in the case of a general drug. Make it longer than.
  • the control unit 11 increases the rotation speed of the medicine container 300 as compared with a general medicine.
  • the control unit 11 also increases the rotation speed of the rotating body 110 as compared with the case of a general medicine. By doing so, even in the case of a special drug that is difficult to be discharged by rotation drive, the time required for drug replenishment can be made closer to that of a general drug, and the drugs can be supplied one by one from the discharge unit 131.
  • each of the rotating body 110 and the vibrating portion 260 is temporarily stopped, and the rotating body 110 is temporarily reversed. Then, the medicine discharged from the discharge portion 131 is held on the slope 110s.
  • the vibrating portion 260 is temporarily stopped, the rotating body 110 is temporarily stopped, and then the medicine is discharged from the discharge portion 131.
  • the medicine to be held may be held on the slope 110s.
  • the control device unit 460 supplies the medicine next to the first medicine supplying apparatus 10 which supplies the medicine according to the packing information.
  • the medicine replenishment unit 12 starts the medicine replenishment.
  • the control device unit 460 sequentially supplies the required number of medicines in one prescription from the first medicine supplying device 10 in accordance with the packaging information, The replenishment of the medicine by the medicine replenishing unit 12 is stopped. As a result, it is possible to prevent the medicine replenishment unit 12 from replenishing the medicine supply module 100 with the medicine excessively.
  • the control device unit 460 receives the medicine detection signal from the medicine detection sensor 235, and the medicine detection sensor 235 receives the medicine detection signal according to the first detection state.
  • the drug detection sensor 235 is in the second detection state, the drug replenishment unit 12 is caused to replenish the drug.
  • the medicine can be appropriately replenished from the medicine replenishing unit 12 to the medicine supply module 100 by a simple control.
  • the control unit 11 receives the drug detection signal from the drug detection sensor 235 and controls the drug replenishment unit 12 according to the drug detection signal.
  • the control unit 11 receives the drug detection signal from the drug detection sensor 235 and controls the drug replenishment unit 12 according to the drug detection signal.
  • the control unit 11 stops the drug replenishment by the drug replenishment unit 12 when the drug detection sensor 235 is in the first detection state, and the drug detection sensor.
  • the medicine replenishing unit is made to replenish the medicine.
  • the medicine can be appropriately replenished from the medicine replenishing unit 12 to the medicine supply module 100 by a simple control.
  • the control unit 11 controls the medicine replenishment unit after the waiting time has elapsed from the time when the medicine detection sensor 235 changes from the first detection state to the second detection state. Let 12 replenish the drug. As a result, it is possible to prevent the medicine replenishment unit 12 from replenishing the medicine supply module 100 with the medicine excessively.
  • the control unit 11 sets the waiting time according to the medicine information. Thereby, the medicine can be appropriately replenished from the medicine replenishing unit 12 to the medicine supply module 100 according to the kind of the medicine.
  • the control unit 11 causes the drug replenishment unit 12 to replenish the drug when the drug detection sensor 235 changes from the second detection state to the first detection state. Stop and stop the above-mentioned time, when the operation amount of the medicine supply module 100 exceeds the set value, and when the medicine detection sensor 235 changes from the first detection state to the second detection state, the medicine is replenished later. Replenishment of the medicine by the section 12 is restarted. As a result, it is possible to prevent the medicine replenishment unit 12 from replenishing the medicine supply module 100 with the medicine excessively.
  • the control unit 11 sets the set value according to the drug information.
  • the medicine can be appropriately replenished from the medicine replenishing unit 12 to the medicine supply module 100 according to the kind of the medicine.
  • the control part 11 inputs the 1st detection signal from the 1st sensor 231, controls the chemical
  • the second detection signal is input from the second sensor 232, and the medicine supplied from the medicine supply module 100 is counted according to the second detection signal. Accordingly, even when the first sensor 231 detects a plurality of medicines in an overlapping state, the second sensor 232 detects a plurality of medicines in a separated state, and thus the plurality of medicines from the discharge unit 131 are detected. It is possible to detect that is discharged at the same time.
  • the control unit 11 when the first detection signal is input, temporarily causes the drug supply module 100 to reverse the drug transport direction. Accordingly, it is possible to prevent the plurality of medicines from being simultaneously discharged from the discharge unit 131.
  • the control unit 11 temporarily stops the drug delivery by the drug supply module 100 when the first detection signal is input. Even in this case, it is possible to prevent the plurality of medicines from being simultaneously discharged from the discharge portion 131.
  • the control unit 11 receives a drug information signal having drug information related to the shape of the drug.
  • the control unit 11 controls the medicine supply module 100 according to the medicine information.
  • the drug supply module 100 temporarily stops the drug transfer, or the drug supply module 100 temporarily reverses the drug transfer direction.
  • the control unit 11 determines which of the above is selected according to the drug information.
  • the control unit 11 determines the time to temporarily stop or the time to temporarily convey in the opposite direction according to the drug information. Accordingly, it is possible to prevent a plurality of drugs from being simultaneously discharged from the discharging unit 131 in a mode according to the type of the drug.
  • the control part 11 will judge with an abnormality, if a 2nd detection signal is input in multiple times during the input interval which a 1st detection signal is input. .. Accordingly, it is possible to detect an abnormality in which a plurality of drugs are simultaneously discharged from the discharge unit 131.

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Medical Preparation Storing Or Oral Administration Devices (AREA)
  • Supply Of Fluid Materials To The Packaging Location (AREA)

Abstract

In the present invention, a drug supply unit comprises a discharge unit, lines the drug up and conveys the same towards the discharge unit, and discharges and individually supplies the drug from the discharge unit in order from the head of the line. A first detection unit outputs a first detection signal upon detecting the arrival of the drug at a first detection position outside the discharge unit. A second detection unit outputs a second detection signal upon detecting that the drug has passed through a second detection position that is further from the drug supply unit than the first detection position. A control unit controls the drug supply unit. The first detection signal from the first detection unit is input to the control unit, which controls the drug supply unit in response to the first detection signal, and the second detection signal from the second detection unit is input to the control unit, which counts the drug supplied from the drug supply unit in response to the second detection signal.

Description

薬剤供給装置Drug supply device
　本発明は、薬剤供給装置に関する。 The present invention relates to a drug supply device.
　薬剤供給装置の構成を開示した先行文献として、国際公開第２０１６／０１３５５３号(特許文献１)がある。特許文献１に記載された薬剤供給装置は、第１回転体と第２回転体とガイド部材とを含む薬剤払出部を備える。第１回転体は、水平面に対して傾斜した状態で回転可能に配置される円形面を有する。第２回転体は、第１回転体の外周側に回転可能に配置され、上記水平面上に配置される環状面を有する。ガイド部材は、第１回転体の円形面の上方に配置され、上記円形面に対して径方向に延び、かつ、径方向外側に向かうに従って第１回転体の回転方向下流側に位置し、第１回転体の回転により第１回転体上に載置された薬剤が当接可能となるガイド面を有する。薬剤は、排出口から排出される。排出口から排出された薬剤は、センサによって検出されて計数可能となっている。 As a prior document disclosing the configuration of the drug supply device, there is International Publication No. 2016/013553 (Patent Document 1). The drug supply device described in Patent Document 1 includes a drug delivery unit including a first rotating body, a second rotating body, and a guide member. The first rotating body has a circular surface that is rotatably arranged in a state of being inclined with respect to the horizontal plane. The second rotating body is rotatably arranged on the outer peripheral side of the first rotating body and has an annular surface arranged on the horizontal plane. The guide member is disposed above the circular surface of the first rotating body, extends in the radial direction with respect to the circular surface, and is located on the downstream side in the rotational direction of the first rotating body as it extends outward in the radial direction. It has a guide surface with which the medicine placed on the first rotating body can come into contact with the rotation of the one rotating body. The medicine is discharged from the discharge port. The drug discharged from the discharge port can be detected and counted by the sensor.
国際公開第２０１６／０１３５５３号International Publication No. 2016/013553
　排出部の近傍に配置されたセンサによって排出された薬剤を計数する場合、複数の薬剤が重なった状態で同時に排出されたときに複数の薬剤が同時に排出されたことを検出することができない。 When counting the drug discharged by a sensor arranged near the discharge part, it is not possible to detect that multiple drugs are discharged at the same time when multiple drugs are simultaneously discharged in an overlapping state.
　本発明は上記の問題点に鑑みてなされたものであって、排出部から複数の薬剤が同時に排出されたことを検出することができる、薬剤供給装置を提供することを目的とする。 The present invention has been made in view of the above problems, and an object of the present invention is to provide a drug supply device capable of detecting that a plurality of drugs have been simultaneously discharged from a discharge unit.
　本発明に基づく薬剤供給装置は、薬剤供給部と、第１検出部と、第２検出部と、制御部とを備える。薬剤供給部は、排出部を有し、排出部に向けて薬剤を整列させつつ搬送し、排出部から薬剤を先頭から順に１つずつ排出して供給する。第１検出部は、排出部の外側の第１検出位置に薬剤が到達したことを検出したときに第１検出信号を出力する。第２検出部は、第１検出位置より薬剤供給部から離れた第２検出位置を薬剤が通過したことを検出したときに第２検出信号を出力する。制御部は、薬剤供給部を制御する。制御部は、第１検出部から第１検出信号を入力され、第１検出信号に応じて薬剤供給部を制御し、かつ、第２検出部から第２検出信号を入力され、第２検出信号に応じて薬剤供給部から供給された薬剤を計数する。 The drug supply device according to the present invention includes a drug supply unit, a first detection unit, a second detection unit, and a control unit. The drug supply unit has a discharge unit, transports the drugs while aligning them toward the discharge unit, and discharges and supplies the drugs one by one from the beginning from the discharge unit. The first detection unit outputs the first detection signal when detecting that the medicine has reached the first detection position outside the discharge unit. The second detection unit outputs the second detection signal when it is detected that the medicine has passed the second detection position that is farther from the medicine supply unit than the first detection position. The control unit controls the drug supply unit. The control unit receives the first detection signal from the first detection unit, controls the drug supply unit according to the first detection signal, receives the second detection signal from the second detection unit, and receives the second detection signal. The drug supplied from the drug supply unit is counted in accordance with the above.
　本発明の一形態においては、制御部は、第１検出信号が入力されると、薬剤供給部による薬剤の搬送を一時的に停止させる。 In one aspect of the present invention, the control unit temporarily stops the delivery of the drug by the drug supply unit when the first detection signal is input.
　本発明の一形態においては、制御部は、第１検出信号が入力されると、薬剤供給部による薬剤の搬送方向を一時的に逆方向にする。 In one aspect of the present invention, when the first detection signal is input, the control unit temporarily causes the drug supply unit to transfer the drug in the reverse direction.
　本発明の一形態においては、制御部には、薬剤の形状に関する薬剤情報を有する薬剤情報信号が入力される。制御部は、第１検出信号が入力されると、薬剤情報に応じた薬剤供給部の制御を行なう。 In one aspect of the present invention, a drug information signal having drug information related to the shape of the drug is input to the control unit. When the first detection signal is input, the control unit controls the drug supply unit according to the drug information.
　本発明の一形態においては、制御部は、第１検出信号が入力される入力間隔中に第２検出信号が複数回入力されると、異常と判断する。 In one aspect of the present invention, the control unit determines that the abnormality is detected when the second detection signal is input a plurality of times during the input interval when the first detection signal is input.
　本発明によれば、排出部から複数の薬剤が同時に排出されたことを検出することができる。 According to the present invention, it is possible to detect that a plurality of drugs have been simultaneously discharged from the discharge part.
本発明の一実施形態に係る薬剤分包装置の外観を示す斜視図である。It is a perspective view showing the appearance of the medicine packing device concerning one embodiment of the present invention. 本発明の一実施形態に係る薬剤分包装置の構成を示す縦断面図である。It is a longitudinal section showing the composition of the medicine packing device concerning one embodiment of the present invention. 図２の薬剤分包装置を矢印ＩＩＩ方向から見た平面図である。It is the top view which looked at the medicine packing apparatus of FIG. 2 from the arrow III direction. 本発明の一実施形態に係る薬剤供給装置の構成を示す正面図である。It is a front view showing composition of a medicine supply device concerning one embodiment of the present invention. 本発明の一実施形態に係る薬剤供給装置が備える薬剤供給部の構成を示す斜視図である。It is a perspective view showing composition of a medicine supply part with which a medicine supply device concerning one embodiment of the present invention is provided. 図５の薬剤供給部を矢印ＶＩ方向から見た平面図である。It is the top view which looked at the chemical|medical agent supply part of FIG. 5 from the arrow VI direction. 図５の薬剤供給部を矢印ＶＩＩ方向から見た斜視図である。It is the perspective view which looked at the chemical|medical agent supply part of FIG. 5 from the arrow VII direction. 図５の薬剤供給部を矢印ＶＩＩＩ方向から見た図である。It is the figure which looked at the chemical|medical agent supply part of FIG. 5 from the arrow VIII direction. 図５の薬剤供給部を矢印ＩＸ方向から見た図である。It is the figure which looked at the chemical|medical agent supply part of FIG. 5 from the arrow IX direction. 本発明の一実施形態に係る薬剤供給装置が備える薬剤供給部が含む回転体の構成を示す側面図である。It is a side view which shows the structure of the rotating body which the chemical|medical agent supply part with which the chemical|medical agent supply apparatus which concerns on one Embodiment of this invention is equipped. 本発明の一実施形態に係る薬剤供給装置が備える薬剤供給部に含まれる蓋部材の外観を示す斜視図である。It is a perspective view showing appearance of a lid member included in a medicine supply part with which a medicine supply device concerning one embodiment of the present invention is provided. 図１１の蓋部材を矢印ＸＩＩ方向から見た図である。It is the figure which looked at the lid member of FIG. 11 from the arrow XII direction. 図１２の蓋部材を矢印ＸＩＩＩ方向から見た図である。It is the figure which looked at the lid member of FIG. 12 from the arrow XIII direction. 図１３の蓋部材を矢印ＸＩＶ方向から見た図である。It is the figure which looked at the lid member of FIG. 13 from the arrow XIV direction. 図１３の蓋部材を矢印ＸＶ方向から見た図である。It is the figure which looked at the lid member of FIG. 13 from the arrow XV direction. 本発明の一実施形態に係る薬剤供給装置が備える薬剤供給部に含まれる開閉部材の外観を示す斜視図である。It is a perspective view showing the appearance of the opening-and-closing member contained in the medicine supply part with which the medicine supply device concerning one embodiment of the present invention is equipped. 図１６の開閉部材を矢印ＸＶＩＩ方向から見た図である。It is the figure which looked at the opening/closing member of FIG. 16 from the arrow XVII direction. 本発明の一実施形態に係る薬剤供給装置が備える薬剤供給部において、開閉部が上方に回動して排出部が開いた状態を示す斜視図である。FIG. 7 is a perspective view showing a state in which the opening/closing section is rotated upward and the discharge section is opened in the medicine supply unit included in the medicine supply device according to the embodiment of the present invention. 本発明の一実施形態に係る薬剤供給装置が備える薬剤補充部の薬剤収容容器の構成を示す斜視図である。It is a perspective view showing composition of a medicine storage container of a medicine replenishment part with which a medicine supply device concerning one embodiment of the present invention is provided. 本発明の一実施形態に係る薬剤供給装置が備える薬剤補充部の薬剤収容容器において、外蓋を取り外した状態を示す斜視図である。It is a perspective view showing the state where the outer lid was removed in the medicine storage container of the medicine replenishing unit included in the medicine supply device according to one embodiment of the present invention. 本発明の一実施形態に係る薬剤供給装置が備える薬剤補充部の薬剤収容容器において、蓋部を取り外した状態を示す斜視図である。It is a perspective view showing the state where the lid was removed in the medicine storage container of the medicine replenishing unit included in the medicine supply device according to the embodiment of the present invention. 本発明の一実施形態に係る薬剤供給装置が備える薬剤補充部の薬剤収容容器において、蓋部を取り外した状態を示す側面図である。It is a side view which shows the state which removed the cover part in the chemical|medical agent container of the chemical|medical agent replenishment part with which the chemical|medical agent supply apparatus which concerns on one Embodiment of this invention is equipped. 本発明の一実施形態に係る薬剤供給装置が備える薬剤補充部の薬剤収容容器において、蓋部を取り外した状態を示す平面図である。It is a top view showing the state where the lid was removed in the medicine storage container of the medicine replenishing unit included in the medicine supply device according to one embodiment of the present invention. 本発明の一実施形態に係る薬剤供給装置が備える薬剤補充部の薬剤収容容器において、蓋部を取り外した状態を示す底面図である。It is a bottom view which shows the state which removed the cover part in the chemical|medical agent container of the chemical|medical agent replenishment part with which the chemical|medical agent supply apparatus which concerns on one Embodiment of this invention is equipped. 本発明の一実施形態に係る薬剤供給装置が備える薬剤補充部の薬剤収容容器において、蓋部を取り外した状態を示す縦断面図である。FIG. 3 is a vertical cross-sectional view showing a state in which a lid is removed, in a drug container of a drug replenishing unit included in a drug supply device according to an embodiment of the present invention. 本発明の一実施形態に係る薬剤供給装置が備える薬剤補充部の薬剤収容容器の開口部側の形状を示す部分斜視図である。FIG. 3 is a partial perspective view showing the shape of the medicine replenishing unit included in the medicine supply device according to the embodiment of the present invention on the side of the opening of the medicine container. 本発明の一実施形態に係る薬剤供給装置が備えるベース部の構成を示す部分斜視図である。It is a partial perspective view which shows the structure of the base part with which the chemical|medical agent supply apparatus which concerns on one Embodiment of this invention is equipped. 本発明の一実施形態に係る薬剤供給装置が備えるベース部の構成を示す部分背面図である。It is a partial rear view which shows the structure of the base part with which the chemical|medical agent supply apparatus which concerns on one Embodiment of this invention is equipped. 本発明の一実施形態に係る薬剤供給装置が備える薬剤供給部が、ベース部に装着された状態を示す部分斜視図である。It is a partial perspective view showing the state where the medicine supply part with which the medicine supply device concerning one embodiment of the present invention was equipped was attached to the base part. 本発明の一実施形態に係る薬剤供給装置が備えるベース部に薬剤供給部および薬剤収容容器の各々が取り付けられた状態において、ベース部の一部のカバーを取り外した状態を示す正面図である。FIG. 4 is a front view showing a state in which a cover of a part of the base part is removed in a state where the drug supply part and the drug container are attached to the base part included in the drug supply device according to the embodiment of the present invention. 本発明の一実施形態に係る薬剤供給装置から、薬剤収容容器およびベース部の一部のカバーを取り外した状態を示す正面側斜視図である。It is a front side perspective view showing the state where a medicine storage container and a part of cover of a base part were removed from a medicine supply device concerning one embodiment of the present invention. 本発明の一実施形態に係る薬剤供給装置からベース部の他の一部のカバーを取り外した状態を示す背面側斜視図である。It is a rear side perspective view showing the state where other cover of a base part was removed from a medicine supply device concerning one embodiment of the present invention. 本発明の一形態に係る薬剤分包装置の接続系統を示すブロック図である。It is a block diagram which shows the connection system of the medicine packaging apparatus which concerns on one form of this invention. 本発明の一形態に係る薬剤供給装置の接続系統を示すブロック図である。It is a block diagram which shows the connection system of the chemical|medical agent supply apparatus which concerns on one form of this invention. 本発明の一形態に係る薬剤分包装置が処方情報に応じて動作する際のタイムチャートである。It is a time chart at the time of the medicine packaging device which concerns on one form of this invention operate|moving according to prescription information. 処方情報および分包情報を説明するための図である。It is a figure for explaining prescription information and packing information. 主制御部から一処方における薬剤の必要数を入力された薬剤供給装置の制御部における動作を説明するフローチャートである。It is a flow chart explaining the operation in the control part of the medicine supply device in which the required number of medicines in one prescription is input from the main control part. 薬剤補充部によって薬剤を補充する際の制御部における動作を説明するフローチャートである。It is a flow chart explaining operation in a control part at the time of replenishing a medicine with a medicine replenishment part. 主制御部から一包における薬剤の必要数および供給指示を入力された薬剤供給装置の制御部における動作を説明するフローチャートである。It is a flowchart explaining operation|movement in the control part of the chemical|medical agent supply apparatus to which the required number and supply instruction|indication of the chemical|medical agent in one package were input from the main control part. 薬剤供給部によって薬剤を供給する際の制御部における動作を説明するフローチャートである。It is a flow chart explaining operation in a control part at the time of supplying a medicine by a medicine supply part. 薬剤供給部によって供給された薬剤を計数する際の制御部における動作を説明するフローチャートである。It is a flow chart explaining operation in a control part at the time of counting the medicine supplied by the medicine supply part.
　以下、本発明の一実施形態に係る薬剤分包装置について図を参照して説明する。以下の実施形態の説明においては、図中の同一または相当部分には同一符号を付して、その説明は繰返さない。 Hereinafter, a medicine packaging apparatus according to an embodiment of the present invention will be described with reference to the drawings. In the following description of the embodiments, the same or corresponding parts in the drawings will be denoted by the same reference numerals, and the description thereof will not be repeated.
　図１は、本発明の一実施形態に係る薬剤分包装置の外観を示す斜視図である。図２は、本発明の一実施形態に係る薬剤分包装置の構成を示す縦断面図である。図３は、図２の薬剤分包装置を矢印ＩＩＩ方向から見た平面図である。なお、図１においては、筐体の扉が開いた状態、かつ、手撒きカセットが筐体の前側にスライド移動した状態を図示している。図３においては、薬剤分包装置の天井部を透視して図示している。 FIG. 1 is a perspective view showing the external appearance of a medicine packaging device according to an embodiment of the present invention. FIG. 2 is a vertical cross-sectional view showing the configuration of the medicine packaging device according to the embodiment of the present invention. FIG. 3 is a plan view of the medicine packaging device of FIG. 2 seen from the direction of arrow III. Note that FIG. 1 illustrates a state in which the door of the housing is open and the manual cassette is slid to the front side of the housing. In FIG. 3, the ceiling part of the medicine packaging apparatus is seen through.
　図１～図３に示すように、本発明の一実施形態に係る薬剤分包装置４００は、薬剤供給装置ユニットと、筐体４１０と、回転ドラム４２０と、ホッパ４３０と、薬剤包装装置ユニット４４０とを備えている。薬剤分包装置４００は、後述する制御装置ユニットをさらに備える。 As shown in FIGS. 1 to 3, a medicine packing apparatus 400 according to an embodiment of the present invention includes a medicine supply device unit, a housing 410, a rotating drum 420, a hopper 430, and a medicine packaging device unit 440. It has and. The medicine packaging device 400 further includes a control device unit described later.
　薬剤供給装置ユニットは、薬剤を供給する複数の薬剤供給装置を有している。具体的には、薬剤供給装置ユニットは、複数の第１薬剤供給装置１０と、複数の第２薬剤供給装置２０と、第３薬剤供給装置３０とを有している。 The drug supply device unit has a plurality of drug supply devices for supplying a drug. Specifically, the drug supply device unit includes a plurality of first drug supply devices 10, a plurality of second drug supply devices 20, and a third drug supply device 30.
　複数の第２薬剤供給装置２０の各々は、複数の薬剤を収容しており、必要数の薬剤を供給可能に構成されている。第２薬剤供給装置２０は、自動薬剤供給カセットである。第３薬剤供給装置３０は、手撒き薬剤供給カセットである。手撒き薬剤供給カセットは、マトリクス状に配置された区画室を有し、各区画室に一包分の薬剤が収容される。 Each of the plurality of second drug supply devices 20 accommodates a plurality of drugs and is configured to be able to supply the required number of drugs. The second medicine supply device 20 is an automatic medicine supply cassette. The third medicine supply device 30 is a manual medicine supply cassette. The hand-delivered medicine supply cassette has compartments arranged in a matrix, and each compartment accommodates one package of medicine.
　複数の第１薬剤供給装置１０の各々は、複数の第２薬剤供給装置２０のうちの薬剤が空になった第２薬剤供給装置２０の代わりに、当該薬剤を供給することができる。また、複数の第１薬剤供給装置１０の各々は、複数の第２薬剤供給装置２０の各々に収容されている薬剤とは異なる他の薬剤を供給することができる。 Each of the plurality of first drug supply devices 10 can supply the drug in place of the second drug supply device 20 of the plurality of second drug supply devices 20, which is empty of the drug. Further, each of the plurality of first drug supply devices 10 can supply another drug different from the drug contained in each of the plurality of second drug supply devices 20.
　薬剤供給装置ユニットは、複数の薬剤供給装置の中から選択された薬剤供給装置から薬剤を一包分ずつ供給する。薬剤包装装置ユニット４４０は、薬剤供給装置ユニットから供給された薬剤を一包分ずつ包装する。制御装置ユニットは、薬剤供給装置ユニットおよび薬剤包装装置ユニットの各々を制御する。 The drug supply device unit supplies the drug one by one from the drug supply device selected from the plurality of drug supply devices. The medicine packaging device unit 440 packages the medicines supplied from the medicine supply device unit one by one. The control device unit controls each of the medicine supply device unit and the medicine packaging device unit.
　筐体４１０は、薬剤供給装置ユニットと、回転ドラム４２０と、ホッパ４３０と、薬剤包装装置ユニット４４０とを収容している。筐体４１０は、開閉可能な扉を有している。筐体４１０の正面に、操作パネル５０が設けられている。 The housing 410 accommodates a drug supply device unit, a rotary drum 420, a hopper 430, and a drug packaging device unit 440. The housing 410 has a door that can be opened and closed. The operation panel 50 is provided on the front surface of the housing 410.
　図２および図３に示すように、回転ドラム４２０は、筐体４１０内において、軸線４まわりに回転可能に支持されている。回転ドラム４２０には、複数の第１薬剤供給装置１０および複数の第２薬剤供給装置２０が取り付けられる。すなわち、第１薬剤供給装置１０は、移動可能な状態で筐体４１０内に収容されている。 As shown in FIGS. 2 and 3, the rotary drum 420 is rotatably supported around the axis 4 in the housing 410. A plurality of first drug supply devices 10 and a plurality of second drug supply devices 20 are attached to the rotary drum 420. That is, the first drug supply device 10 is housed in the housing 410 in a movable state.
　図２に示すように、回転ドラム４２０には、薬剤搬送路４２１が設けられている。薬剤搬送路４２１は、ホッパ４３０の上方に位置している。図３に示すように、回転ドラム４２０の外周側に、第１薬剤供給装置１０および第２薬剤供給装置２０が環状に並んで配置されている。図２に示すように、第１薬剤供給装置１０および第２薬剤供給装置２０の各々は、上下方向に並んで配置されている。第１薬剤供給装置１０および第２薬剤供給装置２０の各々は、薬剤搬送路４２１と接続されている。第１薬剤供給装置１０および第２薬剤供給装置２０の各々から供給された薬剤は、薬剤搬送路４２１を通過してホッパ４３０内に投入される。第３薬剤供給装置３０から供給された薬剤は、ホッパ４３０内に投入される。ホッパ４３０内に投入された薬剤は、薬剤包装装置ユニット４４０にて包装される。 As shown in FIG. 2, the rotary drum 420 is provided with a drug delivery path 421. The medicine transport path 421 is located above the hopper 430. As shown in FIG. 3, the first drug supply device 10 and the second drug supply device 20 are annularly arranged side by side on the outer peripheral side of the rotary drum 420. As shown in FIG. 2, the first drug supply device 10 and the second drug supply device 20 are arranged side by side in the vertical direction. Each of the first drug supply device 10 and the second drug supply device 20 is connected to the drug delivery path 421. The medicine supplied from each of the first medicine supply device 10 and the second medicine supply device 20 passes through the medicine conveyance path 421 and is put into the hopper 430. The medicine supplied from the third medicine supply device 30 is put into the hopper 430. The medicine put into the hopper 430 is packed in the medicine packing device unit 440.
　なお、薬剤分包装置４００の構成は、上記に限られない。たとえば、第１薬剤供給装置１０および第２薬剤供給装置２０の各々が、回転ドラム４２０の代わりにスライド可能なラックに取り付けられていてもよい。この場合、ラックを筐体４１０の外側に引き出すことにより、第１薬剤供給装置１０および第２薬剤供給装置２０の各々を筐体４１０の外側に移動させることができる。なお、ラックのスライド方向は、筐体４１０の前後方向でもよいし、筐体４１０の左右方向でもよい。また、筐体４１０の扉が観音開きする構造であってもよい。 The configuration of the medicine packaging device 400 is not limited to the above. For example, each of the first drug supply device 10 and the second drug supply device 20 may be attached to a slidable rack instead of the rotating drum 420. In this case, each of the first drug supply device 10 and the second drug supply device 20 can be moved to the outside of the casing 410 by pulling out the rack to the outside of the casing 410. The sliding direction of the rack may be the front-rear direction of the housing 410 or the left-right direction of the housing 410. Further, the door of the housing 410 may have a double-door structure.
　次に、本発明の一実施形態に係る薬剤供給装置について図を参照して説明する。図４は、本発明の一実施形態に係る薬剤供給装置の構成を示す正面図である。図４に示すように、本発明の一実施形態に係る第１薬剤供給装置１０は、薬剤供給部である薬剤供給モジュール１００と薬剤補充部１２とを含む。第１薬剤供給装置１０は、ベース部２００をさらに含む。ベース部２００の正面には、表示部２５０および停止スイッチ２３８が設けられている。薬剤補充部１２は、薬剤を収容する薬剤収容容器３００を含む。薬剤供給モジュール１００および薬剤収容容器３００の各々は、別々にベース部２００に着脱可能である。 Next, a drug supply device according to an embodiment of the present invention will be described with reference to the drawings. FIG. 4 is a front view showing the configuration of the drug supply device according to the embodiment of the present invention. As shown in FIG. 4, the first drug supply device 10 according to an embodiment of the present invention includes a drug supply module 100, which is a drug supply unit, and a drug replenishment unit 12. The first medicine supply device 10 further includes a base unit 200. A display unit 250 and a stop switch 238 are provided on the front surface of the base unit 200. The medicine replenishing unit 12 includes a medicine storage container 300 that stores a medicine. Each of the drug supply module 100 and the drug container 300 can be separately attached to and detached from the base unit 200.
　図５は、本発明の一実施形態に係る薬剤供給装置が備える薬剤供給部の構成を示す斜視図である。図６は、図５の薬剤供給部を矢印ＶＩ方向から見た平面図である。図７は、図５の薬剤供給部を矢印ＶＩＩ方向から見た斜視図である。図８は、図５の薬剤供給部を矢印ＶＩＩＩ方向から見た図である。図９は、図５の薬剤供給部を矢印ＩＸ方向から見た図である。 FIG. 5 is a perspective view showing a configuration of a drug supply unit included in the drug supply device according to the embodiment of the present invention. FIG. 6 is a plan view of the medicine supply unit of FIG. 5 viewed from the direction of arrow VI. FIG. 7 is a perspective view of the medicine supply unit of FIG. 5 viewed from the arrow VII direction. FIG. 8 is a diagram of the medicine supply unit of FIG. 5 viewed from the direction of arrow VIII. FIG. 9 is a view of the medicine supply unit of FIG. 5 viewed from the arrow IX direction.
　図６および図７においては、後述する蓋部を透視して図示している。図８においては、後述する蓋部材および開閉部材を図示していない。図９においては、蓋部を透視して図示しており、後述する支持部を図示していない。 In FIGS. 6 and 7, a lid portion described later is shown in a see-through manner. In FIG. 8, a lid member and an opening/closing member which will be described later are not shown. In FIG. 9, the lid portion is shown in a see-through manner, and the support portion described later is not shown.
　図５～図９に示すように、本発明の一実施形態に係る第１薬剤供給装置１０が備える薬剤供給部である薬剤供給モジュール１００は、回転体１１０と、周壁部と、排出部１３１とを備える。本実施形態においては、薬剤供給モジュール１００は、支持部１５０、蓋部１２６および開閉部１４１をさらに備える。後述するように、薬剤供給モジュール１００は、補充された薬剤を受ける薬剤受け位置および排出部１３１を有し、薬剤受け位置から排出部１３１に向けて薬剤を一列に整列させつつ搬送し、排出部１３１から薬剤を先頭から順に１つずつ排出して供給する薬剤供給部として機能する。 As shown in FIGS. 5 to 9, a drug supply module 100, which is a drug supply unit included in the first drug supply device 10 according to an embodiment of the present invention, includes a rotating body 110, a peripheral wall part, and a discharge part 131. Equipped with. In the present embodiment, the drug supply module 100 further includes a support part 150, a lid part 126, and an opening/closing part 141. As will be described later, the drug supply module 100 has a drug receiving position and a discharging unit 131 for receiving the refilled drug, and conveys the drugs while aligning the drugs in a line from the drug receiving position to the discharging unit 131, and the discharging unit. It functions as a drug supply unit that sequentially discharges and supplies the drugs one by one from 131.
　本実施形態においては、薬剤供給モジュール１００は、回転体１１０と周壁部と排出部１３１と開閉部１４１とを含んで一体に構成されている。なお、開閉部１４１は、必ずしも設けられていなくてもよい。すなわち、薬剤供給モジュール１００が、回転体１１０と周壁部と排出部１３１とを含んで一体に構成されていてもよい。 In the present embodiment, the drug supply module 100 is integrally configured by including the rotating body 110, the peripheral wall portion, the discharging portion 131, and the opening/closing portion 141. The opening/closing unit 141 does not necessarily have to be provided. That is, the medicine supply module 100 may be integrally configured by including the rotating body 110, the peripheral wall portion, and the discharging portion 131.
　図１０は、本発明の一実施形態に係る薬剤供給装置が備える薬剤供給部が含む回転体の構成を示す側面図である。図１０においては、回転体を図９と同一方向から見て図示している。図８～図１０に示すように、回転体１１０は、鉛直方向に延びる軸線１を中心として回転し、軸線１を中心とする径方向の外側に行くにしたがって下方に傾斜する軸線１と同軸の円錐面状の斜面１１０ｓを有する。 FIG. 10 is a side view showing the configuration of the rotating body included in the drug supply unit included in the drug supply device according to the embodiment of the present invention. In FIG. 10, the rotating body is shown when viewed from the same direction as in FIG. 9. As shown in FIGS. 8 to 10, the rotating body 110 rotates about an axis 1 that extends in the vertical direction, and is coaxial with the axis 1 that is inclined downward as it goes radially outward about the axis 1. It has a conical slope 110s.
　回転体１１０は、互いに同軸配置された、第１回転部１１１および第２回転部１１２を含む。第２回転部１１２は、第１回転部１１１の下方に位置している。第１回転部１１１の側面と、第２回転部１１２の側面とで、斜面１１０ｓが構成されている。第１回転部１１１および第２回転部１１２の各々は、互いに別々に回転可能に設けられている。図８～図１０に示すように、第１回転部１１１は、第１従動歯車１１１ｇと接続されている。第２回転部１１２は、第２従動歯車１１２ｇと接続されている。 The rotating body 110 includes a first rotating portion 111 and a second rotating portion 112 that are coaxially arranged. The second rotating portion 112 is located below the first rotating portion 111. The side surface of the first rotating portion 111 and the side surface of the second rotating portion 112 form an inclined surface 110s. Each of the first rotating unit 111 and the second rotating unit 112 is rotatably provided separately from each other. As shown in FIGS. 8 to 10, the first rotating portion 111 is connected to the first driven gear 111g. The second rotating portion 112 is connected to the second driven gear 112g.
　本実施形態においては、回転体１１０の斜面１１０ｓには、薬剤の転動を防止する転動防止部が設けられている。転動防止部は、斜面１１０ｓの頂点部から放射状に設けられた凹条部で構成されている。具体的には、転動防止部は、第１回転部１１１に設けられた第１凹条部１１１ｃと、第２回転部１１２に設けられた第２凹条部１１２ｃとから構成されている。なお、転動防止部は、必ずしも設けられていなくてもよい。 In the present embodiment, the slope 110s of the rotating body 110 is provided with a rolling prevention unit that prevents the medicine from rolling. The rolling prevention portion is composed of a concave streak portion radially provided from the apex of the slope 110s. Specifically, the rolling prevention portion is composed of a first groove portion 111c provided on the first rotating portion 111 and a second groove portion 112c provided on the second rotating portion 112. The rolling prevention unit does not necessarily have to be provided.
　図６～図８に示すように、回転体１１０は、回転体１１０の下方に位置する支持部１５０に、回転可能に支持されている。回転体１１０は、支持部１５０に対して着脱可能に設けられている。図８に示すように、支持部１５０は、略円形状の水平面部１５１と、水平面部１５１の縁から略円筒状に立設された立設部１５２と、水平面部１５１から下方に略円筒状に延在する台部１５３を含む。台部１５３の内周側に、第１従動歯車１１１ｇおよび第２従動歯車１１２ｇの各々が位置している。 As shown in FIGS. 6 to 8, the rotating body 110 is rotatably supported by the supporting portion 150 located below the rotating body 110. The rotating body 110 is provided so as to be attachable to and detachable from the supporting unit 150. As shown in FIG. 8, the support portion 150 includes a substantially circular horizontal plane portion 151, an upright portion 152 that stands up from the edge of the horizontal plane portion 151 in a substantially cylindrical shape, and a substantially cylindrical shape below the horizontal plane portion 151. Includes a base 153 extending to. Each of the first driven gear 111g and the second driven gear 112g is located on the inner peripheral side of the base portion 153.
　図６～図９に示すように、本実施形態においては、薬剤供給モジュール１００は、複数の周壁部を含んでいる。具体的には、薬剤供給モジュール１００は、第１周壁部１２１、第２周壁部１２２および第３周壁部１２３を含んでいる。なお、薬剤供給モジュール１００が含む周壁部の数は、３つに限られず、１つ以上であればよい。 As shown in FIGS. 6 to 9, in the present embodiment, the drug supply module 100 includes a plurality of peripheral wall portions. Specifically, the medicine supply module 100 includes a first peripheral wall portion 121, a second peripheral wall portion 122, and a third peripheral wall portion 123. The number of peripheral wall portions included in the drug supply module 100 is not limited to three and may be one or more.
　図６に示すように、第１周壁部１２１、第２周壁部１２２および第３周壁部１２３の各々は、斜面１１０ｓの上方において軸線１を中心とする周方向に沿って円弧状に延在している。第１周壁部１２１、第２周壁部１２２および第３周壁部１２３の各々は、斜面１１０ｓ上に供給された薬剤を上記径方向の外側から支持する。 As shown in FIG. 6, each of the first peripheral wall portion 121, the second peripheral wall portion 122, and the third peripheral wall portion 123 extends in an arc shape along the circumferential direction about the axis 1 above the slope 110s. ing. Each of the 1st peripheral wall part 121, the 2nd peripheral wall part 122, and the 3rd peripheral wall part 123 supports the chemical|medical agent supplied on 110 s of slopes from the outer side of the said radial direction.
　第１周壁部１２１、第２周壁部１２２および第３周壁部１２３は、回転体１１０の回転方向２に互いに並んでおり、かつ、回転方向２の下流側に位置する周壁部ほど上記径方向の外側かつ下方に位置している。具体的には、第２周壁部１２２は、第１周壁部１２１に対して回転方向２の下流側に位置しており、かつ、第１周壁部１２１に対して、上記径方向の外側かつ下方に位置している。第３周壁部１２３は、第２周壁部１２２に対して回転方向２の下流側に位置しており、かつ、第２周壁部１２２に対して、上記径方向の外側かつ下方に位置している。 The 1st peripheral wall part 121, the 2nd peripheral wall part 122, and the 3rd peripheral wall part 123 are located in a line with each other in the rotation direction 2 of the rotating body 110, and the peripheral wall part located in the downstream of the rotation direction 2 has the said radial direction. It is located outside and below. Specifically, the second peripheral wall portion 122 is located on the downstream side in the rotation direction 2 with respect to the first peripheral wall portion 121, and is radially outward and downward with respect to the first peripheral wall portion 121. Is located in. The third peripheral wall portion 123 is located on the downstream side in the rotation direction 2 with respect to the second peripheral wall portion 122, and is located outside and below in the radial direction with respect to the second peripheral wall portion 122. ..
　第１周壁部１２１および第２周壁部１２２の各々は、第１回転部１１１の上方に位置している。第３周壁部１２３は、第２回転部１１２の上方に位置している。よって、第１回転部１１１は、第１周壁部１２１によって支持されている薬剤を、第１周壁部１２１に沿って搬送する。第１回転部１１１は、第２周壁部１２２によって支持されている薬剤を、第２周壁部１２２に沿って搬送する。第２回転部１１２は、第３周壁部１２３によって支持されている薬剤を、第３周壁部１２３に沿って搬送する。 Each of the first peripheral wall portion 121 and the second peripheral wall portion 122 is located above the first rotating portion 111. The third peripheral wall portion 123 is located above the second rotating portion 112. Therefore, the 1st rotation part 111 conveys the chemical|medical agent supported by the 1st surrounding wall part 121 along the 1st surrounding wall part 121. The first rotating unit 111 conveys the drug supported by the second peripheral wall 122 along the second peripheral wall 122. The second rotating portion 112 conveys the medicine supported by the third peripheral wall portion 123 along the third peripheral wall portion 123.
　図９に示すように、第１周壁部１２１、第２周壁部１２２および第３周壁部１２３の各々は、斜面１１０ｓに対して離間している。具体的には、第１周壁部１２１、第２周壁部１２２および第３周壁部１２３の各々は、斜面１１０ｓ上に供給された薬剤を上記径方向の外側から支持可能な範囲で、斜面１１０ｓに対して離間している。 As shown in FIG. 9, each of the first peripheral wall portion 121, the second peripheral wall portion 122, and the third peripheral wall portion 123 is separated from the slope 110s. Specifically, each of the first peripheral wall portion 121, the second peripheral wall portion 122, and the third peripheral wall portion 123 has a slope 110 s within a range in which the medicine supplied onto the slope 110 s can be supported from the outside in the radial direction. Separated from each other.
　図６、図７および図９に示すように、本実施形態においては、回転方向２に互いに隣り合う周壁部同士のうち回転方向２の上流側に位置する周壁部における回転方向２の下流側の端部は、回転方向２の下流側に行くにしたがって斜面１１０ｓから離れている。 As shown in FIGS. 6, 7 and 9, in the present embodiment, among the peripheral wall portions that are adjacent to each other in the rotational direction 2, the peripheral wall portions that are located on the upstream side in the rotational direction 2 are located on the downstream side in the rotational direction 2. The end portion is separated from the slope 110s as it goes downstream in the rotation direction 2.
　具体的には、第１周壁部１２１における回転方向２の下流側の端部は、回転方向２の下流側に行くにしたがって斜面１１０ｓから離れている。同様に、第２周壁部１２２における回転方向２の下流側の端部は、回転方向２の下流側に行くにしたがって斜面１１０ｓから離れている。 Specifically, the downstream end of the first peripheral wall portion 121 in the rotation direction 2 is separated from the slope 110s as it goes to the downstream side in the rotation direction 2. Similarly, the downstream end of the second peripheral wall portion 122 in the rotation direction 2 is separated from the slope 110 s as it goes downstream in the rotation direction 2.
　図６、図７および図９に示すように、本実施形態においては、回転方向２に互いに隣り合う周壁部同士は、回転方向２の下流側に行くにしたがって上記径方向の外側に延在しつつ下降する傾斜壁部にて互いに接続されている。なお、傾斜壁部は、必ずしも設けられていなくてもよい。 As shown in FIGS. 6, 7, and 9, in the present embodiment, the peripheral wall portions adjacent to each other in the rotation direction 2 extend outward in the radial direction as they go downstream in the rotation direction 2. They are connected to each other by a slanted wall portion that descends. The inclined wall portion does not necessarily have to be provided.
　具体的には、第１周壁部１２１と第２周壁部１２２とは、第１傾斜壁部１２４にて互いに接続されている。第２周壁部１２２と第３周壁部１２３とは、第２傾斜壁部１２５にて互いに接続されている。 Specifically, the first peripheral wall portion 121 and the second peripheral wall portion 122 are connected to each other by the first inclined wall portion 124. The second peripheral wall portion 122 and the third peripheral wall portion 123 are connected to each other by the second inclined wall portion 125.
　図７および図９に示すように、第１傾斜壁部１２４および第２傾斜壁部１２５の各々は、斜面１１０ｓから上方に離れるにしたがって、回転方向２の下流側に傾斜している。よって、第１周壁部１２１と第１傾斜壁部１２４との境界線、および、第２周壁部１２２と第１傾斜壁部１２４との境界線の、各々は、斜面１１０ｓから上方に離れるにしたがって、回転方向２の下流側に傾斜している。同様に、第２周壁部１２２と第２傾斜壁部１２５との境界線、および、第３周壁部１２３と第２傾斜壁部１２５との境界線の、各々は、斜面１１０ｓから上方に離れるにしたがって、回転方向２の下流側に傾斜している。 As shown in FIGS. 7 and 9, each of the first inclined wall portion 124 and the second inclined wall portion 125 inclines toward the downstream side in the rotational direction 2 as it goes away from the slope 110s. Therefore, each of the boundary line between the first peripheral wall portion 121 and the first inclined wall portion 124 and the boundary line between the second peripheral wall portion 122 and the first inclined wall portion 124 increases with increasing distance from the slope 110s. , Is inclined to the downstream side in the rotation direction 2. Similarly, each of the boundary line between the second peripheral wall portion 122 and the second inclined wall portion 125 and the boundary line between the third peripheral wall portion 123 and the second inclined wall portion 125 is separated upward from the slope 110s. Therefore, it is inclined to the downstream side in the rotation direction 2.
　図５～図７および図９に示すように、本実施形態においては、第１周壁部１２１、第２周壁部１２２および第３周壁部１２３の各々は、蓋部１２６と一体で構成されている。第１周壁部１２１、第２周壁部１２２および第３周壁部１２３の各々は、蓋部１２６の下面から下方に延在している。なお、蓋部１２６は、必ずしも設けられていなくてもよく、周壁部が斜面１１０ｓの上方に配置されていればよい。 As shown in FIGS. 5 to 7 and 9, in the present embodiment, each of the first peripheral wall portion 121, the second peripheral wall portion 122 and the third peripheral wall portion 123 is configured integrally with the lid portion 126. .. Each of the first peripheral wall 121, the second peripheral wall 122, and the third peripheral wall 123 extends downward from the lower surface of the lid 126. The lid 126 does not necessarily have to be provided, and the peripheral wall may be provided above the slope 110s.
　第１傾斜壁部１２４および第２傾斜壁部１２５の各々は、蓋部１２６と一体で構成されている。第１傾斜壁部１２４および第２傾斜壁部１２５の各々は、蓋部１２６の下面から下方に延在している。 Each of the first inclined wall portion 124 and the second inclined wall portion 125 is configured integrally with the lid portion 126. Each of the first inclined wall portion 124 and the second inclined wall portion 125 extends downward from the lower surface of the lid portion 126.
　蓋部１２６は、斜面１１０ｓを上方から覆っている。蓋部１２６は、斜面１１０ｓを上方に開放可能に設けられている。蓋部１２６は、支持部１５０上に配置されている。具体的には、蓋部１２６は、蓋部材１２０に設けられている。第１周壁部１２１、第２周壁部１２２および第３周壁部１２３の各々は、蓋部材１２０に設けられている。第１傾斜壁部１２４および第２傾斜壁部１２５の各々は、蓋部材１２０に設けられている。 The lid 126 covers the slope 110s from above. The lid 126 is provided so that the slope 110s can be opened upward. The lid 126 is arranged on the support 150. Specifically, the lid 126 is provided on the lid member 120. Each of the first peripheral wall portion 121, the second peripheral wall portion 122, and the third peripheral wall portion 123 is provided on the lid member 120. Each of the first inclined wall portion 124 and the second inclined wall portion 125 is provided on the lid member 120.
　蓋部材１２０は、支持部１５０に対して着脱可能に支持部１５０上に載置されている。本実施形態においては、図６に示すように、蓋部１２６と支持部１５０との間に、緩衝部材１７０が設けられている。具体的には、蓋部材１２０が、円弧形状を有する緩衝部材１７０を介して支持部１５０の水平面部１５１上に載置されている。緩衝部材１７０は、ゴムなどの弾性体で構成されている。なお、緩衝部材１７０は、必ずしも設けられていなくてもよい。 The lid member 120 is detachably mounted on the support portion 150 with respect to the support portion 150. In this embodiment, as shown in FIG. 6, a cushioning member 170 is provided between the lid 126 and the support 150. Specifically, the lid member 120 is placed on the horizontal surface portion 151 of the support portion 150 via the buffer member 170 having an arc shape. The cushioning member 170 is made of an elastic body such as rubber. The buffer member 170 does not necessarily have to be provided.
　蓋部材１２０は、透明部材で構成されている。よって、蓋部１２６、第１周壁部１２１、第２周壁部１２２および第３周壁部１２３の各々は、透明部材で構成されている。これにより、蓋部材１２０の外側から蓋部材１２０の内側を視認可能となっている。ただし、蓋部材１２０は、非透明部材で構成されていてもよい。 The lid member 120 is made of a transparent member. Therefore, each of the lid 126, the first peripheral wall 121, the second peripheral wall 122, and the third peripheral wall 123 is made of a transparent member. Thereby, the inside of the lid member 120 can be visually recognized from the outside of the lid member 120. However, the lid member 120 may be made of a non-transparent member.
　図１１は、本発明の一実施形態に係る薬剤供給装置が備える薬剤供給部に含まれる蓋部材の外観を示す斜視図である。図１２は、図１１の蓋部材を矢印ＸＩＩ方向から見た図である。図１３は、図１２の蓋部材を矢印ＸＩＩＩ方向から見た図である。図１４は、図１３の蓋部材を矢印ＸＩＶ方向から見た図である。図１５は、図１３の蓋部材を矢印ＸＶ方向から見た図である。図１１および図１２においては、後述する振動伝達板が蓋部材１２０から取り外された状態を図示している。 FIG. 11 is a perspective view showing an external appearance of a lid member included in a drug supply unit included in the drug supply device according to the embodiment of the present invention. FIG. 12 is a view of the lid member of FIG. 11 viewed from the arrow XII direction. FIG. 13 is a diagram of the lid member of FIG. 12 viewed from the arrow XIII direction. FIG. 14 is a view of the lid member of FIG. 13 viewed from the arrow XIV direction. FIG. 15 is a view of the lid member of FIG. 13 viewed from the arrow XV direction. 11 and 12 show a state in which a later-described vibration transmission plate is removed from the lid member 120.
　図１１～図１５に示すように、本実施形態においては、蓋部材１２０に、薬剤供給孔１２７、切欠部１２８および取付部１２９が設けられている。具体的には、薬剤供給孔１２７および取付部１２９の各々が、蓋部材１２０の天面に設けられている。切欠部１２８は、蓋部材１２０の下端側の周縁に設けられている。 As shown in FIGS. 11 to 15, in the present embodiment, the lid member 120 is provided with the medicine supply hole 127, the cutout portion 128, and the attachment portion 129. Specifically, each of the medicine supply hole 127 and the attachment portion 129 is provided on the top surface of the lid member 120. The cutout 128 is provided on the peripheral edge of the lid member 120 on the lower end side.
　薬剤供給孔１２７は、蓋部材１２０の外側から蓋部材１２０の内側に薬剤を供給するために設けられている。切欠部１２８は、後述する排出部材を支持部１５０上に配置するために設けられている。取付部１２９は、後述する振動伝達板を蓋部材１２０に取り付けるために設けられている。 The drug supply hole 127 is provided to supply a drug from the outside of the lid member 120 to the inside of the lid member 120. The cutout portion 128 is provided for disposing a discharge member, which will be described later, on the support portion 150. The attachment portion 129 is provided to attach a vibration transmission plate, which will be described later, to the lid member 120.
　図１３～図１５に示すように、蓋部材１２０においては、薬剤供給孔１２７の下側に第１周壁部１２１が位置し、第１周壁部１２１に隣接して第１傾斜壁部１２４が位置し、第１傾斜壁部１２４に隣接して第２周壁部１２２が位置し、第２周壁部１２２に隣接して第２傾斜壁部１２５が位置し、第２傾斜壁部１２５に隣接して第３周壁部１２３が位置し、第３周壁部１２３に隣接して切欠部１２８が位置している。 As shown in FIGS. 13 to 15, in the lid member 120, the first peripheral wall portion 121 is located below the drug supply hole 127, and the first inclined wall portion 124 is located adjacent to the first peripheral wall portion 121. Then, the second peripheral wall portion 122 is positioned adjacent to the first inclined wall portion 124, the second inclined wall portion 125 is positioned adjacent to the second peripheral wall portion 122, and the second inclined wall portion 125 is adjacent. The third peripheral wall portion 123 is located, and the cutout portion 128 is located adjacent to the third peripheral wall portion 123.
　図１１に示すように、取付部１２９には、ねじ孔が設けられている。図５～図７に示すように、取付部１２９には、振動伝達板１６０がねじによって固定されている。振動伝達板１６０は、蓋部１２６の一部を構成している。本実施形態においては、振動伝達板１６０は、磁性体で構成されている。なお、振動伝達板１６０は、非磁性体で構成されていてもよい。振動伝達板１６０は、必ずしも設けられていなくてもよい。 As shown in FIG. 11, the mounting portion 129 is provided with a screw hole. As shown in FIGS. 5 to 7, the vibration transmission plate 160 is fixed to the mounting portion 129 by screws. The vibration transmission plate 160 constitutes a part of the lid 126. In this embodiment, the vibration transmission plate 160 is made of a magnetic material. The vibration transmission plate 160 may be made of a non-magnetic material. The vibration transmission plate 160 does not necessarily have to be provided.
　図５～図７および図９に示すように、切欠部１２８に嵌め込まれるように、排出部材１３０が支持部１５０上に設けられている。排出部材１３０は、切欠部１２８の形状に対応した外形を有している。排出部材１３０と蓋部材１２０との間には、僅かな隙間が設けられている。 As shown in FIGS. 5 to 7 and 9, a discharge member 130 is provided on the support portion 150 so as to be fitted into the cutout portion 128. The discharge member 130 has an outer shape corresponding to the shape of the cutout 128. A slight gap is provided between the discharge member 130 and the lid member 120.
　排出部材１３０には、回転体１１０の回転により、第１周壁部１２１、第２周壁部１２２および第３周壁部１２３の各々に順次沿って搬送された薬剤を斜面１１０ｓ上から排出する排出部１３１が設けられている。 The discharging member 130 discharges the medicine, which is sequentially conveyed along each of the first peripheral wall portion 121, the second peripheral wall portion 122, and the third peripheral wall portion 123, by the rotation of the rotating body 110 from the slope 110s. Is provided.
　図７に示すように、排出部材１３０には、立壁部１３２が設けられている。すなわち、立壁部１３２は、周壁部とは別部材で構成されている。立壁部１３２は、第３周壁部１２３と排出部１３１との間に設けられ、薬剤を上記径方向の外側から支持する。立壁部１３２は、軸線１を中心とする周方向に沿って円弧状に延在している。本実施形態においては、第３周壁部１２３、立壁部１３２および排出部１３１は、軸線１を中心とする周方向に沿って並んでいる。なお、立壁部１３２は、必ずしも設けられていなくてもよい。 As shown in FIG. 7, the discharge member 130 is provided with a standing wall portion 132. That is, the standing wall portion 132 is configured as a member different from the peripheral wall portion. The standing wall portion 132 is provided between the third peripheral wall portion 123 and the discharge portion 131, and supports the medicine from the outside in the radial direction. The standing wall portion 132 extends in an arc shape along the circumferential direction around the axis 1. In the present embodiment, the third peripheral wall portion 123, the standing wall portion 132, and the discharge portion 131 are arranged along the circumferential direction centered on the axis 1. The standing wall portion 132 does not necessarily have to be provided.
　排出部材１３０には、開閉部１４１を回動させる回動軸１４０ｓを支持する１対の軸受部１３０ｂが設けられている。１対の軸受部１３０ｂは、排出部１３１の上方の位置に立設されている。開閉部１４１は、回動軸１４０ｓによって回動させられることにより、排出部１３１を開閉可能に構成されている。 The discharge member 130 is provided with a pair of bearings 130b that supports a rotating shaft 140s that rotates the opening/closing part 141. The pair of bearings 130b is erected at a position above the discharge part 131. The opening/closing part 141 is configured to be able to open/close the discharging part 131 by being rotated by the rotating shaft 140s.
　開閉部１４１は、付勢部材１４０ｔと接続されており、排出部１３１を閉じる方向に付勢されている。本実施形態においては、付勢部材１４０ｔは、トーションばねで構成されているが、トーションばねに限られない。なお、付勢部材１４０ｔは、必ずしも設けられていなくてもよい。ベース部２００には、開閉部１４１の開閉状態を検出する、後述する開閉センサ２３７が設けられている。 The opening/closing part 141 is connected to the biasing member 140t and is biased in the direction of closing the discharging part 131. In the present embodiment, the biasing member 140t is composed of a torsion spring, but is not limited to the torsion spring. The urging member 140t does not necessarily have to be provided. The base unit 200 is provided with an open/close sensor 237 which will be described later and detects the open/closed state of the open/close unit 141.
　図７および図９に示すように、本実施形態においては、薬剤供給モジュール１００は、薬剤止め部１４２をさらに含む。薬剤止め部１４２は、排出部１３１に対して回転体１１０の回転方向２の上流側にて、斜面１１０ｓに沿って上記径方向に延在しつつ排出部１３１と隣接している。薬剤止め部１４２は、斜面１１０ｓに接離可能に設けられている。 As shown in FIGS. 7 and 9, in the present embodiment, the drug supply module 100 further includes a drug stopper 142. The medicine stopping portion 142 is adjacent to the discharging portion 131 while extending in the radial direction along the slope 110s on the upstream side in the rotation direction 2 of the rotating body 110 with respect to the discharging portion 131. The medicine stopper 142 is provided so as to be able to come into contact with and separate from the slope 110s.
　薬剤止め部１４２が斜面１１０ｓに接近した状態において、薬剤は薬剤止め部１４２によって排出部１３１への移動が阻止され、薬剤止め部１４２が斜面１１０ｓから離間した状態において、薬剤は排出部１３１へ移動可能である。薬剤止め部１４２は、開閉部１４１と一体で構成されている。なお、薬剤止め部１４２は、必ずしも設けられていなくてもよい。 In the state where the medicine stopper 142 approaches the slope 110s, the medicine is prevented from moving to the discharge portion 131 by the medicine stopper 142, and the medicine moves to the discharge portion 131 in the state where the medicine stopper 142 is separated from the slope 110s. It is possible. The medicine stopping portion 142 is configured integrally with the opening/closing portion 141. The medicine stopper 142 does not necessarily have to be provided.
　図１６は、本発明の一実施形態に係る薬剤供給装置が備える薬剤供給部に含まれる開閉部材の外観を示す斜視図である。図１７は、図１６の開閉部材を矢印ＸＶＩＩ方向から見た図である。 FIG. 16 is a perspective view showing the outer appearance of the opening/closing member included in the drug supply unit included in the drug supply device according to the embodiment of the present invention. FIG. 17 is a view of the opening/closing member of FIG. 16 seen from the direction of arrow XVII.
　図５～図７、図９、図１６および図１７に示すように、開閉部材１４０に、開閉部１４１、薬剤止め部１４２、および、１対の係合孔１４０ｂが設けられている。具体的には、薬剤止め部１４２は、略平板状の開閉部１４１の幅方向の一方の縁から開閉部１４１に直交するように突出している。１対の係合孔１４０ｂは、開閉部１４１の上方の位置に立設されている。１対の係合孔１４０ｂの各々は、側面視にて、Ｄ字状の内周面を有している。１対の係合孔１４０ｂの各々は、回動軸１４０ｓにおいてＤ字状の横断面形状を有する部分と係合する。 As shown in FIGS. 5 to 7, FIG. 9, FIG. 16 and FIG. 17, the opening/closing member 140 is provided with an opening/closing portion 141, a drug stopping portion 142, and a pair of engagement holes 140b. Specifically, the medicine stopping portion 142 projects from one edge in the width direction of the substantially flat plate-shaped opening/closing portion 141 so as to be orthogonal to the opening/closing portion 141. The pair of engagement holes 140b are erected at a position above the opening/closing portion 141. Each of the pair of engagement holes 140b has a D-shaped inner peripheral surface in a side view. Each of the pair of engagement holes 140b engages with a portion of the rotating shaft 140s having a D-shaped cross section.
　図１８は、本発明の一実施形態に係る薬剤供給装置が備える薬剤供給部において、開閉部が上方に回動して排出部が開いた状態を示す斜視図である。図１８においては、薬剤供給モジュール１００を図５と同一方向から見て図示している。 FIG. 18 is a perspective view showing a state in which the opening/closing section pivots upward and the discharge section is opened in the medicine supply unit included in the medicine supply device according to the embodiment of the present invention. In FIG. 18, the medicine supply module 100 is illustrated when viewed from the same direction as FIG. 5.
　回動軸１４０ｓが一方に回動させられることにより、図１８に示すように、開閉部材１４０が回動軸１４０ｓを中心に回動し、開閉部１４１によって塞がれていた排出部１３１が開放され、薬剤止め部１４２が斜面１１０ｓから離間する。 As the rotating shaft 140s is rotated to one side, as shown in FIG. 18, the opening/closing member 140 rotates around the rotating shaft 140s, and the discharging portion 131 closed by the opening/closing portion 141 is opened. Then, the medicine stopper 142 is separated from the slope 110s.
　回動軸１４０ｓが他方に回動させられることにより、図５に示すように、開閉部材１４０が回動軸１４０ｓを中心に回動し、開閉部１４１によって排出部１３１が閉鎖され、薬剤止め部１４２が斜面１１０ｓに接近する。 As the rotating shaft 140s is rotated to the other side, as shown in FIG. 5, the opening/closing member 140 rotates about the rotating shaft 140s, and the opening/closing part 141 closes the discharge part 131 and the medicine stopping part. 142 approaches the slope 110s.
　図１９は、本発明の一実施形態に係る薬剤供給装置が備える薬剤補充部の薬剤収容容器の構成を示す斜視図である。図２０は、本発明の一実施形態に係る薬剤供給装置が備える薬剤補充部の薬剤収容容器において、外蓋を取り外した状態を示す斜視図である。図２１は、本発明の一実施形態に係る薬剤供給装置が備える薬剤補充部の薬剤収容容器において、蓋部を取り外した状態を示す斜視図である。図２２は、本発明の一実施形態に係る薬剤供給装置が備える薬剤補充部の薬剤収容容器において、蓋部を取り外した状態を示す側面図である。図２３は、本発明の一実施形態に係る薬剤供給装置が備える薬剤補充部の薬剤収容容器において、蓋部を取り外した状態を示す平面図である。図２４は、本発明の一実施形態に係る薬剤供給装置が備える薬剤補充部の薬剤収容容器において、蓋部を取り外した状態を示す底面図である。図２５は、本発明の一実施形態に係る薬剤供給装置が備える薬剤補充部の薬剤収容容器において、蓋部を取り外した状態を示す縦断面図である。 FIG. 19 is a perspective view showing a configuration of a drug container of a drug replenishing unit included in the drug supply device according to the embodiment of the present invention. FIG. 20 is a perspective view showing a state in which the outer lid is removed in the medicine container of the medicine replenishing unit included in the medicine supply device according to the embodiment of the present invention. FIG. 21 is a perspective view showing a state in which the lid is removed in the medicine container of the medicine replenishing unit included in the medicine supply device according to the embodiment of the present invention. FIG. 22 is a side view showing a state in which the lid is removed in the medicine container of the medicine replenishing unit included in the medicine supply device according to the embodiment of the present invention. FIG. 23 is a plan view showing a state in which the lid is removed in the drug container of the drug replenishing unit included in the drug feeding device according to the embodiment of the present invention. FIG. 24 is a bottom view showing a state in which the lid is removed in the medicine container of the medicine replenishing unit included in the medicine supply device according to the embodiment of the present invention. FIG. 25 is a vertical cross-sectional view showing a state in which the lid is removed in the medicine container of the medicine replenishing unit included in the medicine supply device according to the embodiment of the present invention.
　図１９～図２５に示すように、本発明の一実施形態に係る第１薬剤供給装置１０が備える薬剤補充部１２の薬剤収容容器３００は、底部および開口部を含む有底円筒状の形状を有し、かつ、内周面に螺旋溝が形成されている。具体的には、薬剤収容容器３００は、本体筒３１０、円筒部３２０、底部３３０、および、蓋部３４０を含んでいる。 As shown in FIGS. 19 to 25, the drug storage container 300 of the drug replenishing unit 12 included in the first drug supply device 10 according to the embodiment of the present invention has a bottomed cylindrical shape including a bottom and an opening. It also has a spiral groove formed on the inner peripheral surface thereof. Specifically, the drug container 300 includes a main body cylinder 310, a cylindrical portion 320, a bottom portion 330, and a lid portion 340.
　本体筒３１０は、内周面に螺旋溝３１２が形成されている。本体筒３１０は、一方の端部に第１開口部３１３を有し、他方の端部に第２開口部３１４を有する。本体筒３１０の中心軸は、薬剤収容容器３００の軸線３上に位置している。図２５においては、軸線３と垂直な垂線４を図示している。 The main body cylinder 310 has a spiral groove 312 formed on the inner peripheral surface thereof. The main body cylinder 310 has a first opening 313 at one end and a second opening 314 at the other end. The central axis of the main body cylinder 310 is located on the axis 3 of the medicine container 300. In FIG. 25, a vertical line 4 perpendicular to the axis 3 is shown.
　図２５に示すように、本体筒３１０の内周面に形成されている螺旋溝３１２の相対する１対の壁面において、第１開口部３１３側に位置する壁面と垂線４とのなす角αは、第２開口部３１４側に位置する壁面と垂線４とのなす角βより大きい。たとえば、α＝４５°、β＝１０°である。 As shown in FIG. 25, the angle α formed by the perpendicular line 4 and the wall surface located on the side of the first opening 313 on the pair of wall surfaces facing each other of the spiral groove 312 formed on the inner peripheral surface of the main body cylinder 310 is The angle β between the wall surface located on the side of the second opening 314 and the perpendicular 4 is larger than β. For example, α=45° and β=10°.
　図２６は、本発明の一実施形態に係る薬剤供給装置が備える薬剤補充部の薬剤収容容器の開口部側の形状を示す部分斜視図である。図２６においては、円筒部３２０を本体筒３１０から取り外した状態を図示している。 FIG. 26 is a partial perspective view showing the shape of the medicine replenishing section of the medicine supply device according to the embodiment of the present invention on the side of the opening of the medicine container. In FIG. 26, the state where the cylindrical portion 320 is removed from the main body cylinder 310 is shown.
　図２６に示すように、螺旋溝３１２は、本体筒３１０の第１開口部３１３に到達するまで続くように、本体筒３１０の内周面に形成されている。螺旋溝３１２の第１開口部３１３側の終端３１２ｅは、本体筒３１０の第１開口部３１３側の端面に沿って切断されたような形状となっている。 As shown in FIG. 26, the spiral groove 312 is formed on the inner peripheral surface of the main body cylinder 310 so as to continue until it reaches the first opening 313 of the main body cylinder 310. A terminal end 312e of the spiral groove 312 on the first opening 313 side has a shape cut along the end surface of the main body cylinder 310 on the first opening 313 side.
　また、図２５に示すように、螺旋溝３１２は、本体筒３１０の第２開口部３１４に到達する手前の位置まで続くように、本体筒３１０の内周面に形成されている。螺旋溝３１２の第２開口部３１４側の終端は、軸線３を中心とする周方向に延びる周方向溝３１５に接続されている。そのため、本体筒３１０の第２開口部３１４の近傍においても、溝幅が狭くならない。したがって、溝内に薬剤が詰まることを防止することができる。 Further, as shown in FIG. 25, the spiral groove 312 is formed on the inner peripheral surface of the main body cylinder 310 so as to continue to a position before reaching the second opening 314 of the main body cylinder 310. The end of the spiral groove 312 on the second opening 314 side is connected to a circumferential groove 315 extending in the circumferential direction around the axis 3. Therefore, the groove width does not become narrow even in the vicinity of the second opening 314 of the main body cylinder 310. Therefore, it is possible to prevent the medicine from being clogged in the groove.
　円筒部３２０は、本体筒３１０の第１開口部３１３側の外周に取り付けられている。円筒部３２０の軸線３方向における第１開口部３１３側の端部の外周には、蓋部３４０を取り付けるための雄ねじが形成されている。 The cylindrical portion 320 is attached to the outer periphery of the main body cylinder 310 on the side of the first opening 313. A male screw for attaching the lid 340 is formed on the outer circumference of the end of the cylindrical portion 320 on the side of the first opening 313 in the direction of the axis 3.
　底部３３０は、本体筒３１０の第２開口部３１４側の外周に取り付けられている。底部３３０は、第２開口部３１４を閉塞する底面３３０ｂを有している。底面３３０ｂは、軸線３方向において第２開口部３１４から離れる側に凸状に湾曲している。すなわち、薬剤収容容器３００の内側の底面は、薬剤収容容器３００の外側に凸状の曲面形状を有している。 The bottom portion 330 is attached to the outer periphery of the main body cylinder 310 on the second opening 314 side. The bottom portion 330 has a bottom surface 330b that closes the second opening 314. The bottom surface 330b is curved in a convex shape on the side away from the second opening 314 in the axis 3 direction. That is, the inner bottom surface of the medicine container 300 has a convex curved surface shape on the outside of the medicine container 300.
　底部３３０は、底面３３０ｂの周縁から外側に円環状に突出した環状部３３０ｃをさらに有している。本実施形態においては、図２５に示すように、底面３３０ｂと環状部３３０ｃとによって規定される空間に、識別子３３１が配置されている。底部３３０は、底面３３０ｂと環状部３３０ｃとによって規定される空間を閉塞する円板部３３２をさらに有している。円板部３３２は、ねじによって底面３３０ｂに対して固定されている。識別子３３１は、底面３３０ｂと円板部３３２との間に挟み込まれている。 The bottom portion 330 further has an annular portion 330c that protrudes annularly outward from the peripheral edge of the bottom surface 330b. In the present embodiment, as shown in FIG. 25, the identifier 331 is arranged in the space defined by the bottom surface 330b and the annular portion 330c. The bottom portion 330 further includes a disc portion 332 that closes a space defined by the bottom surface 330b and the annular portion 330c. The disc portion 332 is fixed to the bottom surface 330b with a screw. The identifier 331 is sandwiched between the bottom surface 330b and the disc portion 332.
　本実施形態においては、識別子３３１は、永久磁石である。識別子３３１は、複数の薬剤収容容器３００の各々において、互いに異なるように形成されている。すなわち、複数の薬剤収容容器３００の各々は、互いに識別可能な識別子３３１を有している。なお、識別子３３１は、永久磁石に限られず、他の磁性体であってもよい。また、識別子３３１は、必ずしも設けられていなくてもよい。 In this embodiment, the identifier 331 is a permanent magnet. The identifier 331 is formed so as to be different from each other in each of the plurality of drug storage containers 300. That is, each of the plurality of drug storage containers 300 has an identifier 331 that can identify each other. The identifier 331 is not limited to the permanent magnet, and may be another magnetic body. Moreover, the identifier 331 does not necessarily have to be provided.
　図１９に示すように、蓋部３４０は、第１開口部３１３を閉塞可能である。図１９および図２０に示すように、蓋部３４０は、外蓋３４１と内蓋３４２とから構成されている。外蓋３４１は、内蓋３４２に対して回動可能に設けられている。具体的には、外蓋３４１に、１対の係合孔３４１ｈを有するアーム部３４１ａが設けられている。内蓋３４２の側部に、１対の係合突起３４２ｓを有する回動軸部３４２ｐが設けられている。１対の係合孔３４１ｈと１対の係合突起３４２ｓとが互いに係合することにより、アーム部３４１ａが回動軸部３４２ｐを中心に回動可能に支持される。その結果、外蓋３４１が内蓋３４２に対して回動可能となる。 As shown in FIG. 19, the lid 340 can close the first opening 313. As shown in FIGS. 19 and 20, the lid portion 340 is composed of an outer lid 341 and an inner lid 342. The outer lid 341 is rotatably provided with respect to the inner lid 342. Specifically, the outer lid 341 is provided with an arm portion 341a having a pair of engagement holes 341h. A rotary shaft portion 342p having a pair of engagement protrusions 342s is provided on a side portion of the inner lid 342. The pair of engagement holes 341h and the pair of engagement protrusions 342s are engaged with each other, whereby the arm portion 341a is supported rotatably around the rotation shaft portion 342p. As a result, the outer lid 341 becomes rotatable with respect to the inner lid 342.
　内蓋３４２の内蓋面３４２ｃには、複数の開口部３４２ｈが形成されている。外蓋３４１が閉じた状態において、外蓋３４１と内蓋面３４２ｃとの間に、乾燥材または薬剤のＰＴＰ(Press-Through-Package)包装シートの耳などを入れるための空間が形成される。内蓋３４２の内周面に、円筒部３２０の雄ねじと螺合する雌ねじが形成されている。 A plurality of openings 342h are formed on the inner lid surface 342c of the inner lid 342. In a state where the outer lid 341 is closed, a space is formed between the outer lid 341 and the inner lid surface 342c for inserting the ear of a PTP (Press-Through-Package) packaging sheet of a desiccant or a medicine. On the inner peripheral surface of the inner lid 342, a female screw that is screwed with the male screw of the cylindrical portion 320 is formed.
　図２７は、本発明の一実施形態に係る薬剤供給装置が備えるベース部の構成を示す部分斜視図である。図２８は、本発明の一実施形態に係る薬剤供給装置が備えるベース部の構成を示す部分背面図である。図２９は、本発明の一実施形態に係る薬剤供給装置が備える薬剤供給部が、ベース部に装着された状態を示す部分斜視図である。 FIG. 27 is a partial perspective view showing the configuration of the base portion included in the drug supply device according to the embodiment of the present invention. FIG. 28 is a partial rear view showing the configuration of the base portion included in the drug supply device according to the embodiment of the present invention. FIG. 29 is a partial perspective view showing a state in which the drug supply unit included in the drug supply device according to the embodiment of the present invention is mounted on the base unit.
　図２７および図２８に示すように、ベース部２００には、第１駆動軸２１０、第２駆動軸２４０、排出シュート２２０、第１検出部である第１センサ２３１、第２検出部である第２センサ２３２、薬剤検出部である薬剤検出センサ２３５および振動部２６０が設けられている。ベース部２００には、回転体１１０を駆動する第１駆動源である第１モータと、開閉部１４１を駆動する第２駆動源である第２モータとが設けられている。なお、第１センサ２３１、第２センサ２３２、薬剤検出センサ２３５および振動部２６０の各々は、必ずしも設けられていなくてもよい。 As shown in FIGS. 27 and 28, the base unit 200 includes a first drive shaft 210, a second drive shaft 240, a discharge chute 220, a first sensor 231 which is a first detection unit, and a second detection unit which is a second detection unit. Two sensors 232, a drug detection sensor 235 which is a drug detection unit, and a vibration unit 260 are provided. The base unit 200 is provided with a first motor that is a first drive source that drives the rotating body 110 and a second motor that is a second drive source that drives the opening/closing unit 141. Each of the first sensor 231, the second sensor 232, the drug detection sensor 235, and the vibrating section 260 may not necessarily be provided.
　第１駆動軸２１０は、第１モータに接続されている。第１駆動軸２１０は、ベース部２００の底部から上方に向けて延在している。第１駆動軸２１０の先端に、第１駆動歯車２１１ｇおよび第２駆動歯車２１２ｇが設けられている。第１駆動歯車２１１ｇは、第１従動歯車１１１ｇと係合する。第２駆動歯車２１２ｇは、第２従動歯車１１２ｇと係合する。 The first drive shaft 210 is connected to the first motor. The first drive shaft 210 extends upward from the bottom portion of the base portion 200. A first drive gear 211g and a second drive gear 212g are provided at the tip of the first drive shaft 210. The first drive gear 211g engages with the first driven gear 111g. The second drive gear 212g engages with the second driven gear 112g.
　第１モータが駆動して第１駆動軸２１０が回転することにより、第１駆動歯車２１１ｇおよび第１従動歯車１１１ｇを介して第１回転部１１１が回転するとともに、第２駆動歯車２１２ｇおよび第２従動歯車１１２ｇを介して第２回転部１１２が回転する。すなわち、第１回転部１１１および第２回転部１１２の各々は、共通の駆動源によって駆動される。 When the first motor drives and the first drive shaft 210 rotates, the first rotating portion 111 rotates via the first drive gear 211g and the first driven gear 111g, and the second drive gear 212g and the second drive gear 212g. The second rotating portion 112 rotates via the driven gear 112g. That is, each of the first rotating unit 111 and the second rotating unit 112 is driven by the common drive source.
　第２回転部１１２の回転速度は、第１回転部１１１の回転速度より高い。具体的には、第１駆動歯車２１１ｇ、第２駆動歯車２１２ｇ、第１従動歯車１１１ｇおよび第２従動歯車１１２ｇの各々の歯数が、第２回転部１１２の回転速度が第１回転部１１１の回転速度より高くなるように設定されている。 The rotation speed of the second rotation unit 112 is higher than the rotation speed of the first rotation unit 111. Specifically, the number of teeth of each of the first drive gear 211g, the second drive gear 212g, the first driven gear 111g, and the second driven gear 112g is such that the rotation speed of the second rotating portion 112 is equal to that of the first rotating portion 111. It is set to be higher than the rotation speed.
　第２駆動軸２４０は、第２モータに接続されている。第２駆動軸２４０は、ベース部２００の一方の側部から他方の側部に向けて略水平に延在している。第２駆動軸２４０の先端部は、回動軸１４０ｓと係合する。 The second drive shaft 240 is connected to the second motor. The second drive shaft 240 extends substantially horizontally from one side portion of the base portion 200 toward the other side portion. The tip of the second drive shaft 240 engages with the rotating shaft 140s.
　第２モータが駆動して第２駆動軸２４０が回転することにより、回動軸１４０ｓとともに開閉部材１４０が回動する。開閉部材１４０が回動軸１４０ｓを中心に回動することにより、開閉部１４１および薬剤止め部１４２の各々も回動軸１４０ｓを中心に回動する。このように、開閉部１４１および薬剤止め部１４２の各々は、共通の駆動源によって駆動される。 The second motor drives and the second drive shaft 240 rotates, so that the opening/closing member 140 rotates together with the rotating shaft 140s. When the opening/closing member 140 rotates about the rotation shaft 140s, each of the opening/closing unit 141 and the medicine stopping unit 142 also rotates about the rotation shaft 140s. In this way, each of the opening/closing section 141 and the medicine stopping section 142 is driven by the common drive source.
　排出シュート２２０は、排出部１３１から排出された薬剤をベース部２００の外側に導く。排出シュート２２０の入口は、排出部１３１と対向している。排出部１３１に隣接して、第１センサ２３１が配置されている。排出シュート２２０には、第２センサ２３２が配置されている。第２センサ２３２は、第１センサ２３１よりも排出部１３１から離れて位置している。 The discharge chute 220 guides the medicine discharged from the discharge part 131 to the outside of the base part 200. The inlet of the discharge chute 220 faces the discharge part 131. The first sensor 231 is arranged adjacent to the discharging unit 131. A second sensor 232 is arranged on the discharge chute 220. The second sensor 232 is located farther from the discharge unit 131 than the first sensor 231.
　第１センサ２３１は、斜面１１０ｓ上の薬剤が排出部１３１から排出されたことを検出する。第１センサ２３１は、排出部１３１の外側の第１検出位置に薬剤が到達したことを検出したときに第１検出信号を出力する。本実施形態においては、第１センサ２３１は、光電センサで構成されており、排出部１３１のすぐ下流側の領域を互いの間に挟むように配置された投光部および受光部を有する。この投光部と受光部との間の光軸が薬剤によって遮られたことを検出することにより、排出部１３１から排出された薬剤の到達を検出する。 The first sensor 231 detects that the medicine on the slope 110s has been discharged from the discharge portion 131. The first sensor 231 outputs a first detection signal when detecting that the medicine has reached the first detection position outside the discharging unit 131. In the present embodiment, the first sensor 231 is composed of a photoelectric sensor and has a light projecting unit and a light receiving unit which are arranged so as to sandwich the region immediately downstream of the discharge unit 131 between them. The arrival of the drug discharged from the discharge unit 131 is detected by detecting that the optical axis between the light projecting unit and the light receiving unit is blocked by the drug.
　第２センサ２３２は、排出部１３１から排出された薬剤を検出する。第２センサ２３２は、第１検出位置より薬剤供給モジュール１００から離れた第２検出位置を薬剤が通過したことを検出したときに第２検出信号を出力する。本実施形態においては、第２センサ２３２は、光電センサで構成されており、排出シュート２２０によって規定される薬剤通路を互いの間に挟むように配置された投光部および受光部を有する。この投光部と受光部との間の光軸が薬剤によって遮られた状態から元の開通状態に戻ったことを検出することにより、排出部１３１から排出された薬剤の通過を検出する。 The second sensor 232 detects the drug discharged from the discharge unit 131. The second sensor 232 outputs a second detection signal when it is detected that the medicine has passed a second detection position which is far from the medicine supply module 100 from the first detection position. In the present embodiment, the second sensor 232 is composed of a photoelectric sensor and has a light projecting unit and a light receiving unit which are arranged so as to sandwich the drug passage defined by the discharge chute 220 therebetween. The passage of the medicine discharged from the discharging portion 131 is detected by detecting that the optical axis between the light projecting portion and the light receiving portion has returned from the state blocked by the medicine to the original opened state.
　薬剤検出センサ２３５は、薬剤供給モジュール１００の斜面１１０ｓ上の薬剤受け位置における薬剤の有無を検出して薬剤検出信号を出力する。本実施形態においては、薬剤検出センサ２３５は、光電センサで構成されており、薬剤供給孔１２７の下方の領域を互いの間に挟むように配置された投光部および受光部を有する。すなわち、斜面１１０ｓ上において薬剤供給孔１２７の下方に位置する領域が、補充された薬剤を受ける薬剤受け位置である。薬剤検出センサ２３５は、投光部と受光部との間の光軸が薬剤によって遮られているか否かを検出することにより、薬剤受け位置における薬剤の有無を検出する。すなわち、薬剤検出センサ２３５は、薬剤受け位置に薬剤があることを検出している第１検出状態と、薬剤受け位置に薬剤が無いことを検出している第２検出状態とを有する。なお、蓋部材１２０において、少なくとも上記光軸上の部分は、透明になっている。 The drug detection sensor 235 detects the presence or absence of a drug at the drug receiving position on the slope 110s of the drug supply module 100 and outputs a drug detection signal. In the present embodiment, the drug detection sensor 235 is composed of a photoelectric sensor and has a light projecting unit and a light receiving unit which are arranged so as to sandwich the region below the drug supply hole 127 between them. That is, the region located below the drug supply hole 127 on the slope 110s is the drug receiving position for receiving the refilled drug. The drug detection sensor 235 detects the presence or absence of a drug at the drug receiving position by detecting whether or not the optical axis between the light projecting unit and the light receiving unit is blocked by the drug. That is, the drug detection sensor 235 has a first detection state in which it is detected that there is a drug at the drug receiving position, and a second detection state in which it is detected that there is no drug at the drug receiving position. In addition, in the lid member 120, at least a portion on the optical axis is transparent.
　振動部２６０は、第１周壁部１２１、第２周壁部１２２および第３周壁部１２３の各々を振動させる。本実施形態においては、振動部２６０は、蓋部１２６を介して第１周壁部１２１、第２周壁部１２２および第３周壁部１２３の各々を振動させる。 The vibrating section 260 vibrates each of the first peripheral wall section 121, the second peripheral wall section 122, and the third peripheral wall section 123. In the present embodiment, the vibrating section 260 vibrates each of the first peripheral wall section 121, the second peripheral wall section 122, and the third peripheral wall section 123 via the lid section 126.
　具体的には、振動部２６０は、振動伝達板１６０の直上に位置するように設けられている。振動部２６０には、図示しない永久磁石が設けられている。振動伝達板１６０は、磁性体で構成されている。振動部２６０と振動伝達板１６０とは、永久磁石の磁力によって互いに引き合っている。すなわち、振動部２６０および蓋部１２６の各々の接触部は、磁力によって互いに引き合っている。振動部２６０の振動は、蓋部１２６を通じて、第１周壁部１２１、第２周壁部１２２および第３周壁部１２３の各々に伝播する。振動部２６０は、水平面に対して傾斜する方向に振動する。本実施形態においては、振動部２６０は、モータ軸が水平面に対して傾斜するように配置された後述する偏心モータ２７３によって駆動される。 Specifically, the vibration unit 260 is provided so as to be located directly above the vibration transmission plate 160. The vibrating section 260 is provided with a permanent magnet (not shown). The vibration transmission plate 160 is made of a magnetic material. The vibrating section 260 and the vibration transmitting plate 160 are attracted to each other by the magnetic force of the permanent magnet. That is, the contact portions of the vibrating portion 260 and the lid portion 126 are attracted to each other by the magnetic force. The vibration of the vibrating section 260 propagates to each of the first peripheral wall section 121, the second peripheral wall section 122, and the third peripheral wall section 123 through the lid section 126. The vibrating section 260 vibrates in a direction inclined with respect to the horizontal plane. In the present embodiment, the vibrating section 260 is driven by an eccentric motor 273 described later in which the motor shaft is arranged so as to be inclined with respect to the horizontal plane.
　なお、上記のように、排出部材１３０と蓋部材１２０との間に僅かな隙間が設けられており、蓋部１２６と支持部１５０との間に、緩衝部材１７０が設けられているため、振動部２６０による振動は立壁部１３２には直接伝播しない。 Note that, as described above, since a slight gap is provided between the discharge member 130 and the lid member 120, and the cushioning member 170 is provided between the lid portion 126 and the support portion 150, the vibration is generated. The vibration caused by the portion 260 does not directly propagate to the standing wall portion 132.
　振動部２６０とベース部２００との接続部に、振動部２６０からの振動がベース部２００に伝播することを抑制するための緩衝部材が設けられていてもよい。これにより、振動部２６０からの振動が、ベース部２００および支持部１５０を通じて立壁部１３２に伝播することを抑制できる。 A cushioning member may be provided at the connection between the vibrating section 260 and the base section 200 to suppress the vibration from the vibrating section 260 from propagating to the base section 200. Accordingly, it is possible to suppress the vibration from the vibrating section 260 from propagating to the standing wall section 132 through the base section 200 and the supporting section 150.
　図２９に示すように、本実施形態に係る第１薬剤供給装置１０においては、振動部２６０はベース部２００に設けられており、蓋部１２６は薬剤供給モジュール１００に設けられているため、振動部２６０は、蓋部１２６に対して接離可能である。ベース部２００には、薬剤供給モジュール１００が取り付けられたことを検出する、後述するモジュール検出センサ２３６が設けられている。 As shown in FIG. 29, in the first drug supply device 10 according to the present embodiment, the vibration part 260 is provided in the base part 200, and the lid part 126 is provided in the drug supply module 100, so that the vibration is generated. The part 260 can be brought into and out of contact with the lid part 126. The base unit 200 is provided with a module detection sensor 236 which will be described later and detects that the medicine supply module 100 is attached.
　図３０は、本発明の一実施形態に係る薬剤供給装置が備えるベース部に薬剤供給部および薬剤収容容器の各々が取り付けられた状態において、ベース部の一部のカバーを取り外した状態を示す正面図である。図３１は、本発明の一実施形態に係る薬剤供給装置から、薬剤収容容器およびベース部の一部のカバーを取り外した状態を示す正面側斜視図である。図３２は、本発明の一実施形態に係る薬剤供給装置からベース部の他の一部のカバーを取り外した状態を示す背面側斜視図である。 FIG. 30 is a front view showing a state in which a cover of a part of the base part is removed in a state where each of the drug supply part and the drug storage container is attached to the base part included in the drug supply device according to the embodiment of the present invention. It is a figure. FIG. 31 is a front side perspective view showing a state in which the medicine container and the partial cover of the base portion are removed from the medicine supply device according to the embodiment of the present invention. FIG. 32 is a rear perspective view showing a state in which the other part of the cover of the base part is removed from the drug supply device according to the embodiment of the present invention.
　図４および図３０に示すように、本発明の一実施形態に係る第１薬剤供給装置１０において、薬剤収容容器３００は、蓋部３４０を取り外した状態でベース部２００に取り付けられる。ベース部２００に取り付けられた状態の薬剤収容容器３００は、薬剤供給モジュール１００の上方に位置している。薬剤収容容器３００がベース部２００に取り付けられた状態において、薬剤収容容器３００の軸線３は水平面に対して傾斜している。たとえば、薬剤収容容器３００がベース部２００に取り付けられた状態において、薬剤収容容器３００の軸線３は水平面に対して２０°傾斜している。 As shown in FIGS. 4 and 30, in the first drug supply device 10 according to the embodiment of the present invention, the drug container 300 is attached to the base part 200 with the lid part 340 removed. The medicine container 300 attached to the base portion 200 is located above the medicine supply module 100. In a state where the medicine container 300 is attached to the base portion 200, the axis 3 of the medicine container 300 is inclined with respect to the horizontal plane. For example, when the medicine container 300 is attached to the base portion 200, the axis 3 of the medicine container 300 is inclined by 20° with respect to the horizontal plane.
　図３１に示すように、ベース部２００には、薬剤収容容器３００を軸線３まわりに回転可能に支持する４つのローラ部が設けられている。具体的には、ベース部２００に、１対の回転軸が設けられている。１対の回転軸の一方に、互いに間隔をあけて１対のローラ部２８１が取り付けられている。１対の回転軸の他方に、互いに間隔をあけて１対のローラ部２８２が取り付けられている。ベース部２００には、薬剤収容容器３００が取り付けられたことを検出する容器検出センサ２３３が設けられている。 As shown in FIG. 31, the base portion 200 is provided with four roller portions that support the medicine container 300 so as to be rotatable about the axis 3. Specifically, the base portion 200 is provided with a pair of rotating shafts. A pair of roller portions 281 are attached to one of the pair of rotating shafts with a space therebetween. A pair of roller portions 282 are attached to the other of the pair of rotating shafts with a space therebetween. The base unit 200 is provided with a container detection sensor 233 that detects that the medicine container 300 is attached.
　図３０および図３１に示すように、ベース部２００には、薬剤収容容器３００の第１開口部３１３から排出された薬剤を、薬剤供給モジュール１００の蓋部材１２０の薬剤供給孔１２７に導く接続管路２９０が設けられている。 As shown in FIGS. 30 and 31, in the base part 200, a connection pipe for guiding the medicine discharged from the first opening 313 of the medicine container 300 to the medicine supply hole 127 of the lid member 120 of the medicine supply module 100. A path 290 is provided.
　図３０に示すように、ベース部２００には、薬剤収容容器３００の識別子３３１を認識する識別センサ２３４が設けられている。本実施形態においては、識別センサ２３４は、磁気センサである。なお、識別センサ２３４は、磁気センサに限られず、識別子３３１を認識可能なセンサであればよい。また、識別センサ２３４は、必ずしも設けられていなくてもよい。 As shown in FIG. 30, the base unit 200 is provided with an identification sensor 234 that recognizes the identifier 331 of the drug container 300. In the present embodiment, the identification sensor 234 is a magnetic sensor. The identification sensor 234 is not limited to the magnetic sensor and may be any sensor that can recognize the identifier 331. Further, the identification sensor 234 does not necessarily have to be provided.
　図３０に示すように、ベース部２００には、上記のように、回転体１１０を駆動する第１駆動源である第１モータ２７０と、開閉部１４１を駆動する第２駆動源である第２モータ２７１とが設けられている。図３２に示すように、ベース部２００には、上記の１対の回転軸の他方を駆動する第３駆動源である第３モータ２７２が設けられている。 As shown in FIG. 30, in the base unit 200, as described above, the first motor 270 which is the first drive source for driving the rotating body 110 and the second motor source 270 which is the second drive source for driving the opening/closing unit 141 are provided. A motor 271 is provided. As shown in FIG. 32, the base portion 200 is provided with a third motor 272 that is a third drive source that drives the other of the pair of rotating shafts.
　図４および図３０に示す薬剤補充部１２は、薬剤収容容器３００、上記の１対の回転軸、１対のローラ部２８１、１対のローラ部２８２、第３モータ２７２、容器検出センサ２３３および識別センサ２３４を含む。薬剤収容容器３００は、薬剤を収容し、駆動されることにより薬剤供給モジュール１００の薬剤受け位置に薬剤を補充する。すなわち、薬剤補充部１２は、薬剤受け位置に薬剤を補充する。 The drug replenishing unit 12 shown in FIGS. 4 and 30 includes a drug container 300, the above-mentioned pair of rotary shafts, a pair of roller units 281, a pair of roller units 282, a third motor 272, a container detection sensor 233, and An identification sensor 234 is included. The drug storage container 300 stores a drug and is driven to refill the drug receiving position of the drug supply module 100 with the drug. That is, the medicine replenishing unit 12 replenishes the medicine at the medicine receiving position.
　図４および図３１に示すように、ベース部２００の正面には、表示部２５０が設けられている。本実施形態においては、表示部２５０は、複数の色の中から選択的に１つの色で発光する。また、表示部２５０は、点滅発光することも可能である。表示部２５０の発光パターンによって、第１薬剤供給装置１０の状態を表すことができる。 As shown in FIGS. 4 and 31, a display unit 250 is provided on the front surface of the base unit 200. In the present embodiment, the display unit 250 selectively emits light of one color from a plurality of colors. Further, the display unit 250 can also emit blinking light. The light emission pattern of the display unit 250 can indicate the state of the first medicine supply device 10.
　図３３は、本発明の一形態に係る薬剤分包装置の接続系統を示すブロック図である。図３３に示すように、本発明の一実施形態に係る薬剤分包装置４００は、主制御部４１を有している。主制御部４１は、薬剤包装装置ユニット４４０、薬剤供給装置ユニット４５０および操作パネル５０の各々と電気的に接続されている。主制御部４１は、操作パネル５０を介して、処方情報を受け付ける処方情報受付装置９０と電気的に接続されている。 FIG. 33 is a block diagram showing a connection system of the medicine packaging device according to the embodiment of the present invention. As shown in FIG. 33, the medicine packaging device 400 according to the embodiment of the present invention includes a main control unit 41. The main controller 41 is electrically connected to each of the medicine packaging device unit 440, the medicine supply device unit 450, and the operation panel 50. The main controller 41 is electrically connected to a prescription information receiving device 90 that receives prescription information via the operation panel 50.
　図３４は、本発明の一形態に係る薬剤供給装置の接続系統を示すブロック図である。図３４に示すように、本発明の一実施形態に係る第１薬剤供給装置１０は、薬剤供給部である薬剤供給モジュール１００および薬剤補充部１２の各々を制御する制御部１１を有している。制御部１１は、ベース部２００に設けられている。制御部１１は、第１センサ２３１、第２センサ２３２、容器検出センサ２３３、識別センサ２３４、薬剤検出センサ２３５、モジュール検出センサ２３６、開閉センサ２３７、停止スイッチ２３８、表示部２５０、第１モータ２７０、第２モータ２７１、第３モータ２７２および偏心モータ２７３の各々と電気的に接続されている。 FIG. 34 is a block diagram showing a connection system of the drug supply device according to the embodiment of the present invention. As shown in FIG. 34, the first drug supply device 10 according to one embodiment of the present invention has a control unit 11 that controls each of the drug supply module 100, which is a drug supply unit, and the drug replenishment unit 12. .. The control unit 11 is provided in the base unit 200. The control unit 11 includes the first sensor 231, the second sensor 232, the container detection sensor 233, the identification sensor 234, the drug detection sensor 235, the module detection sensor 236, the open/close sensor 237, the stop switch 238, the display unit 250, and the first motor 270. , The second motor 271, the third motor 272, and the eccentric motor 273 are electrically connected.
　制御部１１は、主制御部４１と電気的に接続されている。複数の第１薬剤供給装置１０の各々の制御部１１と、主制御部４１とによって、制御装置ユニット４６０が構成されている。上記のように、薬剤分包装置４００が、制御装置ユニット４６０を備えている。 The control unit 11 is electrically connected to the main control unit 41. A control device unit 460 is configured by the control unit 11 of each of the plurality of first drug supply devices 10 and the main control unit 41. As described above, the medicine packaging device 400 includes the control device unit 460.
　以下、本発明の一実施形態に係る第１薬剤供給装置１０の動作について説明する。まず、薬剤供給部である薬剤供給モジュール１００の動作について説明する。 The operation of the first drug supply device 10 according to the embodiment of the present invention will be described below. First, the operation of the drug supply module 100, which is a drug supply unit, will be described.
　薬剤供給孔１２７から蓋部材１２０の内側に供給された薬剤は、斜面１１０ｓ上の薬剤受け位置にて受け止められ、第１周壁部１２１によって支持される。第１モータ２７０によって、第１回転部１１１および第２回転部１１２の各々が駆動される。 The medicine supplied from the medicine supply hole 127 to the inside of the lid member 120 is received at the medicine receiving position on the slope 110s and is supported by the first peripheral wall portion 121. Each of the first rotating unit 111 and the second rotating unit 112 is driven by the first motor 270.
　第１回転部１１１が駆動されることにより、第１周壁部１２１によって支持されている薬剤が第１周壁部１２１に沿って搬送される。第１周壁部１２１によって支持されている薬剤は、第１周壁部１２１に沿って搬送される間に、第１周壁部１２１に沿って整列させられる。 By driving the first rotating portion 111, the medicine supported by the first peripheral wall portion 121 is conveyed along the first peripheral wall portion 121. The medicines supported by the first peripheral wall portion 121 are aligned along the first peripheral wall portion 121 while being transported along the first peripheral wall portion 121.
　第１周壁部１２１によって支持されている薬剤は、回転方向２の先頭側に位置する薬剤から順次、第１傾斜壁部１２４に沿って下降しつつ軸線１を中心とする径方向の外側に移動することにより、第２周壁部１２２によって支持される。 The medicine supported by the first peripheral wall portion 121 sequentially moves downward from the medicine located on the leading side in the rotation direction 2 along the first inclined wall portion 124 and moves outward in the radial direction around the axis 1. By doing so, it is supported by the second peripheral wall portion 122.
　第１傾斜壁部１２４に沿って下降する薬剤は、重力によって加速されるため、第１周壁部１２１に沿って搬送されている薬剤より移動速度が高くなる。これにより、第１傾斜壁部１２４に沿って下降した薬剤と、第１傾斜壁部１２４に沿って下降する前の薬剤との間隔が広くなる。 The medicine that descends along the first inclined wall portion 124 is accelerated by gravity, and thus has a higher moving speed than the medicine that is conveyed along the first peripheral wall portion 121. As a result, the distance between the medicine that has descended along the first inclined wall portion 124 and the medicine that has not yet descended along the first inclined wall portion 124 becomes wider.
　第１回転部１１１が駆動されることにより、第２周壁部１２２によって支持されている薬剤が第２周壁部１２２に沿って搬送される。第２周壁部１２２によって支持されている薬剤は、回転方向２の先頭側に位置する薬剤から順次、第２傾斜壁部１２５に沿って下降しつつ上記径方向外側に移動することにより、第３周壁部１２３によって支持される。 By driving the first rotating portion 111, the medicine supported by the second peripheral wall portion 122 is conveyed along the second peripheral wall portion 122. The medicine supported by the second peripheral wall portion 122 sequentially moves downward from the medicine located on the leading side in the rotation direction 2 along the second inclined wall portion 125 and moves to the outer side in the radial direction, thereby the third medicine. It is supported by the peripheral wall portion 123.
　第２傾斜壁部１２５に沿って下降する薬剤は、重力によって加速されるため、第２周壁部１２２に沿って搬送されている薬剤より移動速度が高くなる。これにより、第２傾斜壁部１２５に沿って下降した薬剤と、第２傾斜壁部１２５に沿って下降する前の薬剤との間隔が広くなる。 The medicine that descends along the second inclined wall portion 125 is accelerated by gravity, and therefore has a higher moving speed than the medicine that is conveyed along the second peripheral wall portion 122. As a result, the interval between the medicine that has descended along the second inclined wall portion 125 and the medicine that has not yet descended along the second inclined wall portion 125 becomes wider.
　第２回転部１１２が駆動されることにより、第３周壁部１２３によって支持されている薬剤が第３周壁部１２３に沿って搬送される。第２回転部１１２の回転速度は、第１回転部１１１の回転速度より高いため、第３周壁部１２３によって支持されている薬剤と、第２周壁部１２２によって支持されている薬剤との間隔が広くなる。 By driving the second rotating portion 112, the medicine supported by the third peripheral wall portion 123 is conveyed along the third peripheral wall portion 123. Since the rotation speed of the second rotating portion 112 is higher than the rotation speed of the first rotating portion 111, the distance between the medicine supported by the third peripheral wall portion 123 and the medicine supported by the second peripheral wall portion 122 is small. Get wider
　第３周壁部１２３によって支持されている薬剤は、回転方向２の先頭側に位置する薬剤から順次、立壁部１３２によって支持される。第２回転部１１２が駆動されることにより、立壁部１３２によって支持されている薬剤は、立壁部１３２に沿って搬送される。 The medicines supported by the third peripheral wall 123 are sequentially supported by the standing wall 132 from the medicine located on the leading side in the rotation direction 2. By driving the second rotating portion 112, the medicine supported by the standing wall portion 132 is conveyed along the standing wall portion 132.
　薬剤止め部１４２が斜面１１０ｓに接近している状態においては、立壁部１３２に沿って搬送される薬剤の排出部１３１への移動が阻止される。そこで、第２モータ２７１によって、回動軸１４０ｓが回動させられる。 When the medicine stopping portion 142 is close to the slope 110s, the medicine conveyed along the standing wall portion 132 is prevented from moving to the discharging portion 131. Therefore, the rotation shaft 140s is rotated by the second motor 271.
　回動軸１４０ｓが一方に回動させられることにより、開閉部材１４０が回動軸１４０ｓを中心に回動し、開閉部１４１によって塞がれていた排出部１３１が開放され、薬剤止め部１４２が斜面１１０ｓから離間する。これにより、立壁部１３２によって支持されている薬剤のうち回転方向２の先頭側に位置する薬剤が、１つずつ排出部１３１から排出される。 When the rotating shaft 140s is rotated to one side, the opening/closing member 140 is rotated around the rotating shaft 140s, the discharging portion 131 closed by the opening/closing portion 141 is opened, and the medicine stopping portion 142 is opened. It is separated from the slope 110s. As a result, among the medicines supported by the standing wall portion 132, the medicines located on the leading side in the rotation direction 2 are discharged one by one from the discharge portion 131.
　このとき、第１センサ２３１が、斜面１１０ｓ上の薬剤が排出部１３１から排出されたことを検出する。第２センサ２３２が、排出部１３１から排出された薬剤を検出する。 At this time, the first sensor 231 detects that the medicine on the slope 110s is discharged from the discharge portion 131. The second sensor 232 detects the drug discharged from the discharging unit 131.
　排出部１３１から薬剤が排出された後、回動軸１４０ｓが他方に回動させられることにより、開閉部材１４０が回動軸１４０ｓを中心に回動し、開閉部１４１によって排出部１３１が閉鎖され、薬剤止め部１４２が斜面１１０ｓに接近する。 After the medicine is discharged from the discharge portion 131, the rotating shaft 140s is rotated to the other side, whereby the opening/closing member 140 is rotated around the rotating shaft 140s, and the discharge portion 131 is closed by the opening/closing portion 141. The drug stopper 142 approaches the slope 110s.
　これにより、立壁部１３２によって支持されている薬剤は、薬剤止め部１４２によって排出部１３１への移動が阻止されるとともに、開閉部１４１によって排出部１３１からの排出が阻止される。上記のように、開閉部１４１は、薬剤供給部から薬剤を供給するときは開状態となり、薬剤供給部から薬剤を供給しないときは閉状態となる。 Accordingly, the medicine supported by the upright wall portion 132 is prevented from moving to the discharging portion 131 by the medicine stopping portion 142, and is prevented from being discharged from the discharging portion 131 by the opening/closing portion 141. As described above, the opening/closing unit 141 is in the open state when the drug is supplied from the drug supply unit, and is in the closed state when the drug is not supplied from the drug supply unit.
　薬剤供給部が筐体４１０に対して移動するときは、薬剤供給部が停止するとともに開閉部１４１が閉状態となった後、薬剤供給部の移動が開始される。このようにした場合、薬剤供給部の移動中に、排出部１３１から不所望の薬剤が排出されることを抑制できる。 When the medicine supply unit moves with respect to the housing 410, the medicine supply unit is stopped and the opening/closing unit 141 is closed, and then the movement of the medicine supply unit is started. In this case, it is possible to suppress the discharge of the undesired drug from the discharge unit 131 during the movement of the drug supply unit.
　薬剤供給部からの薬剤の供給を再開させるときは、開閉部１４１が開状態となるとともに薬剤供給部が再稼働する。このようにした場合、薬剤供給部の再稼働直後から、薬剤を排出部１３１から排出可能とすることができる。 When resuming the supply of the drug from the drug supply unit, the opening/closing unit 141 is opened and the drug supply unit is restarted. In this case, the drug can be discharged from the discharge unit 131 immediately after the drug supply unit is restarted.
　次に、薬剤補充部１２の動作について説明する。
　第３モータ２７２によって、１対のローラ部２８２が回転することにより、薬剤収容容器３００が軸線３まわりに回転駆動される。 Next, the operation of the medicine replenishing unit 12 will be described.
By rotating the pair of roller portions 282 by the third motor 272, the medicine container 300 is rotationally driven around the axis 3.
　薬剤収容容器３００が軸線３まわりに回転駆動されることにより、薬剤収容容器３００内の薬剤が螺旋溝３１２によって薬剤収容容器３００の底部３３０側から第１開口部３１３側に搬送されて第１開口部３１３から排出される。 When the medicine container 300 is rotationally driven around the axis 3, the medicine in the medicine container 300 is conveyed from the bottom 330 side of the medicine container 300 to the first opening 313 side by the spiral groove 312, and the first opening 313 is formed. It is discharged from the section 313.
　第１開口部３１３から排出された薬剤は、ベース部２００の接続管路２９０内を通過して、蓋部材１２０の薬剤供給孔１２７内に供給される。蓋部材１２０の薬剤供給孔１２７内に供給された薬剤は、薬剤供給モジュール１００の排出部１３１から１つずつ排出される。 The medicine discharged from the first opening 313 passes through the connection conduit 290 of the base 200 and is supplied into the medicine supply hole 127 of the lid member 120. The medicines supplied into the medicine supply holes 127 of the lid member 120 are discharged one by one from the discharge portion 131 of the medicine supply module 100.
　なお、ベース部２００には、複数の薬剤収容容器３００の中から順次選択された１つの薬剤収容容器３００が取り付けられる。複数の薬剤収容容器３００の各々は、識別子３３１に基づいて設定された互いに異なる駆動条件で駆動される。薬剤供給部は、複数の薬剤収容容器３００の各々に対応して駆動される。 Note that the base portion 200 is attached with one medicine container 300 selected in sequence from a plurality of medicine containers 300. Each of the plurality of drug storage containers 300 is driven under different drive conditions set based on the identifier 331. The drug supply unit is driven corresponding to each of the plurality of drug storage containers 300.
　具体的には、薬剤の種類は、小粒の錠剤である一般的な薬剤と、カプセル、長細い錠剤、球形の錠剤または三角柱状の錠剤などの特殊な薬剤とがある。複数の薬剤収容容器３００の各々には、一般的な薬剤または特殊な薬剤が収容される。ベース部２００に薬剤収容容器３００が取り付けられた際、識別センサ２３４からの識別子３３１の検出信号が入力された制御部１１は、ベース部２００に取り付けられた薬剤収容容器３００の内部に収容されている薬剤の種類を判別する。すなわち、制御部１１には、識別センサ２３４からの識別子３３１の検出信号に含まれている、薬剤の形状に関する薬剤情報を有する薬剤情報信号が入力される。 Specifically, there are two types of drugs: general drugs, which are small tablets, and special drugs, such as capsules, long and thin tablets, spherical tablets, and triangular column tablets. A general medicine or a special medicine is stored in each of the plurality of medicine storage containers 300. When the medicine container 300 is attached to the base unit 200, the control unit 11 to which the detection signal of the identifier 331 from the identification sensor 234 is input is housed inside the medicine container 300 attached to the base unit 200. Determine the type of drug present. That is, the control unit 11 is input with a drug information signal including drug information regarding the shape of the drug, which is included in the detection signal of the identifier 331 from the identification sensor 234.
　以下、本発明の一実施形態に係る薬剤分包装置４００が処方情報に応じて薬剤を分包する際の制御フローについて説明する。 Hereinafter, a control flow when the medicine packaging device 400 according to an embodiment of the present invention packages a medicine according to prescription information will be described.
　図３５は、本発明の一形態に係る薬剤分包装置が処方情報に応じて動作する際のタイムチャートである。図３６は、処方情報および分包情報を説明するための図である。 FIG. 35 is a time chart when the medicine packaging device according to an aspect of the present invention operates according to prescription information. FIG. 36 is a diagram for explaining prescription information and packaging information.
　図３５に示すように、処方情報受付装置９０に処方情報が入力される。処方情報には、薬剤の種類、服用時点、服用日数、１日の服用量および各服用時点の服用量などの情報が含まれている。 As shown in FIG. 35, prescription information is input to the prescription information reception device 90. The prescription information includes information such as the type of drug, time of administration, number of days of administration, daily dose, and dose at each time of administration.
　図３６に示す処方情報の一例においては、一処方において３日分の薬剤が処方されており、一処方におけるＡ薬剤の必要数は９個であり、一処方におけるＢ薬剤の必要数は６個である。Ａ薬剤の必要数は、朝食後、昼食後および夕食後の各々において１個である。Ｂ薬剤の必要数は、朝食後および夕食後の各々において０個であり、昼食後において２個である。 In the example of the prescription information shown in FIG. 36, the drug for 3 days is prescribed in one prescription, the required number of drug A in one prescription is 9, and the required number of drug B in one prescription is 6 Is. The required number of drug A is one after breakfast, after lunch, and after dinner. The required number of B drugs is 0 after breakfast and after dinner, and 2 after lunch.
　本実施形態では、一つの処方情報に基づいて一つの分包情報が作成される場合を想定している。この場合、一処方は、一つの処方情報に基づく一つの分包情報に対応する。 In the present embodiment, it is assumed that one packaging information is created based on one prescription information. In this case, one prescription corresponds to one packaging information based on one prescription information.
　他の例としては、一つの処方情報に基づいて複数の分包情報が作成される場合がある。たとえば、一つの処方情報に３種類の薬剤が含まれる場合、３種類の薬剤のうちの２種類の薬剤について第１の分包情報が作成され、残りの１種類について第２の分包情報が作成されることがある。この場合、作成された複数の分包情報の各々が、ここでいう一処方に対応する。 As another example, multiple packaging information may be created based on one prescription information. For example, when one prescription information includes three kinds of medicines, first packaging information is created for two kinds of the three kinds of medicines, and second packaging information for the remaining one kind. May be created. In this case, each of the created plurality of packaging information corresponds to one prescription here.
　さらに他の例として、一つの処方情報の一部に基づいて一つの分包情報が作成される場合もある。たとえば、一つの処方情報に３種類の薬剤が含まれる場合、３種類の薬剤のうちの２種類の薬剤について一つの分包情報が作成され、残りの１種類について分包情報が作成されないことがある。この場合、作成された一つの分包情報が、ここでいう一処方に対応する。 As yet another example, one packaging information may be created based on a part of one prescription information. For example, when one prescription information includes three kinds of medicines, one packaging information may be created for two kinds of the three kinds of medicines and the packaging information may not be created for the remaining one kind of medicines. is there. In this case, one piece of created packaging information corresponds to one prescription here.
　図３５に示すように、処方情報受付装置９０は、入力された処方情報に応じた分包情報を操作パネル５０に入力する。分包情報には、処方情報に応じて薬剤を分包するための情報が含まれている。 As shown in FIG. 35, the prescription information reception device 90 inputs the packaging information according to the input prescription information into the operation panel 50. The packaging information includes information for packaging the medicine according to the prescription information.
　図３５に示すように、操作パネル５０に処方情報受付装置９０から分包情報が入力された後、複数の薬剤供給装置のうちのいずれの薬剤供給装置から薬剤を供給するか選択する選択情報、および、薬剤分包装置４００に分包動作を開始させる分包指示が、操作パネル５０に設けられている入力部から入力される。 As shown in FIG. 35, after the packaging information is input from the prescription information receiving device 90 to the operation panel 50, the selection information for selecting which drug supply device of the plurality of drug supply devices to supply the drug, A packing instruction for causing the medicine packing apparatus 400 to start the packing operation is input from the input unit provided on the operation panel 50.
　図３５に示すように、操作パネル５０の入力部に分包指示が入力されると、選択情報を含む分包情報が操作パネル５０から主制御部４１に入力される。選択情報を含む分包情報を入力された主制御部４１は、選択情報によって選択された第１薬剤供給装置１０の制御部１１に、一処方における薬剤の必要数を入力する。上記のように、複数の第１薬剤供給装置１０の各々の制御部１１と主制御部４１とによって構成される制御装置ユニット４６０には、薬剤の分包情報を有する分包情報信号が入力される。 As shown in FIG. 35, when the packing instruction is input to the input unit of the operation panel 50, the packing information including the selection information is input from the operation panel 50 to the main control unit 41. The main control unit 41, to which the packaging information including the selection information is input, inputs the required number of drugs in one prescription to the control unit 11 of the first drug supply device 10 selected by the selection information. As described above, the packaging information signal having the packaging information of the medicine is input to the control device unit 460 including the control unit 11 and the main control unit 41 of each of the plurality of first drug supply devices 10. It
　その後、一包における薬剤の必要数、および、供給動作を開始させる供給指示が、主制御部４１から制御部１１に、適宜のタイミングで順次、入力される。制御部１１は、供給指示が入力されると、一包分の供給動作を実行する。一包分の供給動作が完了すると、その旨を告げる完了通知が、制御部１１から主制御部４１に入力される。 After that, the required number of medicines in one package and the supply instruction for starting the supply operation are sequentially input from the main control unit 41 to the control unit 11 at appropriate timing. When the supply instruction is input, the control unit 11 executes the supply operation for one package. When the supply operation for one package is completed, a notification of the completion is input from the control unit 11 to the main control unit 41.
　一処方分の分包動作が完了すると、その旨を告げる完了通知が、主制御部４１から操作パネル５０に入力される。 When the packaging operation for one prescription is completed, a completion notification to that effect is input from the main control unit 41 to the operation panel 50.
　図３７は、主制御部から一処方における薬剤の必要数を入力された薬剤供給装置の制御部における動作を説明するフローチャートである。図３７に示すように、主制御部４１から一処方における薬剤の必要数を入力された第１薬剤供給装置１０の制御部１１においては、識別センサ２３４からの入力信号によって薬剤収容容器３００を識別する(工程Ｓ１１)。薬剤収容容器３００を識別した制御部１１は、薬剤補充部１２に薬剤の補充を開始させる(工程Ｓ１２)。 FIG. 37 is a flow chart for explaining the operation of the control unit of the drug supply device, in which the required number of drugs in one prescription is input from the main control unit. As shown in FIG. 37, in the control unit 11 of the first drug supply device 10 to which the required number of drugs in one prescription has been input from the main control unit 41, the drug storage container 300 is identified by the input signal from the identification sensor 234. (Step S11). The control unit 11 that has identified the medicine container 300 causes the medicine replenishment unit 12 to start replenishment of the medicine (step S12).
　図３８は、薬剤補充部によって薬剤を補充する際の制御部における動作を説明するフローチャートである。図３８に示すように、制御部１１は、薬剤補充部１２による薬剤の補充を開始させた(工程Ｓ１２)後、供給数が一処方における薬剤の必要数未満であるかどうかを判別する(工程Ｓ２１)。 FIG. 38 is a flow chart for explaining the operation of the control unit when the medicine is replenished by the medicine replenishing unit. As shown in FIG. 38, the control unit 11 determines whether the supply number is less than the required number of medicines in one prescription after starting the medicine replenishment by the medicine replenishment unit 12 (step S12) (step S12). S21).
　具体的には、図３６に示す分包情報の一例において、Ａ薬剤を収容している薬剤収容容器３００が搭載されている第１薬剤供給装置１０の制御部１１は、Ａ薬剤の供給数が必要数である９未満であるかどうかを判別する。Ｂ薬剤を収容している薬剤収容容器３００が搭載されている第１薬剤供給装置１０の制御部１１は、Ｂ薬剤の供給数が必要数である６未満であるかどうかを判別する。 Specifically, in the example of the packaging information illustrated in FIG. 36, the control unit 11 of the first drug supply device 10 in which the drug storage container 300 that stores the A drug is mounted indicates that the supply number of the A drug is It is determined whether the required number is less than 9. The control unit 11 of the first drug supply device 10 in which the drug storage container 300 containing the B drug is mounted determines whether the number of supplies of the B drug is less than the required number of 6.
　供給数が一処方における薬剤の必要数未満である場合、制御部１１は、薬剤検出部である薬剤検出センサ２３５が薬剤受け位置に薬剤があることを検出しているかどうかを薬剤検出信号から判別する(工程Ｓ２２)。 When the number of supplies is less than the required number of medicines in one prescription, the control unit 11 determines from the medicine detection signal whether the medicine detection sensor 235, which is a medicine detection unit, detects that there is a medicine at the medicine receiving position. (Step S22).
　制御部１１は、薬剤検出センサ２３５が薬剤受け位置に薬剤があることを検出している第１検出状態であるとき、補充用モータである第３モータ２７２を停止させる(工程Ｓ２３)。すなわち、制御部１１は、薬剤検出部が第１検出状態であるとき、薬剤補充部１２による薬剤の補充を停止させる。この後、制御部１１は、工程Ｓ２１に戻る。 The control unit 11 stops the third motor 272, which is a replenishing motor, when the medicine detection sensor 235 is in the first detection state in which the medicine is detected at the medicine receiving position (step S23). That is, the control unit 11 causes the drug replenishment unit 12 to stop refilling the drug when the drug detection unit is in the first detection state. After that, the control unit 11 returns to step S21.
　制御部１１は、薬剤検出センサ２３５が薬剤受け位置に薬剤が無いことを検出している第２検出状態であるとき、第３モータ２７２を正転方向に回転させる(工程Ｓ２４)。すなわち、制御部１１は、薬剤検出部が第２検出状態であるとき、薬剤補充部１２に薬剤を補充させる。この後、制御部１１は、工程Ｓ２１に戻る。 The control unit 11 rotates the third motor 272 in the forward rotation direction in the second detection state in which the medicine detection sensor 235 detects that there is no medicine at the medicine receiving position (step S24). That is, the control unit 11 causes the drug replenishment unit 12 to replenish the drug when the drug detection unit is in the second detection state. After that, the control unit 11 returns to step S21.
　上記のように、制御部１１は、薬剤検出部から薬剤検出信号を入力され、薬剤検出信号に応じて薬剤補充部１２を制御する。 As described above, the control unit 11 receives the drug detection signal from the drug detection unit and controls the drug replenishment unit 12 according to the drug detection signal.
　制御部１１は、薬剤検出部が第１検出状態から第２検出状態になった時点から待機時間の経過後に、薬剤補充部１２に薬剤を補充させるように構成されていてもよい。上記のように、制御部１１には、識別センサ２３４からの識別子３３１の検出信号に含まれている、薬剤の形状に関する薬剤情報を有する薬剤情報信号が入力される。制御部１１は、薬剤情報に応じて上記待機時間を設定する。 The control unit 11 may be configured to cause the drug replenishment unit 12 to replenish the drug after a waiting time has elapsed from the time when the drug detection unit changed from the first detection state to the second detection state. As described above, the control unit 11 receives the drug information signal including the drug information regarding the shape of the drug, which is included in the detection signal of the identifier 331 from the identification sensor 234. The control unit 11 sets the waiting time according to the drug information.
　供給数が一処方における薬剤の必要数以上である場合、制御部１１は、第３モータ２７２を逆転方向に回転させる(工程Ｓ２５)。これにより、薬剤収容容器３００に収容されている薬剤を、第１開口部３１３側から薬剤収容容器３００の内側に戻すことができる。制御部１１は、第３モータ２７２を逆転方向に回転させてから一定時間経過後に、第３モータ２７２を停止させる(工程Ｓ２６)。 When the supplied number is more than the required number of medicines in one prescription, the control unit 11 rotates the third motor 272 in the reverse direction (step S25). Thereby, the medicine contained in the medicine container 300 can be returned to the inside of the medicine container 300 from the first opening 313 side. The control unit 11 stops the third motor 272 after a lapse of a certain time after rotating the third motor 272 in the reverse direction (step S26).
　なお、制御部１１は、供給数が一処方における薬剤の必要数未満である状態において、薬剤検出部が第２検出状態から第１検出状態になった時点で薬剤補充部１２による薬剤の補充を停止させ、第１検出状態になった時点から薬剤供給部の作動量が設定値を超えた時点、および、薬剤検出部が第１検出状態から第２検出状態になった時点、のうちの遅い時点で薬剤補充部１２による薬剤の補充を再開させるように構成されていてもよい。この場合、制御部１１は、上記薬剤情報に応じて上記設定値を設定する。 Note that the control unit 11 causes the drug replenishment unit 12 to replenish the drug when the drug detection unit changes from the second detection state to the first detection state in a state where the number of supplies is less than the required number of drugs in one prescription. It is the later one of the time when the operation amount of the drug supply unit exceeds the set value from the time of stopping and the first detection state and the time when the drug detection unit changes from the first detection state to the second detection state. The medicine replenishment unit 12 may be configured to restart the medicine replenishment at the time point. In this case, the control unit 11 sets the set value according to the drug information.
　上記の薬剤供給部の作動量とは、第１検出状態になった時点からの、薬剤供給部における第１回転部１１１の回転方向２への累積回転角度、または、第１回転部１１１の回転方向２への累積駆動時間である。具体的には、上記累積回転角度の設定値は、たとえば６０°とする。または、上記累積駆動時間の設定値は、上記累積回転角度がたとえば６０°となるのに必要な駆動時間とする。 The operation amount of the drug supply unit is the cumulative rotation angle of the first rotation unit 111 in the rotation direction 2 of the drug supply unit from the time when the first detection state is reached, or the rotation of the first rotation unit 111. It is the cumulative drive time in the direction 2. Specifically, the set value of the cumulative rotation angle is, for example, 60°. Alternatively, the set value of the cumulative drive time is a drive time required for the cumulative rotation angle to be, for example, 60°.
　上記の補充動作は、一処方に必要な薬剤を供給する複数の第１薬剤供給装置１０の各々において随時行なわれる。本実施形態においては、制御装置ユニット４６０は、上記分包情報に応じて、薬剤を供給している第１薬剤供給装置１０の次に薬剤を供給する第１薬剤供給装置１０において、薬剤供給部の最初の作動開始時点より前に、薬剤補充部１２による薬剤の補充を開始させる。詳しくは、第１薬剤供給装置１０の制御部１１は、主制御部４１から、一処方における薬剤の必要数を入力されると、薬剤補充部１２に薬剤の補充を開始させる。第１薬剤供給装置１０の制御部１１は、主制御部４１から、供給指示を入力されていなくても、薬剤補充部１２に薬剤の補充を開始させる。 The above replenishment operation is performed at any time in each of the plurality of first drug supply devices 10 that supplies the drug necessary for one prescription. In the present embodiment, the control device unit 460, in the first drug supply device 10 that supplies the drug next to the first drug supply device 10 that is supplying the drug, according to the packaging information, the drug supply unit. The medicine replenishment unit 12 starts replenishment of the medicine before the first operation start time. Specifically, the control unit 11 of the first medicine supply apparatus 10 causes the medicine replenishment unit 12 to start replenishment of the medicine when the required number of medicines in one prescription is input from the main control unit 41. The control unit 11 of the first medicine supply apparatus 10 causes the medicine replenishment unit 12 to start replenishment of medicines even if the supply instruction is not input from the main control unit 41.
　具体的には、制御装置ユニット４６０は、図３６に示す分包情報の一例においては、たとえば、Ａ薬剤を供給する第１薬剤供給装置１０が朝食後の１日目から３日目までの３包分のＡ薬剤を供給している間に、次に昼食後の１日目から３日目までの３包分のＢ薬剤を供給する第１薬剤供給装置１０において、薬剤供給モジュール１００の第１モータ２７０が駆動開始する時点より前に、薬剤補充部１２による薬剤の補充を開始させる。 Specifically, in the example of the packaging information illustrated in FIG. 36, the control device unit 460, for example, the first medicine supply device 10 that supplies the medicine A has 3 days from the first day to the third day after breakfast. While supplying the drug A for the package, the first drug supply device 10 for supplying the drug B for the three packages from the first day to the third day after lunch is next tested. The medicine replenishment unit 12 starts the medicine replenishment before the time when the 1-motor 270 starts driving.
　より好ましくは、次に薬剤を供給する第１薬剤供給装置１０が薬剤の供給を開始する時点において、薬剤補充部１２は１回目の補充を完了しており、薬剤受け位置に薬剤がある状態になっている。 More preferably, the medicine replenishing unit 12 has completed the first replenishment at the time when the first medicine supplying apparatus 10 that supplies the medicine next starts to supply the medicine, and the medicine is in the medicine receiving position. Has become.
　制御装置ユニット４６０は、上記分包情報に応じて、一処方における必要数の薬剤を供給し終えた第１薬剤供給装置１０から順次、薬剤補充部１２による薬剤の補充を停止させる。 The control device unit 460 stops the drug replenishment by the drug replenishment unit 12 sequentially from the first drug supply device 10 which has finished supplying the required number of drugs in one prescription according to the packaging information.
　具体的には、制御装置ユニット４６０は、図３６に示す分包情報の一例においては、昼食後の１日目から３日目までの３包分に必要なＢ薬剤の供給を終えて、一処方における必要数のＢ薬剤を供給し終えた第１薬剤供給装置１０の薬剤補充部１２によるＢ薬剤の補充を停止させる。制御装置ユニット４６０は、その後、夕食後の１日目から３日目までの３包分に必要なＡ薬剤の供給を終えて、一処方における必要数のＡ薬剤を供給し終えた第１薬剤供給装置１０の薬剤補充部１２によるＡ薬剤の補充を停止させる。 Specifically, in the example of the packaging information shown in FIG. 36, the control device unit 460 finishes the supply of the B medicine necessary for the three packages from the first day to the third day after lunch, The replenishment of the B medicine by the medicine replenishing unit 12 of the first medicine supplying apparatus 10 which has finished supplying the required number of B medicines in the prescription is stopped. The controller unit 460 then completes the supply of the A drug necessary for the 3 packages from the first day to the third day after dinner, and then supplies the necessary number of A drugs in one prescription. The replenishment of the medicine A by the medicine replenishing unit 12 of the supply device 10 is stopped.
　図３９は、主制御部から一包における薬剤の必要数および供給指示を入力された薬剤供給装置の制御部における動作を説明するフローチャートである。図３９に示すように、主制御部４１から一包における薬剤の必要数および供給指示を入力された第１薬剤供給装置１０の制御部１１においては、開閉部１４１によって塞がれていた排出部１３１を開放させる(工程Ｓ３１)。 FIG. 39 is a flowchart for explaining the operation of the control unit of the drug supply device, which is input with the required number of drugs and the supply instruction of the drug from the main control unit. As shown in FIG. 39, in the control unit 11 of the first drug supply device 10 to which the required number of drugs in one package and the supply instruction have been input from the main control unit 41, the discharge unit that is blocked by the opening/closing unit 141. 131 is opened (step S31).
　排出部１３１を開放させた後、制御部１１は、薬剤供給部である薬剤供給モジュール１００に一包における薬剤の供給を開始させる(Ｓ３２)。制御部１１は、薬剤供給モジュール１００による薬剤の供給を開始させた(工程Ｓ３２)後、薬剤供給モジュール１００から供給された薬剤を計数する(工程Ｓ３３)。薬剤の供給数が一包における薬剤の必要数以上になった時点で、薬剤供給モジュール１００による薬剤の供給を終了させる(工程Ｓ３４)。 After opening the discharge unit 131, the control unit 11 causes the drug supply module 100, which is a drug supply unit, to start supplying the drug in one package (S32). After starting the supply of the medicine by the medicine supply module 100 (step S32), the control unit 11 counts the medicines supplied from the medicine supply module 100 (step S33). When the number of medicines supplied exceeds the necessary number of medicines in one package, the medicine supply by the medicine supply module 100 is terminated (step S34).
　この後、制御部１１は、薬剤の供給数が一処方における薬剤の必要数以上であるかどうかを判別する(工程Ｓ３５)。供給数が一処方における薬剤の必要数以上である場合、開閉部１４１によって排出部１３１を閉鎖する(工程Ｓ３６)。供給数が一処方における薬剤の必要数未満である場合、制御部１１は、排出部１３１を開放した状態を維持しつつ、一包分の薬剤の供給動作を終了させる。 After that, the control unit 11 determines whether or not the number of medicines supplied is equal to or larger than the necessary number of medicines in one prescription (step S35). When the supply number is more than the required number of medicines in one prescription, the opening/closing section 141 closes the discharge section 131 (step S36). When the supply number is less than the required number of medicines in one prescription, the control unit 11 ends the operation of supplying one package of medicine while maintaining the discharge unit 131 in an open state.
　図４０は、薬剤供給部によって薬剤を供給する際の制御部における動作を説明するフローチャートである。図４０に示すように、制御部１１は、薬剤供給モジュール１００による薬剤の供給を開始させた(工程Ｓ３２)後、供給数が一包における薬剤の必要数未満であるかどうかを判別する(工程Ｓ４１)。 FIG. 40 is a flow chart for explaining the operation of the control unit when a drug is supplied by the drug supply unit. As shown in FIG. 40, the control unit 11 determines whether the supply number is less than the required number of drugs in one package after starting the supply of the drug by the drug supply module 100 (step S32) (step S32). S41).
　具体的には、図３６に示す分包情報の一例において昼食後の１日目の分包をする際、Ａ薬剤を収容している薬剤収容容器３００が搭載されている第１薬剤供給装置１０の制御部１１は、Ａ薬剤の供給数が必要数である１未満であるかどうかを判別する。Ｂ薬剤を収容している薬剤収容容器３００が搭載されている第１薬剤供給装置１０の制御部１１は、Ｂ薬剤の供給数が必要数である２未満であるかどうかを判別する。 Specifically, in the example of the packaging information shown in FIG. 36, when packaging the first day after lunch, the first drug supply device 10 in which the drug container 300 containing the drug A is mounted The control unit 11 determines whether the supply number of the A medicine is less than the required number of 1. The control unit 11 of the first drug supply device 10 in which the drug storage container 300 that stores the B drug is mounted determines whether the supply number of the B drug is less than the required number of 2.
　供給数が一包における薬剤の必要数未満である場合、制御部１１は、供給用モータである第１モータ２７０を正転方向に駆動させるとともに、振動用モータである偏心モータ２７３を駆動させる(工程Ｓ４２)。これにより、第１回転部１１１および第２回転部１１２の各々が正転方向に回転するとともに振動部２６０が振動する。 When the supply number is less than the required number of medicines in one package, the control unit 11 drives the first motor 270, which is a supply motor, in the forward rotation direction, and also drives the eccentric motor 273, which is a vibration motor ( Step S42). As a result, each of the first rotating portion 111 and the second rotating portion 112 rotates in the forward rotation direction and the vibrating portion 260 vibrates.
　この後、制御部１１は、第１検出部である第１センサ２３１が薬剤を検出したかどうかを第１センサ２３１からの第１検出信号の入力の有無によって判別する(工程Ｓ４３)。 After that, the control unit 11 determines whether or not the first sensor 231 which is the first detection unit has detected the drug based on the presence or absence of the input of the first detection signal from the first sensor 231 (step S43).
　制御部１１は、第１センサ２３１が薬剤を検出した場合、第１モータ２７０を停止させるとともに、偏心モータ２７３を停止させる(工程Ｓ４４)。このように、制御部１１は、第１検出信号が入力されると、薬剤供給部による薬剤の搬送を一時的に停止させる。 When the first sensor 231 detects a drug, the control unit 11 stops the first motor 270 and the eccentric motor 273 (step S44). As described above, when the first detection signal is input, the control unit 11 temporarily stops the drug delivery by the drug supply unit.
　この後、制御部１１は、第１モータ２７０を逆転方向に設定量だけ駆動させる(工程Ｓ４５)。このように、制御部１１は、第１検出信号が入力されると、薬剤供給部による薬剤の搬送方向を一時的に逆方向にする。 After that, the control unit 11 drives the first motor 270 in the reverse rotation direction by the set amount (step S45). In this way, when the first detection signal is input, the control unit 11 temporarily reverses the drug transport direction of the drug supply unit to the reverse direction.
　制御部１１は、第１モータ２７０を逆転方向に設定量だけ駆動させた後、第１モータ２７０を停止させ、工程Ｓ４１に戻る。 The control unit 11 drives the first motor 270 in the reverse rotation direction by the set amount, stops the first motor 270, and returns to step S41.
　供給数が一包における薬剤の必要数以上である場合、制御部１１は、一包分の薬剤の供給動作を終了させる(工程Ｓ３４)。 When the supply number is equal to or more than the required number of medicines in one package, the control unit 11 terminates the supply operation of the medicines for one package (step S34).
　図４１は、薬剤供給部によって供給された薬剤を計数する際の制御部における動作を説明するフローチャートである。図４１に示すように、制御部１１は、薬剤供給部によって供給された薬剤の計数(工程Ｓ３３)が開始されると、第１検出部である第１センサ２３１が薬剤を検出したかどうかを第１センサ２３１からの第１検出信号の入力の有無によって判別する(工程Ｓ５１)。 FIG. 41 is a flowchart illustrating the operation of the control unit when counting the medicines supplied by the medicine supply unit. As shown in FIG. 41, when the counting of the drug supplied by the drug supply unit (step S33) is started, the control unit 11 determines whether the first sensor 231 as the first detection unit has detected the drug. The determination is made based on the presence or absence of the input of the first detection signal from the first sensor 231 (step S51).
　制御部１１は、第１センサ２３１が薬剤を検出した場合、到達フラグをオンにする(工程Ｓ５２)。制御部１１は、第１センサ２３１が薬剤を検出していない場合、到達フラグはそのままにする。 When the first sensor 231 detects a drug, the control unit 11 turns on the arrival flag (step S52). When the first sensor 231 does not detect the medicine, the control unit 11 leaves the arrival flag as it is.
　この後、制御部１１は、第２検出部である第２センサ２３２が薬剤を検出したかどうかを第２センサ２３２からの第２検出信号の入力の有無によって判別する(工程Ｓ５３)。工程Ｓ５３において、第２センサ２３２が薬剤を検出している状態においては、薬剤は第２センサ２３２を構成する投光部と受光部との間の光軸を遮っている状態である。 After that, the control unit 11 determines whether or not the second sensor 232, which is the second detection unit, has detected the drug based on the presence or absence of the input of the second detection signal from the second sensor 232 (step S53). In step S53, when the second sensor 232 is detecting the drug, the drug blocks the optical axis between the light projecting unit and the light receiving unit that configure the second sensor 232.
　制御部１１は、工程Ｓ５３において第２センサ２３２が薬剤を検出した場合、第２検出部である第２センサ２３２が薬剤を非検出となったかどうかを第２センサ２３２からの第２検出信号の入力の有無によって判別する(工程Ｓ５４)。工程Ｓ５４において、第２センサ２３２が薬剤を非検出となっている状態においては、薬剤は第２センサ２３２を構成する投光部と受光部との間の光軸を通過して、当該光軸が元の開通状態に戻った状態である。制御部１１は、工程Ｓ５３において第２センサ２３２が薬剤を検出していない場合、工程Ｓ５１に戻る。 When the second sensor 232 detects the drug in step S53, the control unit 11 determines whether the second sensor 232, which is the second detection unit, detects the drug as a second detection signal from the second sensor 232. It is determined whether or not there is an input (step S54). In step S54, in the state where the second sensor 232 is not detecting the medicine, the medicine passes through the optical axis between the light projecting section and the light receiving section which constitute the second sensor 232, and the optical axis concerned. Is the state in which it has returned to the original open state. When the second sensor 232 does not detect the drug in step S53, the control unit 11 returns to step S51.
　制御部１１は、工程Ｓ５４において第２センサ２３２が薬剤を非検出となった場合、到達フラグがオンになっているか確認する(工程Ｓ５５)。制御部１１は、工程Ｓ５４において第２センサ２３２が薬剤を非検出となっていない場合、工程Ｓ５４に戻る。 When the second sensor 232 does not detect the drug in step S54, the control unit 11 confirms whether the arrival flag is on (step S55). When the second sensor 232 does not detect the drug in step S54, the control unit 11 returns to step S54.
　制御部１１は、工程Ｓ５４において第２センサ２３２が薬剤を非検出となって、到達フラグがオンになっている場合、供給数を１加算して(工程Ｓ５６)、到達フラグをオフにする(工程Ｓ５７)。 When the second sensor 232 does not detect the drug and the arrival flag is on in step S54, the control unit 11 increments the supply number by 1 (step S56) and turns off the arrival flag (step S56). Step S57).
　制御部１１は、第２センサ２３２が薬剤を検出したが、到達フラグがオフである場合、異常と判断し(工程Ｓ５９)、薬剤の計数を終了する。このように、制御部１１は、第１検出信号が入力される入力間隔中に第２検出信号が複数回入力されると、異常と判断する。 When the second sensor 232 detects the drug but the arrival flag is off, the control unit 11 determines that the drug is abnormal (step S59) and ends the drug counting. In this way, the control unit 11 determines that the second detection signal is abnormal when the second detection signal is input a plurality of times during the input interval in which the first detection signal is input.
　工程Ｓ５７において到達フラグをオフにした後、制御部１１は、供給数が一包における薬剤の必要数以上であるかどうかを判別する(工程Ｓ５８)。供給数が一包における薬剤の必要数以上である場合、制御部１１は、薬剤の計数を終了する。供給数が一包における薬剤の必要数未満である場合、制御部１１は、工程Ｓ５１に戻る。 After turning off the arrival flag in step S57, the control unit 11 determines whether the supply number is equal to or more than the required number of medicines in one package (step S58). When the supply number is equal to or more than the required number of medicines in one package, the control unit 11 finishes counting the medicines. When the supply number is less than the required number of medicines in one package, the control unit 11 returns to step S51.
　上記のように、制御部１１は、第１センサ２３１から第１検出信号を入力され、第１検出信号に応じて薬剤供給部を制御し、かつ、第２センサ２３２から第２検出信号を入力され、第２検出信号に応じて薬剤供給部から供給された薬剤を計数する。 As described above, the control unit 11 receives the first detection signal from the first sensor 231, controls the medicine supply unit according to the first detection signal, and inputs the second detection signal from the second sensor 232. Then, the medicines supplied from the medicine supply unit are counted according to the second detection signal.
　本実施形態においては、制御部１１は、第１検出信号が入力されると、薬剤情報に応じた薬剤供給部の制御を行なう。具体的には、薬剤情報から、薬剤収容容器３００の内部に収容されている薬剤が一般的な薬剤と判別された場合には、一般的な薬剤は薬剤収容容器３００の回転量毎の薬剤供給部への排出量が多いため、制御部１１は、薬剤受け位置に薬剤があることを薬剤検出センサ２３５によって検出した直後に、薬剤収容容器３００の回転駆動を停止させる。この後、薬剤検出センサ２３５によって薬剤が検出されなくなると、薬剤収容容器３００の回転駆動を再開する。これによって薬剤供給部に薬剤が過供給されることを防止できる。 In this embodiment, when the first detection signal is input, the control unit 11 controls the drug supply unit according to the drug information. Specifically, when it is determined from the drug information that the drug contained in the drug container 300 is a general drug, the general drug is supplied for each rotation amount of the drug container 300. Since the amount discharged to the portion is large, the control unit 11 stops the rotation drive of the medicine container 300 immediately after the medicine detection sensor 235 detects that there is a medicine at the medicine receiving position. After this, when the drug is no longer detected by the drug detection sensor 235, the rotation of the drug container 300 is restarted. This can prevent the medicine from being excessively supplied to the medicine supply unit.
　薬剤情報から、薬剤収容容器３００の内部に収容されている薬剤が特殊な薬剤と判別された場合には、特殊な薬剤は薬剤収容容器３００の回転量毎の薬剤供給部への排出量が少なくなる傾向にあるため、制御部１１は、薬剤受け位置に薬剤があることを薬剤検出センサ２３５によって検出してから薬剤収容容器３００の回転駆動を停止させるまでの時間を、一般的な薬剤の場合に比較して長くする。若しくは、制御部１１は、薬剤収容容器３００の回転速度を、一般的な薬剤の場合に比較して高くする。さらに、制御部１１は、回転体１１０の回転速度も、一般的な薬剤の場合に比較して高くする。このようにすることにより、回転駆動によって排出しにくい特殊な薬剤の場合においても、薬剤補充に要する時間を一般的な薬剤に近づけるとともに、排出部１３１から１つずつ薬剤を供給することができる。 When it is determined from the drug information that the drug contained in the drug container 300 is a special drug, the amount of the special drug discharged to the drug supply unit for each rotation amount of the drug container 300 is small. Therefore, the control unit 11 determines the time from the detection of the drug at the drug receiving position by the drug detection sensor 235 until the rotation drive of the drug container 300 is stopped in the case of a general drug. Make it longer than. Alternatively, the control unit 11 increases the rotation speed of the medicine container 300 as compared with a general medicine. Further, the control unit 11 also increases the rotation speed of the rotating body 110 as compared with the case of a general medicine. By doing so, even in the case of a special drug that is difficult to be discharged by rotation drive, the time required for drug replenishment can be made closer to that of a general drug, and the drugs can be supplied one by one from the discharge unit 131.
　本実施形態においては、第１薬剤供給装置１０において、排出部１３１から薬剤が排出された際、回転体１１０および振動部２６０の各々を一時的に停止させるとともに、回転体１１０を一時的に逆転させ、次に排出部１３１から排出される薬剤を斜面１１０ｓ上に保持する。 In the present embodiment, in the first medicine supply device 10, when the medicine is discharged from the discharge portion 131, each of the rotating body 110 and the vibrating portion 260 is temporarily stopped, and the rotating body 110 is temporarily reversed. Then, the medicine discharged from the discharge portion 131 is held on the slope 110s.
　なお、第１薬剤供給装置１０において、排出部１３１から薬剤が排出された際、振動部２６０を一時的に停止させるとともに、回転体１１０を一時的に停止させ、次に排出部１３１から排出される薬剤を斜面１１０ｓ上に保持するようにしてもよい。 In the first medicine supply device 10, when the medicine is discharged from the discharge portion 131, the vibrating portion 260 is temporarily stopped, the rotating body 110 is temporarily stopped, and then the medicine is discharged from the discharge portion 131. The medicine to be held may be held on the slope 110s.
　本発明の一実施形態に係る薬剤分包装置４００においては、制御装置ユニット４６０が、分包情報に応じて、薬剤を供給している第１薬剤供給装置１０の次に薬剤を供給する第１薬剤供給装置１０において、薬剤供給モジュール１００の最初の作動開始時点より前に、薬剤補充部１２による薬剤の補充を開始させる。これにより、薬剤供給モジュール１００の供給開始後から薬剤が供給されるまでの時間を短縮することができるため、ひいては、分包するための所要時間を短縮することができる。 In the medicine packing apparatus 400 according to the embodiment of the present invention, the control device unit 460 supplies the medicine next to the first medicine supplying apparatus 10 which supplies the medicine according to the packing information. In the medicine supply device 10, before the first operation of the medicine supply module 100 is started, the medicine replenishment unit 12 starts the medicine replenishment. As a result, the time from the start of supply of the medicine supply module 100 to the supply of the medicine can be shortened, and thus the time required for packaging can be shortened.
　本発明の一実施形態に係る薬剤分包装置４００においては、制御装置ユニット４６０は、分包情報に応じて、一処方における必要数の薬剤を供給し終えた第１薬剤供給装置１０から順次、薬剤補充部１２による薬剤の補充を停止させる。これにより、薬剤補充部１２から薬剤供給モジュール１００に薬剤が過剰に補充されることを抑制することができる。 In the medicine packaging device 400 according to one embodiment of the present invention, the control device unit 460 sequentially supplies the required number of medicines in one prescription from the first medicine supplying device 10 in accordance with the packaging information, The replenishment of the medicine by the medicine replenishing unit 12 is stopped. As a result, it is possible to prevent the medicine replenishment unit 12 from replenishing the medicine supply module 100 with the medicine excessively.
　本発明の一実施形態に係る薬剤分包装置４００においては、制御装置ユニット４６０は、薬剤検出センサ２３５から薬剤検出信号を入力され、薬剤検出信号に応じて、薬剤検出センサ２３５が第１検出状態であるとき、薬剤補充部１２による薬剤の補充を停止させ、薬剤検出センサ２３５が第２検出状態であるとき、薬剤補充部１２に薬剤を補充させる。これにより、簡易な制御によって、薬剤補充部１２から薬剤供給モジュール１００に薬剤を適度に補充することができる。 In the medicine packaging device 400 according to the embodiment of the present invention, the control device unit 460 receives the medicine detection signal from the medicine detection sensor 235, and the medicine detection sensor 235 receives the medicine detection signal according to the first detection state. When the drug detection sensor 235 is in the second detection state, the drug replenishment unit 12 is caused to replenish the drug. Thereby, the medicine can be appropriately replenished from the medicine replenishing unit 12 to the medicine supply module 100 by a simple control.
　本発明の一実施形態に係る第１薬剤供給装置１０においては、制御部１１は、薬剤検出センサ２３５から薬剤検出信号を入力され、薬剤検出信号に応じて薬剤補充部１２を制御する。これにより、薬剤の補充が必要になったことを早期に検出して、薬剤補充部１２から薬剤供給モジュール１００に薬剤を適度に補充することができるため、薬剤を供給するための所要時間を短縮することができる。 In the first drug supply device 10 according to the embodiment of the present invention, the control unit 11 receives the drug detection signal from the drug detection sensor 235 and controls the drug replenishment unit 12 according to the drug detection signal. As a result, it is possible to detect the necessity of replenishing the medicine at an early stage and appropriately replenish the medicine from the medicine replenishing unit 12 to the medicine supply module 100, thereby shortening the time required to supply the medicine. can do.
　本発明の一実施形態に係る第１薬剤供給装置１０においては、制御部１１は、薬剤検出センサ２３５が第１検出状態であるとき、薬剤補充部１２による薬剤の補充を停止させ、薬剤検出センサ２３５が第２検出状態であるとき、薬剤補充部に薬剤を補充させる。これにより、簡易な制御によって、薬剤補充部１２から薬剤供給モジュール１００に薬剤を適度に補充することができる。 In the first drug supply device 10 according to the embodiment of the present invention, the control unit 11 stops the drug replenishment by the drug replenishment unit 12 when the drug detection sensor 235 is in the first detection state, and the drug detection sensor. When 235 is in the second detection state, the medicine replenishing unit is made to replenish the medicine. Thereby, the medicine can be appropriately replenished from the medicine replenishing unit 12 to the medicine supply module 100 by a simple control.
　本発明の一実施形態に係る第１薬剤供給装置１０においては、制御部１１は、薬剤検出センサ２３５が第１検出状態から第２検出状態になった時点から待機時間の経過後に、薬剤補充部１２に薬剤を補充させる。これにより、薬剤補充部１２から薬剤供給モジュール１００に薬剤が過剰に補充されることを抑制することができる。 In the first medicine supply device 10 according to the embodiment of the present invention, the control unit 11 controls the medicine replenishment unit after the waiting time has elapsed from the time when the medicine detection sensor 235 changes from the first detection state to the second detection state. Let 12 replenish the drug. As a result, it is possible to prevent the medicine replenishment unit 12 from replenishing the medicine supply module 100 with the medicine excessively.
　本発明の一実施形態に係る第１薬剤供給装置１０においては、制御部１１は、薬剤情報に応じて上記待機時間を設定する。これにより、薬剤の種類に応じて、薬剤補充部１２から薬剤供給モジュール１００に薬剤を適度に補充することができる。 In the first medicine supply device 10 according to the embodiment of the present invention, the control unit 11 sets the waiting time according to the medicine information. Thereby, the medicine can be appropriately replenished from the medicine replenishing unit 12 to the medicine supply module 100 according to the kind of the medicine.
　本発明の一実施形態に係る第１薬剤供給装置１０においては、制御部１１は、薬剤検出センサ２３５が第２検出状態から第１検出状態になった時点で薬剤補充部１２による薬剤の補充を停止させ、上記時点から薬剤供給モジュール１００の作動量が設定値を超えた時点、および、薬剤検出センサ２３５が第１検出状態から第２検出状態になった時点、のうちの遅い時点で薬剤補充部１２による薬剤の補充を再開させる。これにより、薬剤補充部１２から薬剤供給モジュール１００に薬剤が過剰に補充されることを抑制することができる。 In the first drug supply device 10 according to the embodiment of the present invention, the control unit 11 causes the drug replenishment unit 12 to replenish the drug when the drug detection sensor 235 changes from the second detection state to the first detection state. Stop and stop the above-mentioned time, when the operation amount of the medicine supply module 100 exceeds the set value, and when the medicine detection sensor 235 changes from the first detection state to the second detection state, the medicine is replenished later. Replenishment of the medicine by the section 12 is restarted. As a result, it is possible to prevent the medicine replenishment unit 12 from replenishing the medicine supply module 100 with the medicine excessively.
　本発明の一実施形態に係る第１薬剤供給装置１０においては、制御部１１は、薬剤情報に応じて上記設定値を設定する。薬剤の種類に応じて、薬剤補充部１２から薬剤供給モジュール１００に薬剤を適度に補充することができる。 In the first drug supply device 10 according to the embodiment of the present invention, the control unit 11 sets the set value according to the drug information. The medicine can be appropriately replenished from the medicine replenishing unit 12 to the medicine supply module 100 according to the kind of the medicine.
　本発明の一実施形態に係る第１薬剤供給装置１０においては、制御部１１は、第１センサ２３１から第１検出信号を入力され、第１検出信号に応じて薬剤供給モジュール１００を制御し、かつ、第２センサ２３２から第２検出信号を入力され、第２検出信号に応じて薬剤供給モジュール１００から供給された薬剤を計数する。これにより、第１センサ２３１にて複数の薬剤が重なった状態で検出された場合においても、第２センサ２３２にて複数の薬剤がばらけた状態で検出されるため、排出部１３１から複数の薬剤が同時に排出されたことを検出することができる。 In the 1st chemical|medical agent supply apparatus 10 which concerns on one Embodiment of this invention, the control part 11 inputs the 1st detection signal from the 1st sensor 231, controls the chemical|medical agent supply module 100 according to a 1st detection signal, In addition, the second detection signal is input from the second sensor 232, and the medicine supplied from the medicine supply module 100 is counted according to the second detection signal. Accordingly, even when the first sensor 231 detects a plurality of medicines in an overlapping state, the second sensor 232 detects a plurality of medicines in a separated state, and thus the plurality of medicines from the discharge unit 131 are detected. It is possible to detect that is discharged at the same time.
　本発明の一実施形態に係る第１薬剤供給装置１０においては、制御部１１は、第１検出信号が入力されると、薬剤供給モジュール１００による薬剤の搬送方向を一時的に逆方向にする。これにより、排出部１３１から複数の薬剤が同時に排出されることを抑制することができる。 In the first drug supply device 10 according to the embodiment of the present invention, when the first detection signal is input, the control unit 11 temporarily causes the drug supply module 100 to reverse the drug transport direction. Accordingly, it is possible to prevent the plurality of medicines from being simultaneously discharged from the discharge unit 131.
　本発明の一実施形態に係る第１薬剤供給装置１０においては、制御部１１は、第１検出信号が入力されると、薬剤供給モジュール１００による薬剤の搬送を一時的に停止させる。このようにした場合にも、排出部１３１から複数の薬剤が同時に排出されることを抑制することができる。 In the first drug supply device 10 according to the embodiment of the present invention, the control unit 11 temporarily stops the drug delivery by the drug supply module 100 when the first detection signal is input. Even in this case, it is possible to prevent the plurality of medicines from being simultaneously discharged from the discharge portion 131.
　本発明の一実施形態に係る第１薬剤供給装置１０においては、制御部１１には、薬剤の形状に関する薬剤情報を有する薬剤情報信号が入力される。制御部１１は、第１検出信号が入力されると、薬剤情報に応じた薬剤供給モジュール１００の制御を行なう。上記のように、第１検出信号が入力された後、薬剤供給モジュール１００による薬剤の搬送を一時的に停止させる、または、薬剤供給モジュール１００による薬剤の搬送方向を一時的に逆方向にする、のいずれにするかを、薬剤情報に応じて制御部１１が決定する。また、制御部１１は、薬剤情報に応じて、一時停止させる時間または一時的に逆方向に搬送する時間を決定する。これにより、薬剤の種類に応じた態様で、排出部１３１から複数の薬剤が同時に排出されることを抑制することができる。 In the first drug supply device 10 according to the embodiment of the present invention, the control unit 11 receives a drug information signal having drug information related to the shape of the drug. When the first detection signal is input, the control unit 11 controls the medicine supply module 100 according to the medicine information. As described above, after the first detection signal is input, the drug supply module 100 temporarily stops the drug transfer, or the drug supply module 100 temporarily reverses the drug transfer direction. The control unit 11 determines which of the above is selected according to the drug information. In addition, the control unit 11 determines the time to temporarily stop or the time to temporarily convey in the opposite direction according to the drug information. Accordingly, it is possible to prevent a plurality of drugs from being simultaneously discharged from the discharging unit 131 in a mode according to the type of the drug.
　本発明の一実施形態に係る第１薬剤供給装置１０においては、制御部１１は、第１検出信号が入力される入力間隔中に第２検出信号が複数回入力されると、異常と判断する。これにより、排出部１３１から複数の薬剤が同時に排出された異常を検出することができる。 In the 1st chemical|medical agent supply apparatus 10 which concerns on one Embodiment of this invention, the control part 11 will judge with an abnormality, if a 2nd detection signal is input in multiple times during the input interval which a 1st detection signal is input. .. Accordingly, it is possible to detect an abnormality in which a plurality of drugs are simultaneously discharged from the discharge unit 131.
　なお、今回開示した上記実施形態はすべての点で例示であって、限定的な解釈の根拠となるものではない。したがって、本発明の技術的範囲は、上記した実施形態のみによって解釈されるものではなく、請求の範囲の記載に基づいて画定される。また、請求の範囲と均等の意味および範囲内でのすべての変更が含まれる。 The above-described embodiment disclosed this time is an example in all respects, and is not a basis for a limited interpretation. Therefore, the technical scope of the present invention should not be construed only by the embodiments described above, but should be defined based on the claims. Also, the meaning equivalent to the scope of claims and all modifications within the scope are included.
　１，３　軸線、２　回転方向、４　垂線、１０　第１薬剤供給装置、１１　制御部、１２　薬剤補充部、２０　第２薬剤供給装置、３０　第３薬剤供給装置、４１　主制御部、５０　操作パネル、９０　処方情報受付装置、１００　薬剤供給モジュール、１１０　回転体、１１０ｓ　斜面、１１１　第１回転部、１１１ｃ　第１凹条部、１１１ｇ　第１従動歯車、１１２　第２回転部、１１２ｃ　第２凹条部、１１２ｇ　第２従動歯車、１２０　蓋部材、１２１　第１周壁部、１２２　第２周壁部、１２３　第３周壁部、１２４　第１傾斜壁部、１２５　第２傾斜壁部、１２６，３４０　蓋部、１２７　薬剤供給孔、１２８　切欠部、１２９　取付部、１３０　排出部材、１３０ｂ　軸受部、１３１　排出部、１３２　立壁部、１４０　開閉部材、１４０ｂ，３４１ｈ　係合孔、１４０ｓ　回動軸、１４０ｔ　付勢部材、１４１　開閉部、１４２　薬剤止め部、１５０　支持部、１５１　水平面部、１５２　立設部、１５３　台部、１６０　振動伝達板、１７０　緩衝部材、２００　ベース部、２１０　第１駆動軸、２１１ｇ　第１駆動歯車、２１２ｇ　第２駆動歯車、２２０　排出シュート、２３１　第１センサ、２３２　第２センサ、２３３　容器検出センサ、２３４　識別センサ、２３５　薬剤検出センサ、２３６　モジュール検出センサ、２３７　開閉センサ、２３８　停止スイッチ、２４０　第２駆動軸、２５０　表示部、２６０　振動部、２７０　第１モータ、２７１　第２モータ、２７２　第３モータ、２７３　偏心モータ、２８１，２８２　ローラ部、２９０　接続管路、３００　薬剤収容容器、３１０　本体筒、３１２　螺旋溝、３１２ｅ　終端、３１３　第１開口部、３１４　第２開口部、３１５　周方向溝、３２０　円筒部、３３０　底部、３３０ｂ　底面、３３０ｃ　環状部、３３１　識別子、３３２　円板部、３４１　外蓋、３４１ａ　アーム部、３４２　内蓋、３４２ｃ　内蓋面、３４２ｈ　開口部、３４２ｐ　回動軸部、３４２ｓ　係合突起、４００　薬剤分包装置、４１０　筐体、４２０　回転ドラム、４２１　薬剤搬送路、４３０　ホッパ、４４０　薬剤包装装置ユニット、４５０　薬剤供給装置ユニット、４６０　制御装置ユニット。 1, 3 axis line, 2 rotation direction, 4 normal line, 10 first drug supply device, 11 control unit, 12 drug replenishment unit, 20 second drug supply device, 30 third drug supply device, 41 main control unit, 50 operation panel , 90 prescription information receiving device, 100 drug supply module, 110 rotating body, 110s slope, 111 first rotating part, 111c first recessed part, 111g first driven gear, 112 second rotating part, 112c second recessed part , 112 g second driven gear, 120 lid member, 121 first peripheral wall portion, 122 second peripheral wall portion, 123 third peripheral wall portion, 124 first inclined wall portion, 125 second inclined wall portion, 126,340 lid portion, 127 Drug supply hole, 128 cutout portion, 129 mounting portion, 130 discharge member, 130b bearing portion, 131 discharge portion, 132 standing wall portion, 140 opening/closing member, 140b, 341h engaging hole, 140s rotating shaft, 140t biasing member, 141 Opening/closing part, 142 drug stopper, 150 support part, 151 horizontal surface part, 152 standing part, 153 stand part, 160 vibration transmission plate, 170 cushioning member, 200 base part, 210 first drive shaft, 211g first drive gear, 212g 2nd drive gear, 220 discharge chute, 231, 1st sensor, 232 2nd sensor, 233 container detection sensor, 234 identification sensor, 235 drug detection sensor, 236 module detection sensor, 237 open/close sensor, 238 stop switch, 240 second Drive shaft, 250 display section, 260 vibrating section, 270 first motor, 271 second motor, 272 third motor, 273 eccentric motor, 281,282 roller section, 290 connection line, 300 drug container, 310 main body cylinder, 312 spiral groove, 312e end, 313 first opening, 314 second opening, 315 circumferential groove, 320 cylindrical part, 330 bottom, 330b bottom, 330c annular part, 331 identifier, 332 disc part, 341 outer lid, 341a arm portion, 342 inner lid, 342c inner lid surface, 342h opening portion, 342p rotating shaft portion, 342s engaging protrusion, 400 drug packaging device, 410 housing, 420 rotating drum, 421 drug transport path, 430 hopper, 440 drug packaging device unit, 450 drug supply device unit, 460 control device unit.

Claims (5)

  1. 　排出部を有し、該排出部に向けて薬剤を整列させつつ搬送し、前記排出部から前記薬剤を先頭から順に１つずつ排出して供給する薬剤供給部と、
    　前記排出部の外側の第１検出位置に前記薬剤が到達したことを検出したときに第１検出信号を出力する第１検出部と、
    　前記第１検出位置より前記薬剤供給部から離れた第２検出位置を前記薬剤が通過したことを検出したときに第２検出信号を出力する第２検出部と、
    　前記薬剤供給部を制御する制御部とを備え、
    　前記制御部は、前記第１検出部から前記第１検出信号を入力され、前記第１検出信号に応じて前記薬剤供給部を制御し、かつ、前記第２検出部から前記第２検出信号を入力され、前記第２検出信号に応じて前記薬剤供給部から供給された前記薬剤を計数する、薬剤供給装置。     A drug supply unit that has a discharge unit, conveys the drugs while aligning them toward the discharge unit, and discharges and supplies the drugs one by one from the discharge unit in order,
    A first detection unit that outputs a first detection signal when it is detected that the medicine has reached a first detection position outside the discharge unit;
    A second detection unit that outputs a second detection signal when it is detected that the medicine has passed a second detection position that is farther from the medicine supply unit than the first detection position;
    A control unit for controlling the drug supply unit,
    The control unit receives the first detection signal from the first detection unit, controls the drug supply unit according to the first detection signal, and outputs the second detection signal from the second detection unit. A medicine supply device that counts the medicines that have been input and supplied from the medicine supply unit according to the second detection signal.
  2. 　前記制御部は、前記第１検出信号が入力されると、前記薬剤供給部による前記薬剤の搬送を一時的に停止させる、請求項１に記載の薬剤供給装置。 The medicine supply device according to claim 1, wherein the control unit temporarily stops the conveyance of the medicine by the medicine supply unit when the first detection signal is input.
  3. 　前記制御部は、前記第１検出信号が入力されると、前記薬剤供給部による前記薬剤の搬送方向を一時的に逆方向にする、請求項１に記載の薬剤供給装置。 The drug supply device according to claim 1, wherein the control unit temporarily reverses a transportation direction of the drug by the drug supply unit when the first detection signal is input.
  4. 　前記制御部には、薬剤の形状に関する薬剤情報を有する薬剤情報信号が入力され、
    　前記制御部は、前記第１検出信号が入力されると、前記薬剤情報に応じた前記薬剤供給部の制御を行なう、請求項２または請求項３に記載の薬剤供給装置。     A drug information signal having drug information relating to the shape of the drug is input to the control unit,
    The drug supply device according to claim 2 or 3, wherein the control unit controls the drug supply unit according to the drug information when the first detection signal is input.
  5. 　前記制御部は、前記第１検出信号が入力される入力間隔中に前記第２検出信号が複数回入力されると、異常と判断する、請求項１から請求項４のいずれか１項に記載の薬剤供給装置。 5. The control unit according to claim 1, wherein when the second detection signal is input a plurality of times during an input interval in which the first detection signal is input, the control unit determines that there is an abnormality. Drug supply device.
PCT/JP2019/047822 2019-02-04 2019-12-06 Drug supply device WO2020162021A1 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
JP2019017965A JP7357327B2 (en) 2019-02-04 2019-02-04 drug supply device
JP2019-017965 2019-02-04

Publications (1)

Publication Number Publication Date
WO2020162021A1 true WO2020162021A1 (en) 2020-08-13

Family

ID=71948225

Family Applications (1)

Application Number Title Priority Date Filing Date
PCT/JP2019/047822 WO2020162021A1 (en) 2019-02-04 2019-12-06 Drug supply device

Country Status (2)

Country Link
JP (1) JP7357327B2 (en)
WO (1) WO2020162021A1 (en)

Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2013141130A1 (en) * 2012-03-21 2013-09-26 株式会社湯山製作所 Drug-supplying device and drug-counting device
JP2017169822A (en) * 2016-03-23 2017-09-28 株式会社湯山製作所 Pharmaceutical packaging apparatus and pharmaceutical alignment/discharge device

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP4070848B2 (en) * 1996-10-08 2008-04-02 高園産業株式会社 Substantially cylindrical article dispensing apparatus and substantially cylindrical article dispensing method
CN101795657B (en) * 2007-09-21 2013-04-24 克里腾株式会社 Dispenser of automatically distributing various shaped tablets in medicine packing machine and tablet dispensing method thereof
JP5950876B2 (en) * 2013-07-25 2016-07-13 株式会社トーショー Drug feeder

Patent Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2013141130A1 (en) * 2012-03-21 2013-09-26 株式会社湯山製作所 Drug-supplying device and drug-counting device
JP2017169822A (en) * 2016-03-23 2017-09-28 株式会社湯山製作所 Pharmaceutical packaging apparatus and pharmaceutical alignment/discharge device

Also Published As

Publication number Publication date
JP7357327B2 (en) 2023-10-06
JP2020124328A (en) 2020-08-20

Similar Documents

Publication Publication Date Title
US20170327255A1 (en) Cassette for drug packaging
JP7568337B2 (en) Drug Delivery Device
JP2007314203A (en) Tablet feeding apparatus
WO2020162021A1 (en) Drug supply device
WO2020162019A1 (en) Drug packaging device
JP4638793B2 (en) Tablet supply device and tablet supply method
JP7398838B2 (en) drug supply device
JP7470451B2 (en) Drug Delivery Device
JP7420414B2 (en) drug supply device
JP7357406B2 (en) drug supply device
JP7148961B2 (en) drug supply device
JP7193128B2 (en) drug supply device
WO2020162022A1 (en) Drug packaging device
JP2024033229A (en) Medicine sub-packaging device
JP2009023844A (en) Approximately cylindrical article put-out device
JP4243301B2 (en) Dispensing device for substantially cylindrical article

Legal Events

Date Code Title Description
121 Ep: the epo has been informed by wipo that ep was designated in this application

Ref document number: 19914386

Country of ref document: EP

Kind code of ref document: A1

NENP Non-entry into the national phase

Ref country code: DE

122 Ep: pct application non-entry in european phase

Ref document number: 19914386

Country of ref document: EP

Kind code of ref document: A1